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IHet schrijven van een doctoraat is als een lange reis, vol avonturen, met hoge 
toppen en diepe dalen. Het was wellicht de boeiendste reis van mijn leven, 
maar toch komt het einde nu in zicht. Dat einde gaat gepaard met gemengde 
gevoelens. Enerzijds ben ik blij en opgelucht dat ik het gehaald heb, anderzijds 
betekent het ook afscheid nemen van een fantastische periode. Toen ik aan 
dit doctoraat begon, had ik nooit durven denken dat ik hier vandaag in de 
Italiaanse zon dit laatste stukje van mijn thesis zou schrijven. Het leek altijd 
iets onmogelijk veraf. Daarom ben ik toch een beetje trots en vooral gelukkig 
dat ik het tot een goed einde gebracht heb. Wanneer ik vandaag terugblik, kan 
ik met een gerust hart vaststellen dat het een mooie tijd geweest is en kan ik 
met een tevreden gevoel een nieuwe start nemen. Dat was niet mogelijk ge-
weest zonder de hulp en steun van een heleboel mensen, die ik hiervoor wil 
bedanken. Ik probeer het kort te houden, maar je weet hoe dat gaat bij mij…
Mijn grootste dank gaat uit naar mijn promotor, professor Thierens, de bes-
te gids die ik me tijdens mijn doctoraatsreis kon voorstellen. Uw deur stond 
altijd open voor vragen, problemen, vondsten, bedenkingen… en dat werkte 
ook andersom. Ik kan de uren en dagen niet tellen die we in elkaars bureau 
doorbrachten, gebogen over moeilijke vraagstukken met naast ons een tas kof-
fie, die vaak al eens koud werd. Ons afscheid valt samen en we zullen beiden 
nieuwe wegen inslaan, maar ik ben er zeker van dat de verbondenheid blijft. U 
was mijn promotor en zoveel meer. Hetgeen ik van u geleerd heb, zal ik de rest 
It always seems impossible
Untill it’s done
— Nelson Mandela
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rd van mijn carrière verder proberen uitbouwen en als een mooie herinnering 
meenemen. Bedankt voor het vertrouwen, de leuke werksfeer, uw uitgebreide 
kennis, ervaring en de niet te onderschatten input in dit doctoraat! 
Ook mijn co-promotor, professor Bacher, moet hier zeker bedankt wor-
den. ‘Als we nu Charlot eens vragen of ze geïnteresseerd zou zijn in een doc-
toraat?’ Die vraag moet in het voorjaar van 2010 in het hoofd van Klaus zijn 
opgekomen. Intussen zijn we vijf jaar verder en is Klaus (meer dan verdiend) 
professor Bacher geworden. Hoewel het onderwerp van mijn doctoraat door 
omstandigheden sterk gedevieerd is, zal ik toch nooit vergeten dat je me als 
prille doctoraatsstudent inwijdde in de wereld van congressen, Europese mee-
tings en me meenam naar het Weense hoofdkwartier van het IAEA. Schitte-
rende ervaringen die me een zekere maturiteit gaven voor het vervolgverhaal 
van mijn doctoraat (en van Wenen mijn lievelingsstad in Europa maakten). 
Onderzoek doe je nooit alleen, een belangrijke les die ik tijdens mijn doc-
toraat leerde. Dit doctoraat was nooit gelukt zonder een paar zeer waardevolle 
samenwerkingen, waarvoor ik een heleboel mensen moet bedanken die me 
altijd met raad en daad bijgestaan hebben…
Hier wil ik in de eerste plaats professor Vral bedanken. Anne, jouw deur 
stond altijd voor mij open, ook ’s avonds laat wanneer de werkvloer al lang 
leeggelopen was. Jouw toewijding voor mijn onderzoek en waardevol advies 
betekenden een grote meerwaarde voor deze thesis. Ik wil je ook bedanken 
om me mee te nemen als ‘foci-verantwoordelijke’ naar de RENEB meetings. 
Ook al maakt biologische dosimetrie geen deel uit van dit doctoraat, ik heb 
er veel van opgestoken en ik heb ervaring opgedaan waar ik in mijn verdere 
carrière nog vaak op zal terugvallen. Een meer dan welgemeende bedankt 
voor de mogelijkheden die je me hebt gegeven en om er steeds voor mij te 
zijn! Naast Anne wens ik ook het volledige team van 6B3 te bedanken. Op het 
einde van mijn doctoraat heb veel tijd bij jullie in het labo doorgebracht. Naast 
het INW, kon ik me hier ook ‘thuis’ voelen en het was steeds een plezier bij jul-
lie te mogen vertoeven. Bedankt om me steeds met open armen te ontvangen, 
om me wegwijs te maken in jullie in labo’s en voor de vele PBS voorraden die 
aan mij werden opgeofferd. En ik kan deze passage niet laten passeren zonder 
mijn ‘radiobiologische maatjes’ Julie en Annelot in het bijzonder te bedanken. 
Jullie maakten vaak het verschil tussen ‘weekend’ of ‘geen weekend’! Ik kon 
altijd op jullie rekenen wanneer mijn labo agenda weer even niet haalbaar was 
om alleen te bolwerken. Een grote dankjewel daarvoor! De kers op de taart 
van dit doctoraat was toch wel ons congres in Japan, een onvergetelijke erva-
ring die ik samen met jullie kon beleven. Ook al zit ik aan de andere kant van 
de wereld, mijn deur staat altijd open en ik hoop jullie daar te zien!
Wie deze thesis helemaal leest (maar ik ben er me van bewust dat veel 
mensen na dit stukje zullen afhaken), zal de link met het Europees EPI-CT 
project al snel ontdekken. In the framework of this project, I wish to thank 
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my Biology colleagues for the wonderful meetings and the good atmosphere 
amongst us. Maria, Ute, Janet, Marie, Siamak, Carita and Eileen, it was great 
to be part of the team! Ausra and Daniel, thank you very much for your valua-
ble input for my first paper. A special thank you to Sarah and Hussein, our col-
laboration goes further than EPI-CT and I wish to thank you for all the nice 
moments we shared together. Hussein, it was always a pleasure to work with 
you and good to have you by my side during the meetings. It meant a lot to 
me! Sarah, thank you for your professionalism, enthousiasm, the interesting 
discussions and involving me in the project.
Het is absoluut niet gemakkelijk om iedereen in een paar zinnen te bedan-
ken die aan deze thesis heeft meegeholpen en dat geldt zeker voor het tweede 
artikel in dit doctoraat. Eerst en vooral wil ik de ouders en kindjes bedanken 
die meegewerkt hebben aan deze studie en die de bloedstalen wilden afstaan 
die onmisbaar en noodzakelijk waren voor dit onderzoek. Deze boodschap 
geldt trouwens voor alle vrijwilligers die bloed doneerden voor deze thesis. 
Zonder jullie was het allemaal niet mogelijk geweest! 
Bij het includeren van patiënten voor deze studie kreeg ik ondersteuning 
vanuit meerdere diensten. In Leuven gaat mijn dank eerst en vooral uit naar 
Dr. Luc Breysem die alle ouders persoonlijk opbelde om hen op de hoogte te 
brengen van de studie. Een ongeziene inspanning, die van deze studie een 
succesverhaal maakte in UZ Leuven. Daarnaast wens ik ook Hilde en Ilse be-
danken om alles in goede te banen te leiden wanneer ik in Leuven arriveerde, 
ook Walter en Herman voor het branden van de beelden. In UZ Brussel gaat 
mijn bewondering en dank uit naar Dr. Caroline Ernst. Caroline, bedankt 
voor je onophoudelijk enthousiasme bij je werk en je inzet voor deze studie. In 
AZ Sint-Jan gaat mijn dank uit naar twee artsen, enerzijds radioloog Dr. Kris 
Van De Moortele voor de inspanning om deze studie op te zetten in Brugge en 
anderzijds neonatoloog en pediatrisch cardioloog Dr. Wim Decaluwe en zijn 
nooit aflatende strijd voor elk druppeltje bloed en de toegewijde zorg voor 
elk patiëntje. In UZ Gent gaat mijn dank uit naar Dr. Peter Smeets en Dr. Nele 
Herregods, die ondanks het lage aantal pediatrische CT patiëntjes in UZ Gent 
steeds een inspanning leverden om rekrutering mogelijk te maken. Als laatste 
wens ik in AZ Sint-Lucas Dr. Adelard De Backer te bedanken. Uw interesse en 
motivatie maakten deze studie mogelijk in uw ziekenhuis. Mijn oprechte dank 
voor alle inspanningen en de tijd die u in deze studie investeerde.
Het laatste jaar nam dit doctoraat een interessante wending naar de im-
munologie, wat de basis vormde voor mijn derde artikel. Een insteek die ik te 
danken heb aan professor Jan Philippé. Het was een plezier om met u samen te 
werken! Een meer dan welgemeende dankuwel voor de vrijheid die u mij gaf 
in uw labo, uw interesse in mijn werk en de hulp bij de analyses. Mijn dank 
gaat hierbij ook uit naar Sofie en de rest van uw team, die me zovele keren 
hun flow cytometer in beslag lieten nemen en steeds hielpen bij al mijn vra-
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rd gen. En in dit immunologisch rijtje wens ik ook professor Bart Vandekerckhove 
uitdrukkelijk te bedanken, zonder hem was het hematopoïetische stamcel-
verhaal niet mogelijk geweest. Bedankt om uw ervaring en kennis met ons te 
delen! Hierbij wil ik ook graag Greet, Stijn, Yasmine, Katia en in het bijzonder 
Sophie bedanken. 
Een belangrijk deel van dit onderzoek gebeurde in samenwerking met 
mijn thesisstudenten. Ook zij hebben een belangrijke rol gespeeld voor mij en 
mogen hier dus zeker niet vergeten worden. Delphine, An, Veerle DP, Charlot-
te, Jeroen, Jan, Veerle T en Greet, jullie hebben prima werk geleverd en het was 
bijzonder aangenaam om elk van jullie te begeleiden tijdens jullie thesisjaren!
Plezier hebben in je werk is in grote mate afhankelijk van je werkomge-
ving. Een goede sfeer op een afdeling is essentieel en ik kan zeggen dat die 
sfeer fantastisch is op ons INW! Ik denk dat ik het jullie niet hoef te vertellen, 
maar ik zal met pijn in het hart vertrekken. ‘What happens in the salon, stays 
in the salon’ maar er zijn gelukkig nog heel wat zaken waarover ik wél kan 
schrijven in dit dankwoord.
 Gebouw N7 van het INW herbergt naast de medische fysica, ook de 
fysische controle, die in deze biotoop gezellig samenleven. Straling vormt ons 
raakvlak en ondanks het feit dat we niet rechtstreeks samenwerkten, had ik 
er de allerbeste collega’s. Myriam, bedankt voor de aangename babbels, het 
delen van jouw ervaring, ons geweldig congres in Manchester en de leuke 
zwempauzes. Levi, bedankt om me terug aan te zetten tot frisbeeën (ook al 
was het van korte duur) en om ons vrouwenteam menigmaal als enige man te 
vervoegen! Lothar, je bent toegekomen tijdens de drukste periode van mijn 
doctoraat, maar ik had de kans je te leren kennen als een behulpzame en en-
thousiaste collega, die meteen leek te passen in ons team. Nancy, bedankt voor 
het geduld met mijn dosimeters, jouw grapjes en het feit dat je mijn naam 
nooit vergat! Als laatste fyco-lid wil ik zeker en vast Isabelle bedanken; voor 
het organiseren van de verjaardagslunchen, de cadeautjes en zoveel meer. Bo-
venal wil ik jou bedanken voor het luisteren, jouw dagelijks enthousiasme, 
reiservaringen en de hulp bij alles waar nodig!
Bij de medische fysica, wil ik beginnen bij de lieve Virginie waar geen en-
kele doctoraatsstudent in ons labo omheen kan. Ik weet niet hoe ik je kan 
bedanken voor alles wat je tijdens mijn doctoraat voor mij betekend hebt. Je 
hebt me zo vaak uit de nood geholpen, leefde met alle gebeurtenissen mee en 
ik kon voor alles bij jou terecht. Ik kan alleen maar zeggen dat ik heel blij ben 
dat jij er bent! Liesbeth en An, ik ben de laatste in ons rijtje van 2015 om mijn 
doctoraat af te ronden. Ontzettend bedankt om me door deze periode heen 
te helpen. Maar ook los van thesisraad, wil ik jullie vooral bedanken voor 
de goeie babbels, die lang niet altijd over het werk moesten gaan. Liesbeth 
ook voor de rust in de soms alomtegenwoordige chaos, en An voor de liften 
Vnaar Aalter en de band die ons geboortedorp toch wel tussen ons schiep. An 
DH, alhoewel we nooit rechtstreeks moesten samenwerken, zat je nooit veraf. 
Bedankt voor de grappige momenten en je creatieve inbreng bij elk origineel 
cadeau! Kim, al zat jij dan wat verder weg, je hebt mijn middagpauzes vanaf 
mijn eerste dag op het INW weten op te fleuren. Bedankt om mijn studenten 
op te vangen wanneer nodig, voor jouw ervaring en voor de vele goede bab-
bels. Dimi en Chamberlain, bedankt om het testosterongehalte terug op pijl 
te brengen onder de doctoraatsstudenten en voor jullie enthousiaste bijdrage 
tijdens elke salonparty. Régine, ook al ‘woon’ je officieel niet bij ons in N7, 
ik heb jou altijd als een van ons beschouwd. Bedankt voor alle wijze raad 
en hulp tijdens mijn kort assistent-intermezzo. Ook de collega’s waarmee ik 
maar kort kon samenwerken, verdienen een welgemeende dankjewel. Joke en 
Laurence, bedankt om voor mij het ‘foci-pad’ te effenen! En Nele voor het 
ter hulp springen bij elk computerprobleem. En dan is het de beurt aan mijn 
‘Duinrell-besties’! Bedankt voor alle leuke momenten die we samen beleef-
den! Mijn bureaugenootje Lore, jouw optimisme heeft menige dagen gered. 
Ik wil je bedanken voor al je steunende woorden, het vele luisteren en jouw 
uitmuntend talent als binnenbureau-architect. Ik wens je veel succes met alles 
wat in de toekomst komen zal, maar ik weet dat je het fantastisch goed gaat 
doen. We waren een goed team! Caro, ondanks de soms vreemde robotachtige 
(en andere) interesses, zeker een ingenieur met laag ‘nerd-gehalte’. Bedankt 
om altijd precies die grapjes of opmerkingen te maken die mijn dag opfleur-
den. En Sofie, al even bij ons weg, maar nooit vergeten! Bedankt om niet al-
leen mijn biologiemaatje te zijn, maar ook mijn wijze raadgever op de juiste 
momenten. Je wordt nog steeds gemist op het INW. And I would like to end 
this paragraph with a special thank you to my dear colleague and friend Nati. 
I still regret the fact that I couldn’t spend more time with you during my most 
tough PhD months. I can’t thank you enough for your optimism, the patience 
to read and correct my thesis, your support in the lab and so much more! 
Het doctoraat was vaak zeven dagen op zeven werken, maar toch slaag-
den een aantal mensen er in om mijn drukke dagen op te fleuren. Familie en 
vrienden mogen daarom in dit dankwoord niet ontbreken. 
Mijn biomedische en ‘kanker-straling’ maatjes, sommigen van jullie zitten 
er ook midden in en weten als geen ander hoe het leven tijdens een doctoraat 
kan zijn. Bedankt voor het luisteren en het begrip! Ik bijt de spits af en ben er 
zeker van dat jullie het allemaal nog zoveel beter zullen doen! De boog moest 
gelukkig niet altijd gespannen staan en daar zorgden de kerstfeestjes, etentjes 
en wandelingen voor. Ook de niet-doctorandi mogen zeker niet vergeten wor-
den, een grote dankjewel om ons ‘gezaag’ te aanhoren en ons ook in te wijden 
in jullie minstens even interessante leef- en werkwereld. En hier verdient Iris 
toch een extra woord van dank. We hadden het geluk om in de eerste jaren 
van mijn doctoraat onze vriendschap zowel tijdens als buiten de werkuren 
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rd te beleven. Dat leek soms te mooi om waar te zijn en op een dag heb je de 
moeilijke knoop moeten doorhakken om toch voor jouw onderwijsdroom 
te kiezen. Ik heb je altijd bewonderd in die keuze en ben blij jou vandaag en 
de voorbije jaren zo gelukkig te zien. Daarnaast heb je mij onrechtstreeks de 
kans gegeven om ook mijn juiste weg in te slaan, deze van de radiobiologie, 
waarvoor ik ontzettend dankbaar ben. Ik wens je heel veel succes met alles wat 
komen zal en ben zo fier op jouw twee kleine meisjes!
De ‘Supporters van de Liefde’ die een paar jaar geleden als een toevallig 
samenraapsel van vrienden ontstonden, maar vandaag niet weg te denken zijn 
uit mijn Gentse leven. Merci voor alle leuke momenten, toffe feestjes en de 
vriendschap! Jonas (of Jones of Chippie) voor jou een bijzondere dankjewel 
om de uitdaging aan te gaan om van dit doctoraat een mooi boekje te maken! 
Dat was me zelf nooit gelukt!
De ‘Mestfest club’, een vrolijke bende die me drie jaar geleden meteen als 
een van hen beschouwde. De onvergetelijke Mallorca reis, babyborrels, trouw-
feesten en urenlange babbels na (of tijdens) de basketmatchen, vormden wel-
gekomen pauzes tijdens mijn doctoraat.
En dan mijn lieve vriendinnen, er is helaas geen plaats om voor elk van 
jullie een paragraaf te schrijven. Ik wil jullie ontzettend bedanken voor alle 
steun de voorbije jaren. De zalige vakanties, de pauzes in Londen, de leuke 
trouwfeesten, de ontspannende etentjes, wandelingen, sportintermezzo’s en 
de vele peptalks... het lijstje is eindeloos. Jullie zijn stuk voor stuk fantastisch! 
Toch verdient er eentje een speciale vermelding in dit dankwoord. Mijn liefste 
Hanna, er zullen nooit genoeg woorden zijn om uit te drukken hoe ik jou be-
wonder. Als het donker genoeg is, worden échte sterren zichtbaar. Je bent voor 
elk van ons een inspiratie om ervoor te gaan in ons leven, onze dromen na te 
jagen, maar ook op tijd stil te staan en te genieten. Daar moet ik nog elke dag 
aan werken, maar jij hebt me zoveel geleerd. En die herinnering is, zoals Lene 
en ik met een glimlach en in koor zouden zeggen, voor altijd!
Na de vrienden, komt de familie die er op hun beurt voor zorgden dat ik 
de stress van het doctoraat even kon afwerpen en me de kans gaven om in een 
rustige, ontspannen omgeving te vertoeven.
Eerst en vooral mijn ouders. Ik denk dat ik in alle eerlijkheid kan zeggen 
dat dit proefschrift er niet had gelegen als jullie er niet waren geweest. Papa, 
jij weet als geen ander hoe je me moet stimuleren om datgene te doen wat 
gedaan moet worden en mijn gedachten te ordenen in tijden van chaos, hoe 
hard ik me er ook soms tegen verzet! Bedankt voor alle wijze raad en het 
feit dat ik altijd op jou kon steunen (wat soms leunen was). Mama, jou wil 
ik bedanken voor jouw onvoorwaardelijke toewijding, de zorgende hand die 
meermaals nodig was en de opvang in tijden van crisis. Altijd vol liefde en 
vertrouwen. Een moederhart zoals er geen ander in de wereld bestaat!
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Mijn drie knappe broers en mijn fantastische zus. Wanneer ik over jullie 
spreek, begin ik meteen te glimlachen. Als wij samen zijn, is het altijd plezier! 
Bedankt om mij altijd op te beuren, te luisteren en er gewoon te zijn. Ik ben 
een trotse grote zus!
Ook mijn grootouders mogen niet ontbreken. Opa, jouw wijsheid en ken-
nis ondervinden geen leeftijdsgrenzen. Ik hoop dat ik jouw leergierigheid en 
interesses even lang mag meedragen. En in dit rijtje mag mijn lieve oma Roza 
zeker niet ontbreken. Je bent er altijd voor ons en koestert ons als échte schat-
ten. Bedankt voor alle bemoedigende, lieve oma-knuffels en de honderden 
kaarsjes die je tijdens mijn unief periode hebt moeten branden. Ze hebben 
hun werk goed gedaan!
En dan had ik het geluk om tijdens deze doctoraatsperiode één iemand 
te leren kennen, die intussen zoveel meer is dan een vriend of familielid. Het 
leukste aan elke dag is ’s avonds thuiskomen, bij mijn Thomas. Hij gelooft in 
mij en zie hier, het is me gelukt! Zonder enig bezwaar werd je mee onderge-
dompeld in de wereld van de straling, leerde je leven met mijn onvoorspelbaar 
werkschema, luisterde je ’s avonds laat nog uren naar mijn hersenspinsels en 
daagde je me uit voor een spelletje Carcasonne als het me even teveel werd. In 
dit dankwoord verdienen ook jouw ouders, Ann en Frank, zeker en vast een 
plekje. Jullie Italiaanse gastvrijheid kent geen grenzen en zorgde meermaals 
voor een welgekomen adempauze. Thomas, nadat de voorbije jaren vooral in 
het teken stonden van mijn doctoraat, ben ik vandaag vooral blij dat we ein-
delijk meer tijd zullen hebben om te genieten. En aan ons avontuur in Zuid-
Afrika te beginnen!
Charlot
September 2015
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Computed Tomography (CT) is the examination with the largest contribution 
in dose to the medical diagnostic dose burden in Belgium (55.72%), while 
only 11% of the 16.4 million radiological procedures each year are CT scans 
(1). Furthermore, the annual frequency of medical examinations per caput 
in Belgium is relatively high compared with neighbouring countries. Belgian 
inhabitants receive more than 3 times the average medical radiation dose per 
caput compared to the Netherlands (2). Without any doubt the introduction 
of CT has tremendously improved diagnostic imaging. However, the high x-
ray doses have raised serious health concerns, especially for the radiosensitive 
paediatric patient population. It is generally anticipated that children have a 
higher radiation sensitivity compared to adults regarding ionizing radiation 
(IR) induced malignancies and the associated risk for exposure induced death 
(3). The subject of this PhD dissertation is to assess the health effects of IR ex-
posure in children by using biomarkers of exposure. Within this PhD thesis, 
special attention is paid to the induction of deoxyribonucleic acid double-
strand breaks (DNA DSBs) by CT x-rays in children since these lesions have a 
proven relevance for radiation-induced health effects.
The first part of this PhD dissertation outlines why children are the most 
important target group in medical radiation protection. The susceptibility of 
children to the effects of IR has been a focus of interest for over half a century. 
Compared to adults tissues and organs of children are growing and develop-
ing, which makes them more sensitive to radiation effects since they contain a 
larger proportion of stem cells and growing cells. Furthermore, children have 
a longer life expectancy compared to adults, in which the potential oncogenic 
effects associated with IR exposure can appear. Chapter 1 gives an overview of 
the current epidemiological data to illustrate the age dependency of radiation 
sensitivity. Special attention is given to Annex B of the recent United Nations 
Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) 2013 
report ‘Effects of radiation exposure of children’ (3). Since several epidemio-
logical studies show a strongly increased risk in both incidence and mortality 
of leukaemia after IR exposure in childhood, this chapter also describes the 
functional hierarchy of haematopoiesis and haematopoietic stem and progen-
itor cells (HSPCs) as potential target cells for radiation-induced leukaemo-
genesis. In chapter 2, we describe the medical radiation burden in Belgium 
and the issues related to CT imaging in children. Furthermore, an overview 
is given of epidemiological studies dealing with leukaemia and cancer risks 
related to CT x-ray exposure of children. However, the characterization of 
health effects of IR at low dose levels, as used in CT imaging, remains a chal-
lenge due to the statistical uncertainties associated with the small excess num-
ber of cases at low doses. Special emphasis is given to the ongoing European 
FP7 project, EPI-CT, which will offer opportunities to better address the cur-
rent limitations. In this project it is also anticipated that significant insights 
Xwill emerge from radiation biomarker studies, which will shed new light on 
the cellular and molecular responses at low doses. The latter approach was 
used in this PhD dissertation and chapter 3 gives an overview of the cellular 
and molecular mechanisms involved in the DNA damage response. Several 
biomarkers of exposure are discussed, which are available at a certain time 
point after IR exposure and can be used to validate a correlation between ex-
posure and biological response. For this PhD research, the phosphorylated 
histone subtype H2A isoform X (γ-H2AX) foci assay was used as a sensitive 
biomarker for radiation-induced DNA DSBs, and the micronucleus (MN) as-
say to determine the mutagenic effects of IR exposure. The first part ends with 
the aim (chapter 4) and outline (chapter 5)of the PhD research.
The second part of the PhD thesis consists of the original research, pre-
sented in three scientific papers. Chapter 6 presents a paper in the framework 
of the EPI-CT project. We performed a series of in vitro feasibility experi-
ments to optimise the γ-H2AX foci assay to use it as an exposure biomarker 
in a prospective multicentre paediatric radiology setting. This comprised the 
critical evaluation of a number of ethical and technical hurdles related to bio-
logical sample collection in a paediatric radiology setting (small blood sample 
volume), processing and storing of blood samples (effect of storing blood at 
4°C), the reliability of foci scoring for low-doses by using merge γ-H2AX/p53 
binding protein 1 (53BP1) scoring), as well as the impact of contrast agent 
administration as potential confounding factor. In order to evaluate the fea-
sibility of pooling the γ-H2AX data when different centres are involved in an 
international multicentre study, two intercomparison studies in the low-dose 
range (10-500 mGy) were performed. The results demonstrate that it is feasible 
to apply the γ-H2AX foci assay as a cellular biomarker of exposure in an inter-
national multicentre prospective study of paediatric CT imaging after valida-
tion in an in vivo pilot study. The second paper, presented in chapter 7, shows 
the results of a prospective multicentre study in Belgium in which we used the 
optimised γ-H2AX foci assay to determine the number of x-ray induced DNA 
DSBs in children undergoing a chest or abdomen CT examination. In order to 
estimate the lifetime attributable risk (LAR) of cancer incidence and mortality 
associated with the paediatric CT examinations, the Biological Effects of Ion-
izing Radiation (BEIR) VII risk model was used. To this end patient specific 
blood doses and organs doses were calculated based on the individual patient 
CT images by using ImpactMC simulation software 1.3.1. Plotting of the in 
vivo induced γ-H2AX foci versus the calculated blood dose indicated a low-
dose hypersensitivity, which was supported by an in vitro dose response study 
on umbilical cord blood. Furthermore, differences in patient dose levels be-
tween radiology centres were reflected in differences in DNA damage. The lat-
ter observations emphasize the importance of dose reduction techniques and 
should encourage medical practitioners to maximize the benefit-to-risk ratio 
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of paediatric CT imaging. The study indicated also a diminishing trend of the 
foci-to-dose ratio versus age, however, this age dependency was not statistical 
significant. In a third paper, presented in chapter 8, we investigated further 
the age dependency in radiosensitivity of children compared to adults. To this 
end we compared the residual γ-H2AX/53BP1 foci numbers and chromo-
somal radiosensitivity at cellular level in T-lymphocytes of newborns (umbili-
cal cord blood) and adult volunteers. Newborn T-lymphocytes showed signif-
icantly higher residual foci yields 24 h post-irradiation and a higher number 
of radiation-induced MN. T-lymphocytes of newborns are practically all phe-
notypically immature. Since these cells are characterised by a closed chroma-
tin structure, this could be an underlying mechanism of the observed higher 
radiosensitivity of newborns compared to adults. This was confirmed by a 
comparative study of radiation-induced residual foci and MN in isolated na-
ive (CD45RA+) and memory (CD45RO+) T-lymphocytes of adults. The results 
of paper 3 suggest that the observed differences in radiosensitivity between 
newborn and adult T-lymphocytes can be explained by the immunopheno-
typic change of T-lymphocytes with age. Since radiation-induced leukaemia is 
one of the most prominent malignancies with an apparent higher excess risk 
among those exposed at young ages, studies of the DNA damage response and 
outcome of HSPCs after IR exposure are warranted. In our third paper, we 
could show that a significantly lower number of residual foci was observed in 
newborn Cluster of Differentiation (CD)34+ HSPCs compared to newborn T-
lymphocytes. Together with the high number of radiation-induced MN, these 
results could suggest that HSPC quiescence promotes mutagenesis after IR 
exposure.
The third part presents a general discussion of the results of this PhD dis-
sertation. Chapter 9 addresses the in vitro and in vivo low dose hypersensitiv-
ity observed in the γ-H2AX foci study on paediatric patients undergoing a 
CT examination (paper 2). The results of the current study are compared with 
a previous study of our research group on paediatric patients undergoing a 
cardiac catheterisation (4) and other biomarker studies in paediatric diagnos-
tic radiology. The in vivo biomarker data illustrate the necessity of reduction 
of the CT related x-ray dose for paediatric patients. In this framework the 
plea to “Image Gently” is further explained. The bystander effect, a possible 
underlying mechanism of the observed dose response behaviour, is also dis-
cussed in this chapter. The high radiosensitivity of HSPCs and the potential 
trigger to develop radiation-induced leukaemia are discussed in chapter 10. 
This chapter elucidates that the comparison of murine and human data is not 
that straightforward and several issues need to be addressed as e.g. the impact 
of the niche before we can extrapolate the in vitro results to an in vivo situa-
tion. In chapter 11, we discuss the observed difference in radiosensitivity be-
tween newborns and adults. The observed differences in chromosomal radio-
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sensitivity and residual DNA damage in naive and memory T-lymphocytes 
indicate that the immunophenotypic profile of the lymphocytes can explain 
the higher radiosensitivity of newborn compared to adult. In view of these 
findings we discuss differences in chromatin condensation as a hallmark for 
age dependency in radiation effects. The final conclusions of this PhD disser-
tation are presented in chapter 12, which should encourage the medical field 
to reduce the radiation burden of paediatric patients and create awareness 
to “Image Gently”. The results of this PhD dissertation allow a better under-
standing of the health consequences of low dose exposure in children, as used 
in medical diagnostic applications. Some future perspectives resulting from 
the scientific work performed are described in chapter 13. Further research 
is needed 1) to have a better understanding of the low dose hypersensitivity 
observed in the paediatric CT study; 2) to elucidate differences in radiosensi-
tivity between primitive HSCs and lineage-committed progenitors; and 3) to 
study the chromatin structure of naive and memory lymphocytes in order to 
gain more insight in the role of chromatin condensation on the observed age 
dependency in radiosensitivity.
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Ondanks het feit dat CT onderzoeken slechts 11% uitmaken van de 16,4 
miljoen radiologische onderzoeken die jaarlijks plaatsvinden in België, vor-
men ze toch de belangrijkste bijdrage in stralingsbelasting door medische 
diagnostiek (55,72%) (1). Daarenboven is het aantal medisch diagnostische 
onderzoeken per inwoner in België relatief hoog in vergelijking met onze 
buurlanden. De gemiddelde medische stralingsbelasting per inwoner is 3 keer 
hoger in België dan in Nederland (2). Desondanks de hoge stralingsbelasting, 
bestaat er geen twijfel dat de introductie van CT de diagnostische beeldvor-
ming enorm verbeterd heeft. Het wordt algemeen aangenomen dat kinderen 
gevoeliger zijn voor de negatieve effecten van ioniserende straling (IS), met 
name kankerinductie en mortaliteit, in vergelijking met volwassenen (3). Net 
daarom vormen zij een groep die vanuit stralingsbeschermingsoogpunt extra 
aandacht verdient. Het doel van dit doctoraatsonderzoek was dan ook om met 
behulp van biomerkers de gezondheidsrisico’s voor kinderen, veroorzaakt 
door blootstelling aan IS, te kwantificeren op DNA niveau. In dit doctoraat 
werd specifiek aandacht geschonken aan de inductie van DNA dubbelstreng-
breuken (DSB) door CT x-stralen blootstelling bij kinderen aangezien deze 
lesies zeer relevant zijn in het kader van stralingsgeïnduceerde gezondheids-
risico’s.
In het eerste deel van dit proefschrift wordt toegelicht waarom kinderen 
zo’n belangrijke groep vormen in de medische stralingsbescherming. De 
hoge stralingsgevoeligheid van kinderen vormt al ettelijke decennia een be-
langrijke focus voor onderzoek. Vergeleken met volwassenen zijn de weefsels 
en organen van kinderen volop in groei en ontwikkeling, waardoor ze een 
grotere fractie aan stamcellen en delende cellen bevatten, wat ze gevoeliger 
maakt voor stralingseffecten. Daarnaast hebben kinderen een langere levens-
verwachting in vergelijking met volwassenen, wat resulteert in een langere 
tijdspanne waarin de potentieel oncogene effecten ten gevolge van stralings-
blootstelling tot uiting kunnen komen. Hoofdstuk 1 geeft een overzicht van 
de huidige epidemiologische data om de leeftijdsafhankelijkheid in stralings-
gevoeligheid te illustreren. Er wordt hierbij extra aandacht gegeven aan An-
nex B van het recente UNSCEAR 2013 rapport ‘Effects of radiation exposure 
of children’ (3). Omdat verscheidene epidemiologische studies een sterke stij-
ging tonen in het risico op leukemie ten gevolge van een stralingsblootstelling 
als kind, voor zowel incidentie als mortaliteit, werd in dit hoofdstuk ook de 
functionele hiërarchie van hematopoiese beschreven en de hematopoietische 
stam- en progenitorcellen (HSPC) als potentiële targetcellen voor stralingsge-
induceerde leukemogenese. In hoofdstuk 2 wordt de medische stralingsbe-
lasting in België besproken en de problematiek rond CT beeldvorming voor 
kinderen. Daarnaast wordt er een overzicht gegeven van de recente epidemio-
logische studies op leukemie en kankerrisico’s door CT x-stralen blootstelling 
bij kinderen. Toch blijven dergelijke studies moeilijk door de grote statistische 
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onzekerheid op het aantal gevallen bij lage dosis blootstelling. In dit hoofd-
stuk wordt extra aandacht gegeven aan het Europees FP7 project, EPI-CT, dat 
waarschijnlijk nieuwe opportuniteiten zal bieden om de huidige beperkingen 
bij epidemiologische studies op kinderen die een CT onderzoek ondergaan 
te reduceren. Er wordt verwacht dat ook biomerker studies waardevolle in-
formatie zullen opleveren over de cellulaire en moleculaire effecten van lage 
dosis blootstellingen. Deze manier van werken werd dan ook toegepast in 
dit doctoraatsonderzoek en hoofdstuk 3 geeft een overzicht van de cellulaire 
en moleculaire mechanismen die betrokken zijn in de DNA schade respons. 
Verschillende biomerkers worden besproken die kunnen gebruikt worden om 
stralingsblootstelling te detecteren en meer informatie te verschaffen over de 
dosis-effect relatie. In dit doctoraatsonderzoek werd gebruikt gemaakt van de 
gevoelige γ-H2AX foci techniek voor de detectie van DNA DSB na stralings-
blootstelling en de micronucleus (MN) assay om de mutagene effecten van IS 
bloostelling te bepalen. Het eerste deel van dit proefschrift wordt afgesloten 
met de doelstelling en de uitwerking van dit doctoraatsonderzoek, in hoofd-
stuk 4 en 5 respectievelijk.
Het tweede deel van deze thesis bestaat uit drie wetenschappelijke artikels 
resulterend uit het doctoraatsonderzoek. Hoofdstuk 6 stelt een studie voor 
die uitgevoerd werd in het kader van het Europees EPI-CT project. Er werden 
een aantal in vitro experimenten uitgevoerd om de γ-H2AX foci techniek te 
optimaliseren voor gebruik als biomerker bij lage dosis bloostelling in een 
prospectieve multicenter studie in pediatrische radiologie. Dit deel omvat 
een kritische evaluatie van een aantal ethische en technische moeilijkheden 
gekoppeld aan onder meer bloedafname in een pediatrische setting (kleiner 
volume van de bloedstalen), het verwerken en bewaren van de bloedstalen 
(effect van bewaring op 4°C), de betrouwbaarheid van foci scoring voor lage 
dosis blootstellingen (dubbele γ-H2AX/53BP1 immuunkleuring), alsook de 
impact van de contrastvloeistof op γ-H2AX foci inductie. Om na te gaan of 
het mogelijk zou zijn om de γ-H2AX foci data van verschillende onderzoeks-
instellingen samen te voegen in een internationale multicenter studie wer-
den er twee vergelijkende studies uitgevoerd in het lage dosis gebied (10-500 
mGy). De resultaten van deze in vitro studie tonen aan dat het mogelijk is om 
de γ-H2AX foci techniek te gebruiken als een lage dosis biomerker in een 
internationale multicenter studie, na validatie in een in vivo pilootstudie. Een 
tweede artikel in hoofdstuk 7, stelt de resultaten voor van een prospectieve 
multicenter studie in België. Hierbij werd de geoptimaliseerde γ-H2AX foci 
techniek gebruikt om het aantal x-stralen geïnduceerde DNA DSB te bepa-
len in lymfocyten van kinderen die een CT thorax of abdomen onderzoek 
ondergingen in één van de deelnemende centra. Het BEIR VII risicomodel 
werd gebruikt om het lifetime attributable risk (LAR) op kanker incidentie en 
mortaliteit te bepalen voor de pediatrische patiënten die opgenomen werden 
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in de studie. Hiervoor werden patiënt specifieke bloed- en orgaandosissen 
berekend op basis van de CT beelden van de individuele patiënt met behulp 
van de ImpactMC simulatie software 1.3.1. Wanneer de in vivo γ-H2AX foci 
resultaten uitgezet werden ten opzichte van de berekende bloeddosiswaarden 
werd een lage dosis hypersensitiviteit waargenomen. Deze hypersensitiviteit 
werd bevestigd door een in vitro dosis respons studie op navelstrengbloed. De 
onderlinge verschillen in patiëntdosisniveaus tussen de deelnemende zieken-
huizen waren ook te zien in de overeenkomstige DNA schade. Deze bevindin-
gen benadrukken het belang van dosisreductie technieken en moeten artsen 
en medisch personeel aansporen tot justificatie en optimalisatie van CT scans 
voor kinderen. De studie wees ook op een daling van de foci-versus-dosis ver-
houding met de leeftijd van de patiënten. Helaas was deze trend in leeftijdsaf-
hankelijkheid niet statistisch significant. In een derde artikel dat voorgesteld 
wordt in hoofdstuk 8, gaat het onderzoek dieper in op de leeftijdsafhankelijk-
heid in radiosensitiviteit van kinderen in vergelijking tot volwassenen. Hier-
voor werden het aantal residuele γ-H2AX/53BP1 foci 24 u na blootstelling 
bepaald alsook de chromosomale gevoeligheid met behulp van de MN assay 
in T-lymfocyten afkomstig van pasgeborenen (navelstrengbloed) en volwas-
senen. De T-lymfocyten van de pasgeborenen vertoonden een significant ho-
ger aantal residuele foci en stralingsgeïnduceerde MN. De T-lymfocyten van 
pasgeborenen zijn bijna allemaal fenotypisch immatuur. Deze status wordt 
gekenmerkt door een gesloten chromatine structuur, wat een onderliggende 
oorzaak zou kunnen zijn voor de waargenomen hogere stralingsgevoeligheid 
van pasgeborenen in vergelijking met volwassenen. Dit werd bevestigd in 
een vergelijkende studie naar de stralingsgevoeligheid van geïsoleerde naïeve 
(CD45RA+) en memory (CD45RO+) T-lymfocyten afkomstig van volwasse-
nen, waar opnieuw een hoger aantal residuele foci en MN werden waarge-
nomen in naïeve T-lymfocyten. De resultaten van dit derde artikel suggere-
ren dat het waargenomen verschil in stralingsgevoeligheid van T-lymfocyten 
tussen pasgeborenen en volwassenen zou kunnen verklaard worden door de 
immunofenotypische veranderingen van T-lymfocyten met de leeftijd. Aan-
gezien stralingsgeïnduceerde leukemie één van de meeste prominente ma-
ligniteiten is met een duidelijke leeftijdsafhankelijkheid in radiosensitiviteit, 
werden er in dit doctoraatsonderzoek ook in vitro studies uitgevoerd naar 
de respons op DNA schade en de uitkomst na stralingsgeïnduceerde DNA 
schade in HSPC. De resultaten worden voorgesteld in het derde artikel, waar 
een significant lager aantal residuele foci werd waargenomen in de CD34+ cel-
len in vergelijking met de T-lymfocyten van pasgeborenen. Daarnaast werd 
er ook voor CD34+ cellen een hoog aantal stralingsgeïnduceerde MN terug-
gevonden. Deze resultaten suggereren dat de ‘quiescence’ van HSPC mogelijk 
mutagenese kan promoten na stralingsblootstelling.
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Het derde deel van de doctoraatsproefschrift omvat een algemene discus-
sie. In hoofdstuk 9 lichten we de in vitro en in vivo lage dosis hypersensitiviteit 
verder toe, die geobserveerd werd in de γ-H2AX foci studie op pediatrische 
patiënten die een CT onderzoek ondergingen. De resultaten van de huidige 
studie worden vergeleken met een voorgaande studie van onze onderzoeks-
groep waar deze hypersensitiviteit ook geobserveerd werd bij kinderen die 
een hartkatheterisatie ondergingen (4). De in vivo biomerker resultaten illus-
treren het belang van CT dosisreductie voor pediatrische patiënten. Daarom 
wordt in de hoofdstuk de “Image Gently” campagne toegelicht. Het bystander 
effect wordt gezien als een mogelijk onderliggend mechanisme voor de geob-
serveerde hypersensitiviteit en wordt in dit hoofdstuk ook verder toegelicht. 
De hoge radiosensitiviteit van HSPC, wat een potentiële trigger kan zijn voor 
het ontstaan van stralingsgeïnduceerde leukemie, wordt besproken in hoofd-
stuk 10. Verder komt in dit hoofdstuk ook naar voor dat de vergelijking tussen 
resultaten bekomen met HSPC van muizen en mensen niet altijd zo eenvou-
dig is en dat de projectie van in vitro naar in vivo situaties met o.a. de im-
pact van de “niche” nog verder onderzoek vereist. In hoofdstuk 11 wordt het 
verschil in stralingsgevoeligheid tussen pasgeborenen en volwassenen verder 
besproken. Het verschil in chromosomale stralingsgevoeligheid en residuele 
DNA schade op cellulair niveau tussen naïeve en memory T-lymfocyten wijst 
erop dat het immunofenotypisch profiel van de lymfocyten een rol speelt in 
het waargenomen verschil in stralingsgevoeligheid tussen pasgeborenen en 
volwassenen. Daarom gaat dit hoofdstuk verder in op het verschil in chroma-
tine condensatie als mogelijke verklaring voor de leeftijdsafhankelijkheid van 
stralingseffecten. De finale conclusies van dit doctoraatsproefschrift worden 
voorgesteld in hoofdstuk 12. De resultaten bekomen in dit proefschrift voor 
lage dosis blootstelling van kinderen moeten de medische wereld aansporen 
om de stralingsbelasting van kinderen verder te reduceren en de “Image Gent-
ly” principes in acht te nemen.. Een aantal mogelijke toekomstperspectieven 
die voortvloeien uit dit onderzoek worden aangehaald in hoofdstuk 13. Ver-
der onderzoek is nodig om 1) de lage dosis hypersensitiviteit beter in kaart te 
brengen en te begrijpen; 2) het verschil in stralingsgevoeligheid tussen de pri-
mitieve HSC en de progenitorcellen te ontrafelen; en 3) de chromatine struc-
tuur van naïve en memory lymfocyten beter te kennen zodat we meer inzicht 
krijgen in de rol van de chromatine structuur in de leeftijdsafhankelijke stra-
lingsgevoeligheid.
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Since its discovery, x-rays have become an indispensable tool in current 
medical practice. However, ionizing radiation (IR) is a known carcinogen 
and we need to weight the benefits against the cancer risks (1). Children 
are recognized as a vulnerable population group, since they are consider-
ably more sensitive compared to adults regarding radiation-induced ma-
lignancies and the associated risk for exposure induced death. There are 
several reasons for this difference in radiation sensitivity. First, tissues and 
organs of children are growing and developing and more sensitive to radia-
tion effects than those that are fully mature and differentiated, since they 
contain a larger proportion of stem cells and growing cells (2). Secondly, 
children have a longer life expectancy compared to older adults, in which 
the potential oncogenic effects associated with IR exposure can appear (3). 
The increase in sensitivity varies with age, with the younger ages being 
more at risk (4). The susceptibility of children to the effects of IR has been a 
focus of interest for over half a century. In the following chapter we give an 
overview of the current epidemiological data to illustrate the age depen-
dency in radiation sensitivity, with special emphasis on radiation-induced 
leukaemia.
Radiosensitivity of children to 
radiation-induced malignancies 
with special emphasis 
on leukaemia
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1.1
Ionizing radiation and cancer 
risks in children: what have we 
learned from epidemiology?
Epidemiological studies provide the primary data on the carcinogenic ef-
fects of radiation in humans. The fact that IR causes cancer in humans 
has been known for over a century. In 1902, the first radiation-induced 
cancer had been reported in an area of ulcerated skin. By 1911, there were 
already reports of leukaemia arising in radiation workers. Later, extensive 
epidemiological evidence for cancer risk from IR exposure came from the 
Life Span Study (LSS) of the Japanese atomic bomb survivor cohort (5, 6). 
1.1.1
The use of epidemiology data for 
paediatric risk assessment
Epidemiological studies of cancer following IR exposure are character-
ized by large population size, long-term follow-up of the cohort and well-
characterized dose estimates for individuals. Certainly for children, a large 
population size is usually required since cancer is a rare outcome in this 
population. Radiation-induced leukaemia generally occurs with a mini-
mum latency of about 2-3 years, while solid tumours only start to appear 
a minimum of 10 to 15 years after exposure and often do not occur until 
the child has reached adulthood. The major strength of epidemiological 
studies is that they provide direct information on health risks in humans. 
However, epidemiological studies are observational rather than experi-
mental (the investigator cannot control the circumstances of exposure), 
which introduces a high potential for bias or confounding (7). Analysis 
of epidemiological data on childhood radiation exposure is difficult as it 
is hard to adjust for all the confounding factors which can modify the risk 
of cancer following radiation exposure. These factors include: gender - fe-
males are more sensitive than males for some radiation-induced cancers; 
age at exposure - younger children are more susceptible; attained age - can-
cer might not appear until the child has reached adulthood (when cancer 
typically occurs); time since exposure – especially important for solid tu-
mours with a long latency period of 10 years and longer; the presence of 
underlying diseases; and the influence of other potential carcinogens (e.g. 
cigarette smoke) (8).
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Radiation-induced cancer risks are generally expressed as excess rela-
tive risk (ERR) or excess absolute risk (EAR). Both risk factors represent 
increased cancer rates relative to an unexposed population. ERR assumes 
that a radiation-related risk is proportional to the baseline risk as well as 
the exposure, while EAR assumes that the radiation-related risk does not 
depend on the level of baseline risk (3). Both ERR and EAR will decrease 
with increasing age at exposure. The ERR decreases with increasing at-
tained age, while the EAR increases; these differences reflect the strong 
increase in baseline risk with attained age (9). Furthermore, the ERR of 
certain cancers (e.g. thyroid cancer) after irradiation in childhood is high, 
but the background absolute risk is low so that the EAR is comparatively 
small (7). Despite the mentioned differences, both metrics are useful in 
comparing the impact of exposure in children versus adults. 
Describing the health effects of radiation exposure during childhood 
or adolescence compared to those occurring during adulthood is a com-
plex matter. Many of the large epidemiological studies and reports on the 
sources and effects of IR exposure have also included children as part of 
the study population. To date, however, there is a lack of comprehensive 
reports specifically addressing all aspects of radiation exposure of children 
and the consequent health effects and associated risks. Information is often 
buried in epidemiological reports on general population exposure. The 
current risk estimates are derived from several epidemiological studies: 
•	 The LSS cohort of Japanese atomic bomb survivors (35 382 persons or 
41% of the exposed population was 0-20 years old at exposure) 
•	 Accidents such as Chernobyl (27% of the evacuated people were 0-17 
years old) 
•	 Populations that have been exposed to fallout from the testing of nu-
clear weapons (e.g. Marshall Islands, where 39% of the inhabitants 
were children under 10 years of age) 
•	 Medically exposed populations: radiotherapy for childhood cancers 
and benign conditions or diagnostic x-rays for disease follow-up
If we want to consider the results of the medically irradiated group, they 
should be treated with care since the individuals suffered from a known 
or suspected illness and may not be representative for the whole popula-
tion in their carcinogenic response to radiation. Nonetheless, medical ir-
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radiation studies provide a valuable support to the findings of the Japanese 
survivor studies (7).
Figure 1.1 and Figure 1.2 show the ERR of respectively the incidence 
and mortality at 1 Sievert (Sv) of certain sites of cancer other than leukae-
mia for the LSS cohort presented in the United Nations Scientific Com-
mittee on the Effects of Atomic Radiation (UNSCEAR) 2000 report (7, 
10). The latter committee was established by the General Assembly of the 
United Nations in 1955 and its mandate is to assess and report levels and 
effects of exposure to IR. The assembly has designated 27 countries to 
provide senior scientists, who publish authoritative reports which form a 
scientific basis for evaluating radiation risk and for establishing protec-
tive measures throughout the world (www.unscear.org). The ERR values 
in Fig 1.1 and 1.2 represent the average for all survivors (all ages and both 
sexes) over the entire period of follow-up. The figures illustrate clearly the 
elevated risk for both incidence and mortality of female breast cancer and 
thyroid cancer. Leukaemia risks are not presented in Figure 1.1 and 1.2 
since the ERR is dramatically higher than for other cancers; the ERR at 1 
Sv for leukaemia incidence is 4.4 (90% confidence interval (CI): 3.2-5.6) 
(7). Furthermore radiation-induced leukaemia has a short latency period, 
a different dose-response relationship and time post-exposure behaviour 
compared to solid tumours Most types of leukaemia,acute myeloid leu-
kaemia (AML), chronic myeloid leukaemia (CML) and acute lymphoid 
leukaemia (ALL), were in excess with the notable exception of chronic 
lymphoid leukaemia (CLL). The radiation-induced risk of leukaemia is es-
pecially pronounced at young ages at exposure. The ERR for the survivors 
exposed as young children (age at exposure < 15 y) approaches 100/Sv 
within the subsequent decade (8). The excess risk for leukaemia is charac-
terized by a wave that peaks within about 10 years of exposure and then 
subsides. For solid tumour incidence during 1958-1987, the ERR at 1 Sv 
is 0.63 (95% CI: 0.52-0.74) (11), whereas mortality during 1950-1990 it is 
0.40 (90% CI: 0.31-0.51) (7).
As already mentioned, the above risk estimates are an average for a 
population of all ages and result in a risk of radiation-induced cancer of 
about 10% for an acute dose of 1 Sv (1 Gy of x-rays). However, if this dose 
is spread out over a longer period of time at a lower dose-rate or in a series 
of fractions a dose and dose-rate effectiveness factor (DDREF) of 2 has to 
be taken into account and the risk is about 5%/Sv (2, 12). The International 
Commission on Radiological Protection (ICRP) deduced from these data 
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FIGURE 1.2
The ERR at 1 Sv for cancer mortality during 1950-1990 and 
corresponding 90% CI of different cancer sites among the Japanese 
atomic bomb survivors (UNSCEAR 2000) (♦ indicates that the lower 
90% confidence limit is lower than this value). Figure from (7). The ERR 
represents the elevated risk of cancer incidence due to a radiation 
exposure of 1 Sv, proportional to the baseline cancer risk for the 
different organs.
FIGURE 1.1
The ERR at 1 Sv for cancer incidence up to 1987 and corresponding 90% 
CI of different cancer sites among the Japanese atomic bomb survivors 
(UNSCEAR 2000) (♦ indicates that the lower 90% confidence limit is 
lower than this value). Figure from (7). The ERR represents the elevated 
risk of cancer incidence due to a radiation exposure of 1 Sv, proportional 
to the baseline cancer risk for the different organs.
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the dependence of cancer incidence and mortality on age at exposure for 
both males and females, illustrated in Figure 1.3. ICRP has developed, 
maintained and elaborated the International System of Radiological Pro-
tection used world-wide as the common basis for radiological protection 
standards, legislation and guidelines. For individuals in the first decade 
of life, the risk is closer to 15%/Sv, while for adults exposed in late middle 
age, the risk drops to 1-2%/Sv (13, 14). Figure 1.3 shows also a clear gen-
der difference, especially at early ages, which indicates that girls are more 
radiosensitive than boys.
FIGURE 1.3 
The attributable lifetime risk of cancer as a function of age for a 
single whole-body radiation dose of 1 Sv, which shows a decrease in 
radiosensitivity with age. These estimates are based on a multiplicative 
model and a DDREF of two (2).
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1.1.2
UNSCEAR 2013: Are children more 
sensitive to radiation than adults?
At present, there is a lack of statistically sufficient projections of lifetime 
risks for specific tumour sites following exposure at young ages. The cur-
rent estimates do not adequately capture the known variation and addi-
tional work is needed. Therefore, UNSCEAR has dedicated an entire vol-
ume on the scientific findings on effects of radiation exposure of children 
in volume 2 of the 2013 Report (15). The definition of “child” is not always 
consistent in scientific literature, therefore, the UNSCEAR committee had 
defined “children” as those exposed as infants, children and adolescents 
(age < 20 years). 
According to the latest findings of the UNSCEAR committee, the gen-
eral perception that children are more vulnerable to radiation exposure 
than adults is not universally true. In the UNSCEAR 2006 Report, the 
committee stated that lifetime cancer risk estimates for those exposed as 
children were uncertain and might be a factor of 2-3 times higher than 
estimates for a population exposed at all ages. This conclusion was based 
upon a lifetime projection model combining all tumour types (16). In the 
2013 report, the UNSCEAR committee has reviewed 23 different cancer 
types and reports the following scientific findings:
•	 For about 25% of tumour types, children are clearly more radiosensi-
tive. These include leukaemia, as well as thyroid, skin, breast and brain 
cancer.
•	 For about 15% of tumour types (e.g. bladder cancer) children appear 
to have about the same radiosensitivity for tumour induction as adults.
•	 For about 10% of tumour types (e.g. lung cancer) children appear less 
sensitive to external radiation exposure than adults.
•	 For 20 % of tumour types (e.g. oesophagus cancer), the data are too 
weak to draw a conclusion regarding differences in risk with age at 
exposure.
•	 For about 30% of tumour types (including multiple myeloma, Hodg-
kin lymphoma, pancreas, prostate, rectum, and uterus cancer), there 
is only a weak or no relationship between radiation exposure and risk 
at any age of exposure.
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Thus, the commonly held notion that children might be two-three 
times more sensitive to radiation than adults is true for some malignancies 
but certainly not for all. The UNSCEAR committee recommends to avoid 
generalization of the risk of childhood radiation exposure. Furthermore, 
the currently used estimates do not adequately capture the known varia-
tions and additional work is needed. Nevertheless, current scientific data 
still highlight the fact that infants and children are a target group of high 
concern in medical radiation protection. As shown in the last reviews of 
the atomic bomb survivors, both ERR and EAR for all solid cancers were 
and still continue to be higher for younger ages at exposure. The lifetime 
risk on a radiation-induced malignancy for a given dose is seriously higher 
in children than in adults: 2-3 times for all solid tumours (depending on 
the models and the compared ages) and 3-5 times for leukaemia.
One of the reasons why children are more sensitive to IR is related 
to aspects of developmental anatomy that affect their response to radia-
tion. Tissues and organs of children are growing and developing, more-
over, the growth period of the human body is unusually long compared to 
other mammalian species. In addition, there are remarkable differences in 
growth rate of different parts of the human body. For example, the head 
and the brain are proportionally much larger in young children, which 
could mean that the absorbed dose in specific organs is quite different at 
different ages and developmental stages. Figure 1.4 illustrates the differ-
ence in organ size and growth across tissue types and age. The lymphoid 
tissue is large at birth and grows rapidly until late childhood, and then 
declines in absolute mass. The neural group grows rapidly and completes 
>90% of the postnatal increase by the end of early childhood (17), while 
the musculoskeletal tissues grow primarily during childhood and early 
adolescence, and gonads do not mature until late adolescence (15).
In the following sections, we will discuss the tumour types for which 
children are clearly more sensitive than adults as presented in the UN-
SCEAR 2013 report. For some of these malignancies, depending upon the 
circumstances, the risks for children can be quite high, but it remains im-
portant to keep in mind that tumour induction in children compared to 
adults is quite variable and depends on tumour type, age and gender. 
Due to the differences in dose quantities used in the cited publications, 
the risk estimates will be expressed per organ equivalent dose in Sievert 
(Sv) or absorbed organ dose in Gray (Gy) in the following sections. An 
absorbed organ dose in Gy is used when no allowance was made for the 
11
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biologic effectiveness of different types of radiation. This is particularly 
important for the risk estimates derived from the LSS cohort, as a given 
dose of neutrons has a greater biological effectiveness than the same dose 
of γ- or x- rays. Allowance can be made for the different effectiveness of 
various types of radiation, by using a radiation weighting factor wR, result-
ing in an equivalent dose expressed in Sv. The ICRP has assigned radiation 
weighting factors to specified radiation types (sometimes called radiation 
qualities) dependent on their relative biological effectiveness. The wR for 
x-rays and γ-rays is typically 1, for protons 2, for high-energy neutrons 10 
and for alpha particles 20. Thus for example, an absorbed dose of 1 Gy by 
high-energy neutrons will lead to an equivalent dose of 10 Sv. 
1.1.2.1
Leukaemia
The LSS studies showed a strong increased risk in both incidence and mor-
tality of leukaemia (18, 19). Most types of leukaemia, except CLL, can be 
induced by IR with a minimum latency of about two years (15). The acute 
FIGURE 1.4
Growth curves of different parts and tissues of the body, showing four 
main patterns of growth. All the curves are attained as a percentage of 
the total gain from birth to maturity, and plotted so that size at 20 years 
of age is 100% on the vertical scale (purple line). Figure from (15), based 
on (17).
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forms of leukaemia predominate and occur more rapidly after exposure 
than chronic leukaemia. Leukaemia risk is best described by a linear-qua-
dratic dose response model (18) and this model has been adapted by the 
ICRP (14), the Biological Effects of Ionizing Radiation (BEIR) (20) and 
UNSCEAR (16) committees. International and national authorities rely 
on the work of these committees for the evaluation of the scientific in-
formation on the health effects of exposure to IR. The most substantial 
human data on radiation-induced leukaemia come from studies of three 
major population groups, which included also children: the survivors of 
the atomic bombing in Japan, persons exposed to high doses of pelvic ra-
diation therapy and persons treated with x-rays for ankylosing spondylitis 
or other benign diseases.
By the late 1940’s, physicians in Hiroshima and Nagasaki had noticed 
an apparent increase in leukaemia incidence among survivors (particu-
larly children) who were near the hypocentres at the time of the atomic 
bombing. The first published report of an increased risk of leukaemia 
among the atomic bomb survivors appeared in 1952 (19). Since then, risks 
of leukaemia and other haematological malignancies have been the subject 
of several studies on the LSS cohort, showing a clear age-at-exposure effect 
for leukaemia (18, 19, 21, 22). Richardson et al. demonstrated a marked 
variation of ERR with age at exposure in the LSS cohort, with the risk be-
ing notably higher at younger ages at exposure, as illustrated in Figure 1.5 
(21). Richardson and colleagues examined the leukaemia mortality among 
atomic bomb survivors during 1950-2000 using the estimated red bone 
marrow (RBM) dose. Adjusted RBM dose estimates were reported in this 
study, taking into account random errors attributable to the survivor’s lo-
cation and shielding. The calculated doses represent a weighted dose per 
Gy, which is the sum of the γ- and neutron irradiation. Figure 1.5 shows 
clearly the higher excess deaths in the earlier years among those exposed 
at young age, which is followed by a rapid decline with time. The majority 
of excess leukaemia deaths from radiation among those exposed as chil-
dren occurred during the follow-up period before 1975 (23). For child of 
10 years at the time of the bombing, the ERR/1 Gy RBM dose peaks at ∼65 
some 7 years after exposure and then attenuates with time since exposure, 
such that at 25 years after the bombings the ERR was still raised but at a 
level comparable with the ERR for those exposed as adults. There is, how-
ever, still evidence of a small increase in leukaemia risk among the survi-
vors still alive and a significant linear radiation dose response for myelod-
13
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Several studies have identified an increased risk for childhood leukae-
mia incidence or mortality after radiotherapy for the treatment of benign 
disease (24-27), whereas others have not (28). Lundell and Holm did not 
find an association between incidence of childhood leukaemia and radia-
tion dose for infants who were treated with radiotherapy for skin haeman-
giomas (28). Despite the relatively large number of infants studied, the 
low average dose to the bone marrow probably limited the possibility of 
detecting a small radiation risk. Darby et al. reported a 3-fold increase in 
leukaemia mortality in children treated with radiotherapy for ankylosing 
spondylitis (24). There was evidence that the risks of acute myeloid (AML), 
FIGURE 1.5
Estimated ERR at 1 Gy for leukaemia 
mortality, taking into account all types of 
leukaemia as a function of age at exposure 
and time since exposure in the LSS cohort 
(15, 21).
ysplastic syndromes in A-bomb survivors 40 to 60 years after the radiation 
exposure (23). The latter syndromes are characterized by an increased risk 
of developing AML. 
PA
RT
 I 
14
Children are the most important target group in mediCal radiation proteCtion
acute lymphoid (ALL), and chronic myeloid leukaemia (CML) were all in-
creased, but no evidence of any increase in CLL. Murray et al. found more 
leukaemia deaths than expected in children exposed to ionizing radiation 
for thymic enlargement (ratio of observed to expected deaths was 4.5) 
(26). Children treated with radiotherapy for tinea capitis (ringworm of the 
scalp) exhibited a subsequent excess risk of leukaemia that commenced a 
few years after exposure in both an Israeli cohort of almost 11 000 children 
(mean age at treatment, 7.1 years) (25) and a smaller cohort of just over 
2000 children from New York City (mean age at treatment, 7.8 years) (27). 
In the group of Israeli children, the assessed individual bone marrow dose 
was 0.3 Gy and the ERR/Gy for leukaemia at all ages was 4.4 over the entire 
follow-up (on average up to 26 years). 
Overall, the risk of radiation-induced leukaemia in children appears to 
be three- to fivefold greater than the risk to adults, based on several studies 
covering various types of exposure (15). 
1.1.2.2
Thyroid cancer
Thyroid carcinoma is the most frequent type of endocrine tumour and 
accounts for about 1% of all malignancies (29). Thyroid cancer is approxi-
mately twice as common in females as in males, with an increasing inci-
dence with age. In 1950, Duffy and Fitzgerald reported that IR appears to 
be an important causal factor for thyroid cancer (30). Several following 
studies confirmed this finding, including data from the LSS cohort, the ra-
dioiodine exposure in Chernobyl, and head and neck radiotherapy popu-
lations. Robbins et al. estimated that 9% of thyroid cancers in the general 
population may be attributable to IR (31). Especially the thyroid gland of 
children is highly susceptible to the carcinogenic effect of IR (32). 
There are several factors that modify the risk of thyroid cancer (15): 
•	 The latency period from IR exposure to the clinical development of 
thyroid neoplasms, which varies widely among epidemiology studies 
of radiation-induced thyroid cancer. On the basis of pooled analysis of 
seven previously published studies (five cohort and two case-control) 
of acute external irradiation and thyroid cancer. Ron et al. reported 
that thyroid cancer risk peaked at about 15-19 years after IR exposure, 
but was still elevated beyond 40 years (33). 
15
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•	 The age at exposure, since the thyroid of children and adolescents is 
more radiosensitive than in adults. Except for high therapeutic doses, 
exposure over the age of 30 years from external radiation have not 
been found to significantly increase the risk of thyroid cancer (15).
•	 Gender appears also to be a modifying factors, since several epidemio-
logical studies indicate that females are more sensitive than males. The 
EAR for females may be 2 - 4 times higher than in males (34), while 
the ERR per dose unit is about the same for both sexes or only slightly 
higher in females, due to the higher incidence of spontaneous thyroid 
carcinoma in females.
•	 Also ethnic background appears to be a modifying factor. This has par-
ticularly been reported in studies of persons of Jewish ancestry (35).
•	 Several authors suggested that iodine deficiency may be a prompt-
ing factor in radiation-induced thyroid cancer. Iodine deficiency may 
induce an increasing incidence of benign thyroid conditions, but very 
high iodine intake also affects thyroid function and, possibly, thyroid 
cancer risk (36, 37). An important epidemiological study on radia-
tion-induced thyroid cancer of Cardis et al. indicates that in areas of 
iodine deficiency, the radiation-related cancer risk may be three times 
higher than in areas of normal iodine levels (38). They also suggest 
that with iodine prophylaxis, the risk can be reduced by about a factor 
of three. On the other hand, the study of Brenner et al. on the Ukrain-
ian cohort did not find a statistical significant modification of radia-
tion risk in the case of either low iodine excretion levels or the use of 
stable iodine prophylaxis (39). 
Several reports were published on the incidence of thyroid cancer 
among the atomic bomb survivors (40-42). The LSS mortality studies did 
not include thyroid cancer, because the death rate from thyroid cancer is 
very low compared with most other cancers. As already mentioned the 
incidence of thyroid cancer increases with decreasing age at exposure and 
attained age. In the last review of thyroid cancer incidence in the LSS co-
hort from 1958 through 2005 (42), both the ERR and EAR significantly 
and rapidly decreased with increasing age at exposure by 53% and 70% re-
spectively, per decade increase in age at exposure. Allowing for the modi-
fying effect of age at exposure, the ERR tended to decrease and the EAR to 
increase with increasing attained age (see Figure 1.6).
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Numerous epidemiological studies were published on radiation-in-
duced thyroid cancer incidence for paediatric populations treated with 
radiotherapy for benign diseases or other types of cancer (e.g. Hodgkin’s 
disease, neuroblastoma…). A pooled analysis (atomic bomb survivors, 
children treated for tinea capitis, two studies of children irradiated for en-
larged tonsils, and infants irradiated for an enlarged thymus gland) was 
published by Ron et al. and gives the best estimate of risk for individuals 
exposed under 15 years of age to external radiation (33). The ERR at 1 Gy 
was estimated to be 7.7 following exposures in childhood (age less than 15 
years), which is one of the highest risk estimates for any tissue. 
One of the most dramatic findings after the Chernobyl incident was a 
large increase in thyroid cancers in children. Particularly, internal irradia-
tion from 131I intake by the ingestion of fresh contaminated milk gave more 
than 80% of the total thyroid dose (15). Cardis et al. identified an excess 
risk at all thyroid doses above 0.2 Gy (38). In some locations where con-
tamination was highest, as in the Gomel region, the incidence of thyroid 
cancer increased over a 100-fold. 
FIGURE 1.6 
Fitted temporal patterns and age-at-exposure variation in the 
radiation-associated risk for thyroid cancer in the LSS cohort. 
The left panel presents the ERR at a thyroid dose of 1 Gy and 
the right panel the fitted EAR at 105 person-years-Gy-1. Thyroid 
dose estimates from the current survivor dosimetry system 
(DS02) were used for the analyses. All curves and data points 
are gender-averaged estimates. Figure from (43).
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1.1.2.3
Breast cancer
Breast cancer is the most common cancer among women, one in ten of 
all new cancer diagnosed worldwide each year is a cancer of the female 
breast (44). The data concerning female breast cancer risk following ra-
diation exposure come primarily from three major population groups: the 
LSS cohort, patients who underwent a diagnostic radiology exposure, and 
persons who have had radiotherapy to the breast for benign (thymic en-
largement in infancy, skin haemangioma, etc.) or malignant (Hodgkin’s 
lymphoma, Wilm’s tumour, sarcomas, etc.) diseases in which the develop-
ing breast tissue was exposed to radiation (15). Several population studies 
have suggested a number of factors that modify radiation-induced breast 
cancer risk: irradiation at the time of menarche or the time of first preg-
nancy, nulliparity, obesity, family history of breast cancer, history of be-
nign breast disease and genetic factors (BRCA1/BRCA2 and ataxia telan-
giectasia mutated (ATM) gene mutations) (15). However, these modifying 
factors should be interpreted cautiously. Up to now, age at exposure and 
the age at risk (attained age), are the only two strong modifying factors that 
were repeatedly observed by different investigators (45). 
The excess risk of breast carcinoma among female survivors of the 
atomic bombs in Japan was already noticed in 1968 (46). Several updates 
followed since then and indicated a linear and statistically highly signifi-
cant radiation dose response. Preston et al. (45) reported ERRs at 1 Gy for 
those exposed at ages 5, 25 and 45 years of 2.6, 1.8 and 1.1 respectively. The 
corresponding EARs were 21.1, 11.6 and 4.9 per 104 person years per Gy. 
An analysis of ‘age at exposure effects’ on females breast cancer risk 
was performed by Land et al. (47) and McDougall et al. (48). Both studies 
found similar higher risk estimates for those irradiated in early childhood 
and around the time of puberty (before age 20) compared to individuals 
after age 20. Tokunaga et al. (49) reported that the ERR per Sv depends 
strongly on the age of exposure in the LSS cohort, also called age at time 
of bombing (ATB), which decreased by approximately 3.7% per additional 
year. The ERR of the age ranges 0-19, 20-39 and ≥ 40 years ATB were 2.41, 
1.25 and 0.48 per Sv, respectively (see Figure 1.7 which shows more steps 
in age range: 0-9; 10-19; 20-29; 30-39; 40-49). Only marginally statistically 
significant ERR was found for the group ≥ 40 years at time of exposure. 
In this study risk rates were analysed by taking into account the average 
breast equivalent dose in Sv, assuming a wR of 10 for neutrons. Land et 
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Besides the studies of the survivors of the atomic bombings in Japan, 
there are several studies reporting the occurrence of excess breast cancer 
incidence and mortality among a Canadian cohort of female patients ex-
posed to multiple fluoroscopic examinations before 1965 for the treatment 
of pulmonary tuberculosis by artificial pneumothorax (51, 52). The latest 
report on the Canadian multiple fluoroscopic examination study, based on 
the mortality experience from 1950 to 1987, reported a statistically signifi-
cant higher radiation risk for those exposed before the age of 10 than after 
FIGURE 1.7
Estimated excess relative risk per Sv (breast equivalent dose), by interval 
of age at the time of bombings (ATB). Estimates and 90% confidence 
limits are stratified on city, ATB and attained age. The corresponding 
total number of cases appears above the upper confidence limit for 
each interval of ATB (49).
al. (50) evaluated if early childhood exposure may result in breast cancer 
at a younger age. Women who were exposed at ages 0-19 years in the LSS 
cohort had a corresponding high ERR of 13.5 at 1 Gy before the age of 35, 
which is two times higher than the ERR at 1 Gy for cancers occurring after 
age 35. Despite the fact that risk estimates vary between different publi-
cations, a higher risk of breast cancer for those exposed at young ages is 
evident from the LSS cohort.
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that age in the fluoroscopy study (53). This is an inconsistency with the 
LSS cohort, where a maximal ERR for those exposed between ages 10 and 
14 years was observed, and a lower risk for those exposed before age 10. In 
the fluoroscopy study, however, the highest ERR is seen for those exposed 
between ages 0 and 9, with a substantially lower ERR for those exposed 
between 10 and 14 years. The authors reported estimates of ERR of breast 
cancer mortality for the combined Canadian fluoroscopy and atomic-
bombing survivor cohorts at 1 Sv of 1.41, 0.44, 0.24, 0.05 and -0.01 after 
exposure at age ranges of 0-9, 10-19, 20-29, 30-39 and 40-49, respectively. 
Besides the Canadian cohort, other epidemiology studies were published 
on radiation-induced breast cancer in diagnostic medically exposed popu-
lations, including a Massachusetts tuberculosis cohort (54) and scoliosis 
cohort (55) monitored by radiography x-rays (RX) or fluoroscopic exami-
nations for treatment efficacy and disease progress. 
A number of studies have examined the risk of breast cancer after ra-
diotherapy for various childhood malignancies (Hodgkin’s lymphoma, 
Wilm’s tumour, sarcomas, etc.) and benign diseases (thymic enlargement 
in infancy and skin haemangiomas). These reports took into account rel-
evant variables such as the radiation dose both to breast tissue and to the 
ovaries (the latter related to oestrogen secretion), patient age, and genetic 
variations related to the primary malignancy (15, 56). The mean absorbed 
dose to the breast in the study of Hildreth et al. on the increased breast 
cancer risk in girls treated for presumed thymic enlargement in infancy 
was 0.71 Gy (about 90% of the patients was less than 6 months of age at 
time of exposure) (57). The dose response ERR for breast cancer was 1.10 
per 1 Gy. Follow-up studies after treatment of Hodgkin’s disease with man-
tle radiotherapy have indicated at least a fourfold increase of breast cancer 
risk, with doses to the breast varying from 4 to 40 Gy, depending upon the 
technical factors and positioning (15). Radiation-induced breast cancer 
has been reported to have more adverse clinicopathological features com-
pared with breast cancer in age-matched population controls, especially 
the incidence of bilateral breast cancer seems to be increased in women 
treated with radiation exposure of the chest for paediatric or young adult 
cancer (58, 59).
Overall, several studies indicate the higher risk of radiation-induced 
breast cancer from exposure in childhood compared to adulthood. The 
increased risk in children appears to be about three-to fivefold (60). Epi-
demiological data support a linear dose response relationship for doses to 
the breast up to about 3 Gy (15). 
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1.1.2.4
Brain and central nervous system 
(CNS) tumours
The most commonly described intracranial radiation-induced malignan-
cies are meningioma, sarcoma, and glioma (61). It is often difficult to sepa-
rate brain tumours into either strictly malignant or non-malignant cat-
egories, because some tumour types may be slowly growing (15). Primary 
malignancies of the CNS are among the most lethal of cancers. In the Unit-
ed States, the 5-year survival for malignant CNS tumours is approximately 
30% (16). The first report of a radiation-induced tumour of the CNS was 
published by Mann et al. in 1953 (62). The LSS reports showed only a mod-
erate degree of association between IR and tumours of the CNS, because 
CNS tumours are relatively rare. Preston et al. reported a dose dependent 
ERR for nervous system tumours with an ERR of 1.2 per Sv and the largest 
ERR of 4.5 per Sv was observed for schwannomas (63). Individual weight-
ed brain doses were calculated as the sum of the γ-ray dose plus 10 times 
the neutron dose by using the DS86 system. The data suggested an age at 
exposure effect for nervous system tumours (except schwannoma), with a 
higher ERR of 1.2/Sv for individuals exposed before age 20 compared to 
individuals exposed after age 20 for whom the ERR was 0.2/Sv. 
Brain tumours, both malignant and benign, have been reported fol-
lowing radiotherapy for tinea capitis and haemangioma, after exposure 
of the order of 1 Gy. The health effects associated with radiation therapy 
for childhood tinea capitis was reported by Shore et al. for the New York 
cohort (64) and by Ron et al. for the Israeli patients (25). The mean dose 
to the brain in both studies was between 1.4 and 1.5 Gy. A linear model 
provided the most adequate fit for malignant brain tumours and menin-
giomas up to a dose of 2.7 Gy. The ERR/Gy was 4.63 for benign meningi-
omas, while for malignant brain tumours, the ERR/Gy was 1.98. The ERR/
Gy decreased with increasing age at exposure for malignant but not for be-
nign tumours. Similar findings were reported by Sadetzski et al., who did 
not see an age at exposure effect for benign meningiomas, but noted a sig-
nificant decrease in the ERR/Gy with age at exposure for malignant brain 
tumours of 3.6, 2.2 and 0.5 for ages 0-4, 5-9 and 10-15 years, respectively 
{Sadetzki, 2005, Long-term follow-up for brain tumor development after 
childhood exposure to ionizing radiation for tinea capitis}(65). Among 
the haemangioma cohort (66), the mean absorbed intracranial dose was 
lower (0.07 Gy). In this cohort, the ERR was 2.7 per Gy for malignant and 
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benign tumours combined, and the ERR decreased with increasing age 
at exposure. These studies on radiotherapy for benign conditions noted a 
strong dose response relationship, a decreasing risk of brain tumours with 
increasing age at exposure, and an elevated risk at 30 and more years after 
exposure.
Finally, a number of studies have linked subsequent neoplasms of the 
CNS, mainly gliomas, to previous cranial radiation for childhood cancers, 
especially for ALL (67). Neglia et al. published a report in 2006 on subse-
quent primary neoplasms of the CNS occurring within a cohort of 14 361 
5-year survivors of childhood cancers (Childhood Cancer Survivor Study) 
(68). Gliomas occurred at a median time of 9 years from original diagno-
sis. Radiation exposure was associated with increased risk of subsequent 
glioma (odds ratio of 6.78). The ERR per Gy was highest among children 
exposed at less than 5 years of age, which may reflect the higher suscepti-
bility of the developing brain to radiation. The UNSCEAR report of 2006 
points out that malignant tumours of the CNS are seen mostly after high 
doses from radiotherapy and the risk is predominantly after exposure in 
childhood (16).
1.2
Origin of radiation-induced 
leukaemia: the pursuit 
of genomic stability of 
haematopoietic stem cells
Leukaemia is the most common childhood cancer, accounting for almost 
1 out of 3 cancers diagnosed in children under 15 years of age in indus-
trialized countries (69-71). Acute leukaemia accounts for the majority of 
paediatric cases, with 80% ALL and approximately 20% AML (72). An ad-
visory group of the National Radiological Protection Board (NRPB 2003) 
tasked with estimating the incidence of different types of cancer for the 
UK population reported that myeloid leukaemias made up just over a 
third of spontaneous leukaemias, whereas radiation-induced myeloid leu-
kaemias (especially AML) were over-represented compared to their lym-
phoid counterparts (73), as illustrated in Table 1.1. As described in section 
1.1.2.1, the leukaemia risk depends strongly on the age at exposure (see 
Figure 1.5). The age effect involves different types of leukaemias; ALL is 
more common among children whereas CML and AML are more com-
PA
RT
 I 
22
Children are the most important target group in mediCal radiation proteCtion
Leukaemia is a cancer of blood-forming cells, that usually begins in 
the bone marrow with high numbers of abnormal white blood cells. These 
white blood cells are not fully developed and are called ‘blasts’ or leukae-
mia cells. The various types of leukaemia are primarily identified by the 
target cell that undergoes transformation. When the cancer develops in the 
lymphoid lineage, it is called lymphoid leukaemia (or lymphocytic leukae-
mia), while cancer of the myeloid lineage (monocytes and granulocytes) 
is described as myeloid leukaemia. The rate of disease progression is an 
additional feature used in classification. In chronic leukaemias, the blasts 
accumulate slowly and continue to differentiate into haematopoietic cells, 
AML CML CML CLL
Spontaneous 27% 9% 9% 55%
Low-LET radiation 53% 22% 25% 0%
Thorotrast (high-LET) 80% 15% 5% 0%
mon among adults (19). This was also confirmed by Bartley et al. in a study 
on diagnostic x-ray exposure and risk of childhood leukaemia, showing 
an increased risk of childhood ALL (specifically B-cell ALL) but not AML 
(74). A possible explanation for the difference between the time and age 
distribution for ALL risk compared with that for AML and CML, is that 
ALL is concentrated largely in childhood in the general population while 
the incidence of AML and CML generally increases progressively with at-
tained age. It is possible that the much higher risk for ALL in childhood ex-
posure compared to exposure at adult age reflects the population dynam-
ics of the relevant “target” population. It is known that normal lymphoid 
lineage-committed progenitors are most active early in life and decline in 
activity thereafter (75). 
TABLE 1.1
Comparison of the percentage incidence rates 
for spontaneous and radiation-induced leukaemia 
(assuming 0% radiation-induced CLL), in a 
population of all ages, based on (71). The term 
LET refers to Linear Energy Transfer.
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therefore, the disease progression is slow. In contrast, acute leukaemias are 
characterized by a rapid increase of blast cells, which decreases the capac-
ity of the bone marrow to produce healthy blood cells, resulting in a rapid 
disease progression.
•	 Chronic myeloid leukaemia: CML is a malignant, clonal myelopro-
liferative disorder, affecting myeloid, erythroid and megakaryocytic 
blood elements. It was the first identified haematological malignancy 
that is associated with a specific chromosomal abnormality, identified 
as the Philadelphia chromosome (76). 
•	 Acute myeloid leukaemia: AML has been described as a clonal disor-
der in which transformation and uncontrolled proliferation of an ab-
normally differentiated, long-lived myeloid progenitor cell results in 
high circulating numbers of immature blood forms and replacement 
of the bone marrow by malignant cells(78). Several specific cytoge-
netic abnormalities are closely, and sometimes uniquely, associated 
with morphologically and clinically distinct subsets of AML and can 
help to determine disease aggressiveness, response to treatment and 
prognosis (78). For example, the finding of a translocation between 
chromosomes 15 and 17, or t(15;17), is associated with a diagnosis of 
acute promyelocytic leukaemia (79).
•	 Chronic lymphoid leukaemia: CLL represents a monoclonal expan-
sion of lymphocytes and in a majority of cases, B-lymphocytes are 
involved. The neoplastic cell is characterized as a hypoproliferative, 
immunologically incompetent small lymphocyte, refractory to ap-
optosis. B-CLL’s apoptosis resistance depends in part on the altered 
activation of various survival pathways, triggered by the microenvi-
ronment and the B-CLL cells themselves (80). The disease primarily 
involves the bone marrow, with secondary release of the neoplastic 
cells in the peripheral blood. The circulating cells further selectively 
infiltrate the lymph nodes, spleen and liver (77).
•	 Acute lymphoid leukaemia: ALL is a malignant clonal disorder of the 
bone marrow lymphoid precursor cells, resulting in a high number of 
circulating blasts that lack the potential for differentiation and matu-
ration. The normal development of haematopoietic cells is inhibited, 
followed by a replacement of the normal marrow cells by malignant 
cells (76).
PA
RT
 I 
24
Children are the most important target group in mediCal radiation proteCtion
As described in the previous sections, epidemiological studies of mod-
erately or highly exposed groups have confirmed that leukaemia is particu-
larly sensitive to induction by IR; and especially those exposed at young 
ages are at high risk (15, 18). Furthermore, Brenner et al. and Little et al. 
reported significant excesses of leukaemia in children exposed to low-dose 
IR (81, 82). Together with a recent study in the United Kingdom, which 
reported elevated risks of leukaemia and brain tumours after CT scans in 
childhood and adolescence (see chapter 3), we can consider leukaemia as 
the most important malignancy after radiation exposure during childhood 
(83). Most leukaemias originate from precursor cells in the bone marrow. 
Therefore, red bone marrow, which harbours haematopoietic stem and 
progenitor cells (HSPCs), is of critical interest.
1.2.1
Haematopoiesis
The HSPC population forms the fundamental base from which all ma-
jor blood lines are derived through a process called haematopoiesis (or 
haemopoiesis). Two major cell lineages arise from the HSPCs: myeloid 
(granulocytes, erythrocytes, platelets and mononuclear phagocytes)and 
lymphoid (lymphocytes) cell lineages (84). Haematopoiesis is driven by a 
rare population of haematopoietic stem cells (HSCs) that asymmetrically 
self-renew, a process in which the ‘parent’ stem cell forms another parent 
stem cell and a daughter cell. In this biological process of self-renewal the 
HSC with long-term differentiation capability generates progeny with the 
same potential to differentiate into mature blood cells, without depletion 
of the stem cell pool. 
In mammals, haematopoiesis occurs as a sequential process that moves 
to different anatomic sites during embryonic and foetal development, 
childhood and adult life (see Figure 1.8). In the prenatal period, the sites 
of haematopoiesis include the yolk sac, where blood formation occurs in 
blood islands; the foetal liver, spleen and finally, the bone marrow. Dur-
ing childhood and adult life, the bone marrow is the only source of new 
blood cells. However, maturation, activation, and some proliferation of 
lymphoid cells occur in secondary lymphoid organs (spleen, thymus and 
lymph nodes). In infancy, all the bone marrow is haematopoietic but dur-
ing childhood there is progressive replacement of red active marrow by 
yellow inactive adipose tissue throughout the long bones, so that in adult 
life active red marrow is confined to the bones of the axial skeleton (cra-
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A functional hierarchy has been proposed for the haematopoietic com-
partment, illustrated in Figure 1.9. Haematopoiesis starts with stem cell di-
vision in which one cell replaces the stem cell (self-renewal) and the other 
is committed to differentiation. The early committed progenitors express 
low levels of transcription factors that may commit them to discrete cell 
lineages. Which cell lineage is selected for differentiation may depend both 
on chance (stochastic theory) and on the external signals received by pro-
genitor cells (determinism theory). Several transcription factors have been 
isolated that regulate differentiation along the major cell lineages. 
Self-renewing multipotent HSCs are at the apex of the haematopoietic 
hierarchy based on their ability to give rise to all cell types of the haema-
topoietic system (Figure 1.9). The self-renewing long-term HSCs first dif-
FIGURE 1.8
Illustration of the different sites of human haematopoiesis in 
pre- and postnatal periods. Marrow cellularity is the volume 
ratio of haematopoiesis and fat. The figure illustrates the age 
dependency of cellularity. In newborns, nearly all marrow is 
haematopoietic and with aging, cellularity diminishes due to the 
increase in the amount of fat in the long bones. Figure from (87).
nium, sternum, ribs and vertebrae) (85). Within the bone marrow exists a 
tightly controlled local microenvironment, also called bone marrow niche, 
that regulates the quiescence, proliferation and differentiation of HSCs. 
Regulatory signals within the niche emanate from surrounding cells in the 
form of secreted molecules and also from physical signals such as oxygen 
tension, shear stress, contractile forces and temperature (86).
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HSC and their differentiated progenitor populations are distinguish-
able from other blood cells by the expression of specific cell surface lineage 
markers, such as Clusters of Differentiation (CD) proteins and cytokine 
receptors. The most important positive marker for HSPCs is the adhesion 
molecule CD34, which plays a central role in HSPC recognition. Table 1.2 
presents the commonly expressed CD markers reported in literature for 
various subpopulations of HSPCs (90, 91). CD34+ cells can be used in the 
FIGURE 1.9
Illustration of the ‘classical 
model’ of haematopoietic 
hierarchy. A crucial postulate of 
the classical model is that the 
earliest commitment decision 
(downstream of MPPs), segregates 
lymphoid and myeloid lineages. 
Abbreviations not explained in the 
text: granulocyte and macrophage 
progenitor (GMP); megakaryocyte 
and erythrocyte progenitor (MEP); 
natural killer (NK). Figure from (89). 
ferentiate into short-term HSCs and multipotent progenitors (MPPs) with 
less self-renewal capacity. Together, these three cell types constitute the 
HSPC population. In this classical model, the lineage decision occurs as 
a stepwise bifurcation to a myeloid and lymphoid line (88). MPPs further 
differentiate into the two main branches of haematopoietic development 
that arise from the common lymphoid progenitor (CLP) and the common 
myeloid progenitor (CMP). All mature peripheral blood cells, shown on 
the right part of Figure 1.9, are derived from these progenitors. 
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Cell Type CD Marker Definition
HSC Haematopoietic Stem Cell CD34+CD38-CD90+CD45RA-CD49f+
MPP Multipotent Progenitor CD34+CD38-CD90-CD45RA-CD49f-
CLP Common Lymphoid Progenitor CD34+CD10+CD7+
CMP Common Myeloid Progenitor CD34+CD38+CD123medCD135+CD45RA-
GMP Granulocyte and Macrophage Progenitor CD34+CD38+CD123medCD135+CD45RA+
MEP Granulocyte and Macrophage Progenitor CD34+CD38+CD123-CD135-CD45RA-CD110+
TABLE 1.2
CD marker combinations of different HSPC 
subpopulations of the classical human 
haematopoiesis model.
treatment of various malignant and genetic diseases. Clinically applica-
ble sources of CD34+ HSPCs are umbilical cord blood (UCB), bone mar-
row (BM) and mobilized peripheral blood (mPB) after administration of 
growth factors (e.g. granulocyte colony-stimulating factor, G-CSF) (92). 
The HSPC source used for an individual patient may depend on the avail-
ability of the graft, the disease, the age of the patient and the risks of com-
plications after the transplant. The number of detectable CD34+ cells is 
very low in healthy donors, the CD34 antigen is expressed on 1-3% of BM 
cells and 0.1-0.4% of UCB cells (93). The characterization and isolation 
of HSPCs from these samples provides valuable information for clinical 
research and has emerged as a model system for stem cell biology. The 
mechanisms controlling HSPC homing to the bone marrow, self-renewal 
and differentiation, are thought to be influenced by a diverse set of cy-
tokines, chemokines, receptors and intracellular signalling molecules. 
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Figure 1.10 shows the major classes of human HSPCs defined by cell 
surface phenotypes. However, this figure deviates from the classical model 
of haematopoiesis shown in Figure 1.9, since CLP is replaced by a multi-
lymphoid progenitor (MLP). The latter cell is still a progenitor giving rise 
to al lymphoid lineages (B, T and NK cells), but experimental data have 
shown that early lymphoid progenitors in humans retain myeloid pro-
grams (94). Therefore, Doulatov et al. proposed a broader term – mul-
tilymphoid progenitor – to describe lymphoid progenitors that may have 
additional myeloid potentials (88). Hence, the MLPs presented in Figure 
1.10 are not lymphoid restricted and possess myeloid potential. However, 
there still remain uncertainties on the precise lineage output of the lym-
phoid progenitors. Both Figure 1.9 and 1.10 show that genomic instability 
in CD34+ HSPCs can give rise to both myeloid and lymphoid leukaemias.
FIGURE 1.10
Model of lineage determination in human 
haematopoietic hierarchies, illustrating the 
major classes of HSPCs defined by cell surface 
phenotypes which are listed next to each 
population. Figure from (88).
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1.2.2
Radiation-sensitivity of HSPCs
A characteristic feature of HSCPs is their ability to self-renew and dif-
ferentiate throughout life. Due to their long life span, accumulation of 
radiation damage in stem cells can compromise their genomic integrity 
and potentially give rise to cancer. Stem cells may thus be the major target 
of radiation-induced carcinogenesis (95). On the other hand, unrepaired 
genotoxic damage may cause cell death and stem cell pool depletion, re-
sulting in degradation of haematopoietic cell function and failure of hae-
matopoiesis, which is the most critical direct effect of whole body high 
dose radiation exposure. Proper regulation of DNA damage responses in 
HSPCs is crucial and appropriate regulation of the cell cycle is required 
for homeostasis. During the constant replenishment of blood cells, HSPCs 
migrate from the bone marrow into the blood stream. Therefore, HSPCs 
reflect the genomic integrity of the stem cell pool and are an ideal model to 
study the possible health risk of radiation exposure on the bone marrow. 
The haematopoietic system is a traceable tissue with cellular components 
which can be analysed or purified based on their cell-surface CD markers, 
and which can serve as a model system to unravel the origin radiation-
induced leukaemia. However, little is known about the radiation sensitiv-
ity of human HSPCs. The suppression of haematopoiesis is a severe side 
effect of high dose IR exposure as used in radiotherapy for cancer patients 
and it is believed that haematotoxicity mainly arises from the impairment 
of HSPCs. Therefore, most of the studies on radiation responsiveness of 
HSPCs focus on self-renewal and (clonogenic) survival (92, 96-98). How-
ever, in this PhD dissertation we focus on mutagenic and consequential 
leukaemogenic effects of IR exposure. Therefore, we are interested in the 
nonlethal DNA modifications in HSPCs, that can be unrepaired or misre-
paired and eventually lead to malignant disease. However, the cellular out-
come of unrepaired DNA double-strand breaks (DSBs) remains unclear 
and will be further discussed in the Discussion section of this PhD thesis.
Radiation-induced genomic instability is a hallmark of cancer devel-
opment and a possible mechanism through which radiation exposure 
may induce the transformation of HSPCs to leukemic cancer cells (99). 
Milyavsky et al. provided a genetic approach to gain mechanistic insight 
into the response of human HSPCs to DNA damage (100). Significant dif-
ferences in response were observed between HSC/MPP and progenitors, 
with HSC/MPP undergoing higher levels of apoptosis compared to the 
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progenitor population. However, other publications, mostly on murine 
HSPCs, report that more primitive HSCs are more radioresistant to apop-
tosis compared to their progenitor cells, in order to ensure repopulation of 
the damaged bone marrow (92, 95). In the latter hypothesis, tissue mainte-
nance is favoured in haematopoietic tissue, as the rare HSCs appear to be 
more resistant than their daughter progenitor cells. A possible mechanism 
of the relative resistance of HSCs is their increased antioxidant defence, 
since they contain lower levels of reactive oxygen species (ROS) compared 
to progenitors (101). The contradiction between human and murine stud-
ies on the radiosensitivity of HSPCs will be further discussed in the Dis-
cussion section of this PhD thesis (see chapter 10). 
The haematopoietic tissue is at high risk for carcinogenesis, demon-
strated by epidemiological studies, suggesting that the DNA repair may 
not be optimum. HSCs adopt a quiescent state within the bone marrow 
niche and remain largely in the G0 and G1 phase of the cell cycle, which is 
necessary for their long-term population maintenance (102). Non-divid-
ing HSCs employ the error-prone non-homologous end joining pathway 
(NHEJ) to repair DNA DSBs (103), but the survival of cells with misre-
paired damage can favour long-term accumulation of genetic anomalies. 
Evidence suggests that the quiescent stage of HSCs results in an attenu-
ation of checkpoint control and DNA damage responses for repair and 
apoptosis, which is a dangerous mechanism through which potentially 
dangerous lesions can accumulate in the stem cell pool with age (104). The 
characteristic that certain types of leukaemia may be stem cell-driven, pro-
vided one the first conclusive pieces of evidence for the existence of cancer 
stem cells (105). A cancer stem cell is defined as a self-renewing cell within 
a tumour that has the capacity to regenerate the phenotypic diversity of the 
original tumour (106). Accumulation of radiation-induced DNA damage 
could trigger HSPCs to become leukemic stem cells. Tissues in which ma-
lignancies originate, such as blood, brain, breast, skin and gut, are organ-
ised as a cellular hierarchy with a small population of tissue-specific stem 
cells responsible for both development and maintenance of tissues over the 
human lifetime (106). Despite the multiple regulatory systems that prevent 
abnormal proliferation, mutations do occur. Most mutations are inconse-
quential since the abnormal cell is eventually eliminated from the pool of 
replicating cells, but at some low frequency these mutations may accumu-
late and eventually lead to cancer. 
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The use of IR in medical applications has resulted in a significant im-
provement of patient care. Several epidemiological studies provided evi-
dence for adverse health effects of moderate and high doses of IR exposure 
(see chapter 1). However, the characterization of health effects of IR at low 
levels, as used in medical diagnostics, is more difficult due to the statistical 
uncertainties associated with the small excess risks at low doses. As the 
use of IR in diagnostic medicine continuously increases over the years, the 
risk of low dose IR became of societal importance. In this second chapter, 
we will focus on the increasing number of paediatric computed tomogra-
phy (CT) scans and the associated cancer risks of low levels of low linear 
energy transfer (LET) IR (e.g. x-rays), as used in CT imaging in children. 
Use of x-rays in paediatric 
diagnostic imaging
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2.1
Medical radiation burden
In the 1890s, Wilhelm Conrad Roentgen, Henri Becquerel and Marie and 
Pierre Curie discovered man-made x-rays and naturally occurring ra-
dioactivity, which laid the foundation for the use of ionizing radiation in 
medicine. The discovery of x-rays resulted in the construction of x-ray ma-
chines, nowadays used to image structures in the human body. As a result, 
IR has been increasingly applied in medicine for diagnosis and therapy 
during the last century. Hence, medical radiation exposure has become 
an important component of the total radiation exposure of the popula-
tion and the use of IR in medicine continues to increase over the years 
(1). The average radiation exposure in Belgium is 5.45 mSv/year per caput. 
The population burden due to medical diagnostic procedures amounts up 
to 2.66 mSv/inhabitant per year, of which 2.46 mSv/year is attributable to 
the radiology dose burden and 0.2 mSv/year to diagnostic nuclear medi-
cine procedures (2). The radiation quality used in diagnostic radiology is 
defined as low-LET radiation. LET is a measure of the density of energy 
deposition along the radiation track of a given type of IR in matter. Low-
LET radiation deposits less energy in the cell along the radiation path and 
is considered less destructive per radiation track than high-LET radiation. 
It is this kind of low-LET radiation, including x-rays and γ-rays, producing 
sparse ionizations throughout a cell which is subject of this PhD research.
FIGURE 2.1
A. Frequency distribution of the different radiology examinations in 
Belgium (% of the annual 16.4 million procedures).
B. Contribution of the different radiology procedures to annual 
radiology dose burden (% of the annual radiology population dose of 
2.46 mSv/year, which is the medical radiation burden in Belgium without 
0.2 mSv/year from diagnostic nuclear medicine). Figure from (4).
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The main contributor to the medical radiology dose burden in Belgium 
is CT (55.72%), while only 11% of the 16.4 million radiological proce-
dures each year are CT scans (see Figure 2.1). The high CT contribution 
in Belgium is comparable with the data published in the Dose Datamed 2 
(DDM2) project report in 2010 on radiodiagnostic procedures in 36 Euro-
pean countries (3). The DDM2 project showed that CT examinations are 
the largest contributor to the collective medical x-ray radiation burden in 
Europe, representing 55% of the annual effective dose. The total annual fre-
quency of x-ray procedures in the European countries is 1.1 examination 
per caput, while the frequency in Belgium is 1.5 examination per caput.
Thus, in comparison with neighbouring countries, the annual frequen-
cy of medical examinations per caput in Belgium is relatively high. Belgian 
inhabitants receive more than 3 times the average medical radiation dose 
per caput of the Netherlands, which was estimated as 1.96 mSv and 0.63 
mSv respectively in the DDM2 report in 2010 (Figure 2.2) (3). 
The high medical radiation burden in Belgium is due to the use of in-
creasingly sophisticated medical imaging, computed tomography (CT) 
in particular, which improves the quality of diagnosis. Every year, on the 
average 1 out of 5 Belgian inhabitants undergoes a CT examination and 
every inhabitant undergoes on the average one RX examination (5). CT 
FIGURE 2.2
The effective dose per caput for the 36 participating countries of the 
DDMED 2 survey. The contribution of fluoroscopy and interventional 
radiology were not available for Greece (EL). The graph illustrates the 
high medical radiation burden in Belgium (3).
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examinations result in higher organ doses than conventional RX exami-
nations. Both imaging techniques use diagnostic x-rays, but a CT image 
is acquired by combining rotation of the x-ray source around the patient, 
producing human body images in cross-sections after computerised re-
construction. For comparison, a CT abdomen and RX abdomen examina-
tion results in an effective dose of 12 mSv and 0.82 mSv respectively (1). To 
put this radiation burden of CT in perspective, one CT abdomen exami-
nation corresponds to approximately 1600 days (or 4.5 years) of natural 
background exposure.
The increasing frequency of radiological examinations and the corre-
sponding high radiation burden, have put special attention on the man-
agement of patient dose in diagnostic radiology at national and interna-
tional level. There are three factors making especially CT examinations the 
focus of recent concern (6):
•	 CT scans contribute to a large extent to the high amount of radiation 
exposure in diagnostic imaging (see Figure 2.1).
•	 The indications for CT scans and the number of CT scans are increas-
ing rapidly (7).
•	 CT examinations can be performed by using a wide range of tech-
niques, resulting in different levels of radiation exposure. Both scan-
ner design and clinical protocol factors affect the radiation dose to the 
patient. Traditionally a higher dose corresponds with an increase in 
image quality in CT imaging. However, above a certain level of image 
quality, the decrease in image noise with increasing radiation dose will 
have no effect on diagnostic accuracy of the CT examination while the 
exposure may have been unnecessarily high, especially in children (5).
This is of special importance for the paediatric patient population, as 
children are more susceptible to radiation-induced carcinogenesis com-
pared to adults. In this PhD, a population of paediatric patients undergo-
ing a CT examination is considered, therefore we will focus on this specific 
population in the following sections.
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2.2
Issues related to CT imaging 
in children
Because of its proven diagnostic value, CT became an indispensable tool in 
modern medicine. The growing use of CT in paediatric radiology has been 
driven by new and improved imaging techniques, enabled by the advent 
of spiral and multi-slice CT (MSCT) scanning. MSCT allows faster imag-
ing, resulting in less motion artefacts and reduction of the need for general 
anaesthesia in young children. Due to the shorter scanning time, it is also 
possible to extend the scope of some examinations, which allows to image 
larger volumes (e.g. staging of malignant lymphoma in children, which 
requires staging of neck and the entire trunk in one scan). Furthermore, 
MSCT allows to scan the same volumes with a better isotropic resolution, 
so organs can be evaluated in different planes. Children have smaller or-
gans and less fat, resulting in less contrast between organs of similar densi-
ty. This means that the improvement of image quality is even more advan-
tageous in the paediatric patient group. Unfortunately, the ease of image 
acquisition results sometimes in unnecessary exposure of patients. 
2.2.1
Frequency of CT imaging in children
Limited data are available on the frequency of medical diagnostic x-ray 
procedures in Belgian children. The data of the UNSCEAR 2013 report 
on percentages of medical examinations in children are presented in Table 
2.1 (8). There exists a large variation among countries, but in summary 3 - 
10% of all medical radiation procedures are performed on children.
In 2011, 2 044 219 CT examinations were performed (190.1 per 1000 
inhabitants) in Belgium of which 25 492 in children (age 0 to 12 years), 
corresponding to approximately 1 - 2% of CT procedures. The percentages 
of childhood CT scans reported in literature are higher, 6% of CT exami-
nations are presumably performed in children (6, 8). However, former data 
are mainly based on studies from the USA where CT is more frequently 
used in children. A German study reported a similar lower percentage of 
paediatric CT examinations in the order of only 1% of all CT scans as in 
Belgium (9), which is again much smaller than in the USA. However, as 
described previously, although CT scanning represents just a small pro-
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portion of the x-ray imaging examinations, it represents the main source 
of medical IR exposure.
A survey of the Netherlands and Germany showed that the most fre-
quent type of paediatric CT examination is head CT (50-60%), followed 
by chest (17%) and only 7% of CT scans is performed for abdomen indi-
cations (6, 9). Thus, most paediatric CT examinations are performed to 
scan the head region, whereas CT scans of the abdomen are quite rare 
for children (Figure 2.3). On the contrary, almost 60% of the paediatric 
CT examinations in the USA were performed for abdomen indications. In 
most European countries, ultrasound (US) is performed by radiologists, 
which is widely accepted and frequently used for abdomen indications in 
children if possible. 
TABLE 2.1
Percentage of various types of medical examinations performed on 
infants and children (0-15 years old) in well-developed countries, as 
published in UNSCEAR 2013 (8).
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2.2.2
Why are age-appropriate CT settings 
required for children?
When medical equipment and procedures are designed or set-up with an 
adult patient in mind, these settings can result in significantly higher doses 
for paediatric patients. Moreover, for a given dose, there is a significant 
difference in cancer risk from radiation exposure in children, compared 
to adults. There are several underlying reasons for this difference in cancer 
risk (see also chapter 1) (10):
 
•	 Tissues and organs of children are growing and developing, which 
makes them more sensitive to radiation effects than those that are ful-
ly mature and differentiated. Especially the thyroid gland, brain and 
breast tissue are structures with an increased sensitivity to radiation 
in growing children (see chapter 1). The increased sensitivity varies 
FIGURE 2.3
Illustration of the frequency distribution (%) for 
different types of paediatric CT examination in 
Germany. Data from (6).
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with age, with the younger ages being more at risk. Some of these re-
gions are routinely involved in chest CT imaging, such as thyroid and 
breast tissue. Furthermore, breast tissue might also be included in the 
uppermost part of a CT abdomen scan despite the fact that this is not 
clinically indicated (11). Also scatter may affect the organs close to the 
scanning area and specific attention should be paid when scanning 
newborns and infants in spiral CT mode with multi-slice CT scan-
ners, as the additional exposure from overscanning effects can mount 
up to 20-30 % due to the short scan ranges (12). 
•	 Children have a longer life expectancy to express the oncogenic effect 
of radiation exposure. Radiation exposure for elderly people doesn’t 
carry the same risk, because most of the radiation-induced solid ma-
lignancies will not occur within the first decade after exposure. Radi-
ation-induced leukaemia generally occurs with a minimum latency 
of about 2-3 years, while solid tumours only start to appear a mini-
mum of 10 to 15 years after exposure (8). Moreover, the cancer risk 
is assumed to be cumulative over a lifetime, so each CT examination 
contributes to the lifetime exposure (11). This makes the risk more 
significant for the younger populations, for whom the risks are higher 
and there is more opportunity for repeated imaging.
•	 Identical CT settings provide higher organ doses in children com-
pared to adults, due to their smaller cross-section. Although children 
absorb less radiation than adults, their organs are smaller and the ac-
tual dose to the organ is higher (12). The latter is illustrated in Figure 
2.4, which shows the difference in effective dose between infants and 
adults versus x-ray tube voltage (kV) for a constant mAs value. Note 
that the patient effective dose increases by about a factor of five when 
the x-ray tube voltage increases from 80 to 140 kVp (13). The effec-
tive dose for infants is much higher than in adults for the same kVp 
settings.
In 2001, a number of surveys showed that adjustment of CT protocols 
for paediatric patients were not routinely made based on variations in size 
of children (14-16). The exposure parameters used in paediatrics were too 
high in comparison with adult protocols (17), even though a lower dose 
can provide equivalent image quality (6, 18). Since then, numerous rec-
ommendations have been published to adapt exposure settings in accord-
ance with patient size and there is a strong radiation protection awareness 
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2.3
Dose Reference Levels (DRLs) 
in paediatric CT imaging
The optimisation of patient protection in paediatric CT imaging requires 
the application of examination-specific scan protocols tailored to patient 
age or size, scan region and clinical indication in order to ensure that the 
dose to each patient is as low as reasonably achievable (ALARA) for the 
clinical purpose of the CT examination. Dose reference levels (DRLs) are 
a practical tool to compare the existing protocols between different radiol-
ogy centres and to promote the development of new and improved proto-
cols. The levels are expected not to be exceeded for standard patients when 
good and normal practice regarding diagnostic and technical performance 
FIGURE 2.4
Effective dose versus x-ray tube voltage for 
infants and adult patients having a head CT 
examination with constant 340 mAs. Figure 
from (13).
among CT users of paediatric radiology today. This is mainly the result 
of extensive campaigns at national and international level. An initiative 
definitely worth mentioning in this context, is the Image Gently campaign 
(see www.imagegently.org). Nevertheless, dose reduction in paediatric CT 
imaging remains a challenging topic that will be addressed in the Discus-
sion of this PhD dissertation (see chapter 9).
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is applied. A DRL value is advisory, and when the value is exceeded regu-
larly, this does not mean necessarily a case of unacceptable practice. Rath-
er, the practice requires explanation, review, or possibly a new approach 
(19). In the following paragraphs we present the practical dose quantities 
used to monitor CT practice, national and international DRLs, in order to 
outline current practice in paediatric CT imaging.
2.3.1
Dose quantities in CT imaging
DRLs should be set in terms of the practical dose quantities used to moni-
tor CT practice: volume weighted CT Dose Index (CTDIvol, expressed in 
mGy) and Dose-Length Product (DLP in mGycm), as commonly displayed 
by CT scanners. CTDIvol is a standardized measure of radiation dose out-
put of a CT scanner which allows the user to compare radiation output of 
different CT scanners. DLP represents the product of CTDIvol and the scan 
length. These quantities are not patient doses, but dose indicators charac-
terising radiation exposure in CT. CTDI and DLP are specified in relation 
to dose measurements in the standard CT dosimetry phantoms, which are 
acrylic cylinders with diameters of 16 cm (commonly referenced for adult 
head protocols) and 32 cm (commonly referenced for adult body proto-
cols). However, the large 32 cm dosimetry phantom underestimates dose 
in paediatric CT. A standard 16 cm phantom is a reasonable presentation 
of paediatric patient size, but phantoms with smaller diameters (between 8 
and 16 cm) would provide a better representation of younger age groups, 
such as infants (12).
CTDI is quantity which represents the mean dose within a CT slice. It 
is defined as the integral of the dose profile along a line parallel to the axis 
of rotation (z-axis) for a single rotation, divided by the nominal thickness 
of the x-ray beam (19):
Where N represents the number of slices simultaneously scanned for 
MSCT, h is the nominal slice thickness and D(z) represents the dose profile 
along the z-axis. The weighted CTDI (CTDIw) reflects the weighted sum of 
two thirds peripheral dose and one third central dose in a 100-mm range 
in the acrylic CT dosimetry phantoms. 
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The CTDIw defined above assumes procedures consisting of contiguous 
slices, which is normally the case for axial scans. However, the table move-
ment per rotation, defined as helical pitch, should be taken into account 
for helical CT (20). Pitch is the table movement per rotation divided by the 
slice thickness (multiplied by N for a MSCT scanner). To account for the 
effect of pitch in helical CT scanning, the indicator CTDIvol was introduced 
(21):
CTDI (in any form) is an estimate of average radiation dose only in 
the irradiated volume. Risk from IR exposure in CT imaging, however, is 
more closely related to the total amount of the radiation dose (i.e. energy) 
deposited in the patient (20). The indicator DLP gives a better representa-
tion of the overall energy delivered by a given scan protocol. Since CTDIvol 
represents the average dose per tube rotation, DLP can be easily derived by 
taking into account the scan length (21):
2.3.2
National DRLs
National DRLs are based on large scale surveys of the dose parameters 
representing typical practice for a patient group (e.g. adults or children of 
different ages) at a range of representative national CT centres for a spe-
cific type of CT examination, taking into account different CT scanners 
and scanning protocols. National DRLs (NDRLs) are commonly set at the 
third quartiles of the national distribution (22) (see Figure 2.5). As such, 
NDRLs are not optimum doses, but nevertheless they are helpful in iden-
tifying potentially unusual practice (the highest 25% of the distribution). 
NDRLs are intended to promote awareness, dose audit and serve as a basis 
for improving patient radiation protection, while maintaining required di-
agnostic quality. 
In 2007-2009, a multicentre study was set up in Belgium to evaluate 
CT exposure of children by investigating radiological practice and patient 
doses for five common CT examinations over four age ranges (0-1 y; 1-5 
y; 5-10 y and 10-15y) (12). The survey revealed a strong radiation protec-
tion awareness among the CT users today and all centres adapted their CT 
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Since 2006, the Federal Agency of Nuclear Control (FANC) in Belgium 
has started studies on patient dosimetry in radiology, in order to assess the 
patient dose received by the most common CT examinations. These sur-
veys are conducted periodically and in the meantime, already three itera-
tions were completed. Based on this national benchmarking, NDRLs were 
determined for standard paediatric CT examinations. Table 2.2 presents 
the national DRLs after the third iteration of the patient dosimetry study. 
The 75th percentiles of the analysed patient dose distributions represent 
the NDRLs, as identified the European MED guidelines (97/43/Euratom). 
In addition, the 25th percentiles are presented, defined as target values. 
These target values represent good clinical practice and demonstrate that 
optimisation should go further than the NDRLs.
FIGURE 2.5
Illustration of CTDIvol and DLP (for the total examination) frequency 
distribution used for the determination of the NDRLs for abdomen CT 
examinations in Belgium (paediatric frequency distribution were not 
available). 25P = 25th percentile, 75P = 75th percentile. Figure from (23).
exposure parameters when children were scanned. This is encouraging, 
however, large differences in dose distributions between the different cen-
tres were observed.
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2.3.3
European DRLs
Several European countries published NDRLs for paediatric CT imaging 
(9, 24-28). In the framework of the DDM2 project, a European wide survey 
on the availability of these national DRLs was performed in 36 countries 
(29). This survey revealed that only 39% of the countries have established 
DRLs for paediatric x-ray examinations and 45% of EU and EFTA coun-
tries (Iceland, Norway, Switzerland). However, no Belgian DRLs for paedi-
atric radiology were included in the survey (they were probably not pub-
lished at that time). The results of the DDMED 2 project show that there 
is still a long way to go to update and establish European DRLs for paedi-
atric CT imaging. The minimum over maximum ratio’s show large varia-
tions for some specific ages and procedures, e.g. CT chest examination 
for newborns. The results of the survey in terms of DRLs are presented in 
Table 2.3. Up to now, no European DRLs for paediatric CT imaging were 
published. In order to consolidate what is available at the moment and to 
provide guidance on what actions are needed for using DRLs to further 
enhance the radiation protection of children, the European Commission 
funded the PiDRL (European Diagnostic Reference Levels for Paediatric 
Imaging) project to establish European DRLs for paediatric patients. 
TABLE 2.2
Belgian DRLs for paediatric CT examinations 
based on the third patient dosimetry CT survey 
(source: www.fanc.fgov.be).
CT examination
CTDIvol DLP (total investigation)
Percentile 
25
Percentile 
75
Percentile 
25
Percentile 
75
Cranium (brain) 21 44.5 350 755
Sinus 2.2 6.0 28 75
Chest 1.3 3.6 33 125
Abdomen 3.2 6.7 120 320
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2.4
Overview of epidemiological 
studies on paediatric CT imaging
As the field of epidemiology advances, a better understanding of the health 
effects of low-dose exposures is the next challenge (30). Up to now, there 
are a few epidemiological studies dealing with leukaemia and cancer risks 
related to CT x-ray exposure of children which will be presented in the 
following paragraphs.
In 2012, Pearce et al. published in The Lancet the results of a record 
linkage study of leukaemia and brain cancer incidence after childhood 
CT exposure (31). The authors focussed on leukaemia and brain tumours, 
since red bone marrow and brain are highly radiosensitive tissues in chil-
dren (as described in chapter 1), and the short latency period of leukaemia 
(and to an extent brain cancer). The average follow-up time was a little un-
der 10 years and the cohort of this epidemiological study comprised of 178 
604 children (0 – 21 years) without previous malignant disease, who un-
derwent a CT scan between 1985 and 2002 in various hospitals in the UK. 
The collection of CT settings was not possible for every individual patient 
from the electronic database during the study period. Therefore typical CT 
TABLE 2.3
Range of DRLs for paediatric patients, in terms of DLP. The 
values are based on national surveys conducted in Austria, 
France, Ireland, the Netherlands, UK and Switzerland (29).
CT examination DLP (mGycm)
Age
0 1 5 10 15
Head
range 270 - 340 270 - 470 470 - 700 620 - 900 850 - 920
min/max 1.3 1.7 1.3 1.5 1.1
Chest
range 12 - 200 28 - 200 55 - 230 105 - 370 200 - 205
min/max 16.7 7.1 4.2 3.5 1.0
Abdomen
range 27 - 130 70 - 166 125 - 230 240 - 400 400 - 500
min/max 4.8 2.3 1.8 1.7 1.3
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FIGURE 2.6
Relative risk of leukaemia and brain tumours in relation to estimated 
radiation doses to the red bone marrow and brain (mGy). Left graph – 
Leukaemia, Right graph – Brain tumours. The dotted line represents the 
fitted linear dose-response (ERR per mGy). Data from (31). 
settings from two national surveys, together with data from a series of hy-
brid computational phantoms (reference male and female between 0 and 
22 years) and Monte Carlo radiation transport techniques were used to es-
timate absorbed doses to the red bone marrow and brain. Significant dose 
responses were reported for leukaemia and brain cancers, see Figure 2.6. 
The data of Pearce et al. confirm that the cancer risk associated with CT x-
ray examination of children is very small, but not zero. The individual risk 
is very small and far outweighed by the benefit of the diagnosis, provided 
the scan is clinically justified. The estimated lifetime risk for leukaemia 
from one paediatric CT scan based on the LSS data was about 1 in 10 000 
(32), which is in good agreement with the estimate of approximately 1 in 
10 000 of Pearce et al. (31). The lifetime risk estimate for brain cancer in 
the study of Pearce et al. was 1 in 10 000, however, the average length of 
follow-up in this study was only 8 – 10 years (25). The study of children 
epilated with x-rays for the treatment of tinea capitis highlighted that only 
10 % of the final risk of brain cancer shows up in the first decade after ir-
radiation (33). This would indicate that the risk for brain cancer reported 
by Pearce et al. is certainly an underestimate.
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An Australian linkage study, with a mean follow-up 9.5 years, was con-
ducted by Mathews et al. (34). The study cohort included 10 939 680 peo-
ple, from which 680 211 (6.2%) were children and adolescents allocated 
into the CT exposed group and 18% of the exposed group had more than 
one scan. An increase of 24% in cancer incidence was reported for exposed 
compared to unexposed individuals. The largest incidence risk was found 
for brain cancers, although incidence was also increased significantly for 
cancers of the digestive organs, melanoma, soft tissue, female genital or-
gans, urinary tract, thyroid, Hodgkin lymphoma, other lymphoid cancers, 
all leukaemias and myelodysplasias. However, no separate increase in in-
cidence risk for breast cancer was reported. It seems implausible that in-
creased radiation risks were reported for melanoma, which is not known 
to be associated with radiation, but not for breast cancer, a radiosensitive 
site.
When we compare the ERR per mGy of the Australian study with the 
study of Pearce et al. in the UK, similar estimates were found for leukae-
mia; Australian ERR of 0.039 (1 year lag) versus UK ERR of 0.036 (2 year 
lag). For brain cancers, the ERR per mGy was also comparable for a 5 year 
lag period, Australian ERR of 0.021 versus UK ERR of 0.023. However, the 
ERR for brain tumours are higher in both epidemiological studies com-
pared to the LSS results for a 10 year lag period, which is more appropriate 
for brain cancers (e.g. Australian ERR of 0.015 compared to LSS ERR of 
0.006). This points to the phenomenon of ‘reverse causation’, this means 
that cancers may have been caused by the medical indications prompting 
the CT scan rather than by the CT dose (35). 
Finally, there were also the studies of Huang et al. (36) and Krille et al. 
(37). The first authors evaluated the association between a paediatric head 
CT scan and the risk of a malignant and benign brain tumour in a Taiwan 
cohort of 24 418 participants under 18 years of age who underwent a head 
CT examination between 1998 and 2006 (36). The risk of a brain tumour 
was 2.6 times higher in the exposed cohort than in the unexposed cohort 
after 8 year follow-up. In the same study, the risks of leukaemia and all 
cancers combined were increased as well. Krille et al. assessed the risk of 
developing cancer, specifically leukaemia, tumours of the central nervous 
system and lymphoma, before the age of 15 years in children previously 
exposed to CT in a German cohort of 44 584 children (37). They reported 
standardised incidence ratios (SIR) using incidence rates from the general 
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population. For leukaemia, the SIR was 1.72 and for brain tumours, the 
SIR was 1.35. 
An overview of the differences in study designs, exposed cohorts and 
epidemiological risk estimates between the four presented studies can be 
found in Table 2.4. 
Besides the limited dosimetry and short follow-up time, one of the ma-
jor limitations in these studies is the lack of information about indications 
for the CT scans and the consequent potential for “reverse causation”. The 
authors of the mentioned publications tried to reduce the reverse causa-
tion by using a latency period to exclude patients from the cohort who had 
an exit date of less than 1 or 2 years in the case of leukaemia or less than 1, 
2 or 5 years for brain tumours after the first scan, depending on the study 
(see Table 2.4). Furthermore, the adolescents with ages above 18 years as 
reported in the studies of Pearce et al. (31) and Mathews et al. (34), can 
no longer be considered as children and certainly not for brain tumours, 
where the susceptibility decreases as brain development nears completion.
UK Australia Taiwan Germany
Cohort
Size 178 604 10 939 680 122 086 44 584
Exposed 178 604 680 211 24 418 (head CT) 44 584
Age at exposure 0 to <22 0 to <19 0 to <18 0 to <14
Follow-up period 1985 - 2008 1985 - 2007 1998 - 2008 1980 - 2010
Leukaemia
Risk estimate 3.18 1.23 1.90 1.72
95% CI 1.46 - 6.94 1.08 - 1.41 0.82 - 4.40 0.89 - 3.01
Latency 2 years 1 year 2 years 2 years
Brain and CNS tumours
Risk estimate 2.82 2.13 2.56 1.35
95% CI 1.33 - 6.03 1.88 - 2.41 1.44 - 4.45 0.54 - 2.78
 Latency 5 years 1 year 2 years 2 years
TABLE 2.4
Comparison of the cohort composition and the risk estimates 
for leukaemia and CNS or brain tumours for the four described 
epidemiological cohort studies on cancer risk after CT scans in 
childhood. Table from (37).
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Journy et al. tried to deal with the bias by indication and studied a co-
hort of 67 274 children who had a first CT before the age of 10 years from 
2000 to 2010 in 23 French radiology departments (35). The cancer risk 
related to childhood CT was estimated and the influence of cancer-predis-
posing factors (PFs) (from discharge diagnoses) on the radiation-related 
risk was examined. The adjustment for PFs resulted in different estimates 
of the ERR. For an exclusion period of 2 years after the first CT scan and 
adjusting for all PFs, the ERR per mGy in the study of Journy et al. changed 
from 0.022 to 0.012 for CNS cancer, from 0.057 to 0.047 for leukaemia and 
from 0.018 to 0.008 for lymphoma (35). Although a dose-response trend 
was suggested for the risk of CNS cancer (but not for haematological can-
cers), no significant effect was actually observed. The ERR estimated for 
leukaemia, without any adjustment for PF, appeared comparable with the 
estimates from the UK study of Pearce et al. for children under 10 years 
of age at the first scan (31). These results confirm the need to consider 
the existence of PFs in estimating the cancer risks potentially induced by 
CT scans. However, the median follow-up was only 4 years in the French 
study, which is too short to provide any conclusive results about radiation-
induced cancer risks.
These recent epidemiological studies on childhood CT exposure have 
raised criticism with respect to the results in issues such as reverse cau-
sation, short follow-up periods, potentially missed exposure information 
and the absence of individual patient dosimetry. Epidemiological studies 
make it possible to estimate the expected magnitude of potential risk, and 
besides the recent studies presented above, additional studies are under-
way (38). The European FP7 project, EPI-CT (Epidemiological study to 
quantify risks for paediatric computerised tomography and to optimise 
doses) will offer opportunities to better address the current limitations 
(http://epi-ct.iarc.fr/). Because the risks associated with low doses of IR 
from CT scans are expected to be small, this multinational collaborative 
study is undertaken to ensure sufficient statistical power. The project in-
cludes nine national cohorts, including some of the previously mentioned 
cohorts, and has following objectives:
•	 Establish a large multinational cohort of more than 1 million patients 
who received CT scans during childhood.
•	 Develop individual estimates of organ-specific doses from paediatric 
CT scans using improved methods for dose estimation for paediatric 
patients.
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•	 Evaluate the radiation-related risk of cancer in the cohort and pilot 
test biological markers of CT-irradiation effects.
•	 Develop methods to characterise quality of CT images in relation to 
the corresponding examination dose.
•	 Provide recommendations for a “harmonised” approach to CT dose 
optimisation for paediatric patients in Europe.
Despite limitations, estimates are all we will have in the near future and 
even if they are only approximately, they are important at a time of increas-
ing concern about the major increase in the collective dose of diagnostic 
CT scanning. These epidemiological studies are an important piece of ad-
ditional evidence to show that low doses of radiation do carry some (ad-
mittedly small) risk, which must be taken into account (39). Furthermore, 
we passed an important bridge in the field of low dose radiation risks, since 
it is no longer tenable to claim that CT risks are “too low to be detectable 
and may be non-existent”. The conclusion of these epidemiological studies 
is that the individual risks are small but real (40). Since the associated risks 
are small, we can conclude that if a CT examination is clinically justified, 
there is no doubt that its benefits will by far exceed its risks. 
2.5
Estimation of radiation risk in paediatric 
radiology: the BEIR VII model
As described in the previous section, the quantification of the risk of low 
dose IR exposure (< 100 mSv) remains complex. So far, no epidemiological 
evidence has invalidated the risk predictions extrapolated from studies at 
high doses under the linear dose-response assumption (31, 41). However, 
the described epidemiological studies are inherently difficult and large un-
certainties remain to be solved. 
The most widely accepted model of low-dose risk estimation using cur-
rent scientific evidence is predominantly based on LSS data, with a linear 
extrapolation of the risks at high doses down to low doses, with no thresh-
old (42, 43). The use of this linear no-threshold (LNT) model is the main 
paradigm of radiation protection and still subject of an active debate (44, 
45). However, despite the lack of extensive epidemiological evidence, the 
LNT model remains the most reasonable assumption regarding the dose-
response relationship at low levels. 
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A model for estimating the theoretical lifetime attributable risk (LAR) 
due to low-dose and low LET radiation exposure is provided in the Bio-
logical Effects of Ionizing Radiation (BEIR) VII report (42). This report 
represents the seventh in a series of reports from the National Research 
Council (NRC) prepared to advise the United States government on the re-
lationship between exposure to IR and human health. This seventh report 
is an update on the older BEIR V report (NRC 1990), using new informa-
tion from epidemiologic and experimental research that has accumulated 
during the previous 14 years. Since the 1990 BEIR V report, substantial 
new information on radiation-induced cancer has become available from 
the Hiroshima and Nagasaki survivors, slightly less than half of whom 
were alive in 2000. Of special importance are cancer incidence data from 
the Hiroshima and Nagasaki tumour registries. The risk estimation pre-
dominantly relies on LSS data, although other medically exposed cohorts 
were also taken into account for the risk assessment of breast and thyroid 
cancer. The use of LSS data has several advantages like the large size of the 
exposed cohort, including men, women and children, the extensive large 
follow-up, a wide range of doses and the whole body exposure resulting 
in an opportunity to asses cancer risks to several specific sites (42). In the 
BEIR VII report, a distinction is made between cancer incidence and can-
cer mortality rates, and the risk is dependent on gender and age (see Figure 
2.7). In the framework of this PhD, a paediatric population exposed to CT 
imaging was studied. The LAR method of the BEIR VII committee was the 
best choice to estimate radiation risks since patient’s age and gender can 
be taken into account. Based on the Monte Carlo simulated organ doses, 
site-dependent LAR of cancer incidence and mortality can be calculated 
for the organs in the field of view of CT scanning. 
The extrapolation from a high acute dose at a high dose rate as in the 
LSS studies to either a low dose or to a low dose rate can be embodied into 
a single correction factor, namely DDREF. For solid cancers, the BEIR VII 
committee proposes that risks are divided by a DDREF of 1.5 when esti-
mating risks for the relatively low doses in medical exposures (< 100 mGy) 
(46, 47). However, there remains uncertainty in the appropriate value of a 
DDREF for adjusting the low-dose risks based on linear estimates; ICRP 
and NRCP propose a value of 2, while UNSCEAR suggests even a DDREF 
of no more than 3. For the risk calculations performed in the framework 
of this PhD, a DDREF of 2 was chosen. 
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A lot of studies reported lifetime cancer risk estimates associated with 
low dose CT exposure as a function of age at exposure (14, 48, 49). These 
risk estimates were based on age-specific, gender-specific and organ-spe-
cific cancer risks derived primarily from the Japanese A-bomb survivors 
(14). The results of these ‘risk projection studies’ are not so far from the 
lifetime risk estimates for CT based on the epidemiological data (see 2.4), 
which are rescaled to the lifetime risk attributable to a single CT examina-
tion (40). For example, Brenner et al. estimated in 2001 a lifetime leukae-
mia risk of about 1 in 10 000 for one paediatric head CT (14), which is 
comparable with an estimated risk of 1 in 7500 lifetime risk with the data 
of Pearce et al. when a comparable age at exposure was taken into account 
(31, 40). The lifetime brain tumour risk in the study of Brenner et al. was 1 
in 2000, compared with the 1 in 1000 lifetime estimate calculated with the 
data of Pearce et al. (31, 40). We can conclude that the standard method of 
estimating radiation risks in the risk projection studies, yields fairly rea-
sonable results. Given the fact that we will have to wait several more dec-
FIGURE 2.7
Overall cancer incidence and mortality 
attributable to radiation exposure for all solid 
cancers and leukaemia for males (▲) and for 
females (■). Data from (41, 42).
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ades for epidemiologically based lifetime risks (when follow-up times of 
20, 30 or 40 years after exposure are reached), we will have to rely on this 
standard risk estimation method for several years to come (40). However, it 
should be noted that we must be cautious with the prediction of thousands 
of radiation-induced cancer and cancer deaths in the population in future 
years based on these risk models, a statement well adressed by Hendee and 
O’Connor in Radiology (41). For example, Berrington de Gonzalez et al. 
predicted 29 000 additional cancers and 14 500 cancer deaths caused by 
CT examinations each year (42). These predictions raised serious health 
concerns among the public and provokes anxiety in patients and families. 
Predictions of the effects of low doses of ionizing radiation should disclose 
all of the limitations in the current state of knowledge about low dose ra-
diation effects. In the meantime, efforts should be made with respect to 
justification of a CT examination in children and optimisation of CT doses 
in paediatric radiology.
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Biomarkers of x-ray induced 
DNA damage and repair
As described in the previous chapters, IR is a known carcinogen but 
the understanding of health risks at low doses and dose-rates remains con-
troversial in view of the restricted amount of epidemiological data. It is 
anticipated that significant insights will emerge from radiation biomarker 
studies. European initiatives, such as DoReMi and MELODI have sup-
ported the introduction of sensitive assays and biomarkers to shed new 
light on the cellular and molecular responses at low doses (1). A biomarker 
is defined as “any measurement reflecting an interaction between a bio-
logical system and a potential hazard, which may be chemical, physical, or 
biological. The measured response may be functional and physiological, 
biochemical at the cellular level, or a molecular interaction” (2). Within 
this PhD, we will focus on biomarkers of exposure, which are available at a 
certain time point after IR exposure and can be used to validate a correla-
tion between exposure and biological response (1).
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3.1
The DNA damage response
The integrity of an individual’s genome is continuously challenged by both 
endogenous and exogenous DNA damaging agents. Damaging agents can 
induce a wide variety of lesions in the DNA, such as single strand breaks 
(SSBs), double strand breaks (DSBs), oxidative lesions and pyrimidine di-
mers (3). The DNA damage induced by IR exposure is due to the direct 
effect of radiation on DNA molecules, which accounts for 30-40% of le-
sions, or by the generation of free radicals in intracellular H2O that in turn 
damage DNA, which accounts for 60-70% (4). The ratio of SSBs:DSBs in-
duced by IR is 20:1 (5). Of the various forms of damage induced by IR, the 
DNA DSB is considered to be the principle cytotoxic lesion, since inac-
curate repair or lack of repair of DSB can lead to mutations or cell death 
(6). Furthermore, there is experimental evidence for a causal link between 
the generation of DSBs and the induction of mutations and chromosomal 
translocations with tumorigenic potential (7-9). In order to maintain the 
genomic integrity of the DNA, cells have an integrated network of signal-
ling pathways to counteract the genotoxic effects of the lesions induced by 
IR exposure, known as the DNA damage response (DDR). Although the 
majority of lesions are effectively repaired, the advent of a single DSB poses 
such a threat to cell survival that DNA damage checkpoint proteins have 
to be activated to bring the cell into arrest. This provides time for repair to 
proceed or, in the case of overwhelming damage, apoptosis programs are 
started (10). 
The DDR provides a mechanism for transducing a signal from a sensor 
(DNA-damage binding protein) that in turn triggers the activation of a 
‘mediator/transducer’ system (protein kinase cascade), to target eventually 
a series of downstream ‘effectors’ that determine the cellular outcome of 
DNA damage caused by radiation (see Figure 3.1). The three main effector 
outcomes are 1) cell-cycle arrest to slow down progression in cell cycle in 
order to provide time for repair, followed by the activation of DNA repair 
by recruiting DNA repair proteins to the DNA DSB or cellular senescence; 
or 2) the triggering of programmed cell death (apoptosis). 
The signalling of DNA DSBs is fundamental for cells and the DDR path-
way exhibits a critical function on the protection against human cancer, as 
indicated by the high cancer predisposition of individuals with germ-line 
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mutations in DDR genes (12, 13). The signalling network is highly regulat-
ed and provides an accessible classification system of sensors, signal trans-
ducers, mediators and effectors; however, several publications indicate that 
many proteins satisfy the criteria of more than one category, pointing to-
wards a series of highly cooperative pathways with overlapping functions 
(10). In the following sections, we give an overview of the major proteins 
involved in DDR in response to DNA DSBs.
FIGURE 3.1
The general organization of the DNA-damage response 
pathway. The presence of a DSB is recognized by a sensor, 
which transmits the signal to a series of downstream effector 
molecules through a transduction cascade of DNA damage 
mediators, to activate signalling mechanisms for cell-cycle 
arrest and induction of repair, or cell death. The central role of 
ATM and ATR in DNA damage response is illustrated. Figure 
from (11).
PA
RT
 I 
66
Children are the most important target group in mediCal radiation proteCtion
3.1.1
DNA damage sensors and transducers
Members of the phosphatidylinositol 3-kinase like kinase (PIKK) serine/
threonine protein kinase family play an important role in different stages 
of DNA signalling. This protein kinase family includes DNA-dependent 
protein kinase catalytic subunit (DNA-PKcs), the ATM and ATM- and 
Rad3-related (ATR) protein kinases. While ATM and DNA-PKcs are criti-
cal for the signalling of DSBs, ATR is mainly activated by single-stranded 
DNA (ssDNA) regions that arise from stalled replication forks or process-
ing of bulky lesions (10) (see Figure 3.1). It has been shown that when 
ATM activity is compromised, DNA PKcs can compensate to a certain de-
gree for the defective ATM in some situations (14). 
There remains controversy about the proteins that initially sense the 
DNA DSBs and start the signalling response. Critical roles in the detection 
of DNA damage have been ascribed to the Mre11/Rad50/Nbs1 (MRN) 
complex and the Ku70/80 proteins function as sensors of DSBs, which are 
also involved in the processing of DNA break ends (12). The MRN com-
plex recruits ATM via the interaction with the C-terminus of Nbs1, while 
Ku70/80 recruits DNA PKcs to DNA lesion sites (15). A similar sensing 
process exists for ATR, where ATR is recruited to ssDNA regions marked 
with Replication Protein A (RPA) via a process that requires the ATR inter-
acting protein (ATRIP), Rad17 and the so-called 9-1-1 complex of Rad1-
Rad9 and Hus1, that stimulate the kinase activity of ATR (see Figure 3.1). 
Because cells derived from Ataxia Telangiectasia (AT) patients display 
hypersensitivity to ionizing radiation, and defects in cell cycle checkpoint 
activation, ATM is considered to be a key protein kinase involved in DSB 
responses (16). In undamaged cells, ATM forms an inactive dimer (or 
multimer). When DSBs are generated and ATM interacts with Nbs1, the 
effective concentration of ATM increases and ATM is autophosphorylated 
on serine 1981 leading to its dissociation in kinase active monomers (10). 
In addition to the phosphorylation process, there occurs also dephospho-
rylation of ATM by several phosphatases such as protein phosphatase 2A 
(PP2A), which is necessary for the regulation of ATM activity (17) (see 
Figure 3.2). Experimental evidence has showed that the MRN complex 
is required for ATM auto-phosphorylation and for retention of ATM on 
chromatin following DNA damage. This suggests that the MRN complex 
functions indeed as a sensor upstream of ATM during the early stages of 
the DNA damage response (18, 19). Activated ATM monomers have been 
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A critical target of ATM is the phosphorylation of the C-terminus of the 
histone variant H2AX (γ-H2AX), although this step can also be carried out 
by DNA PKcs or ATR. H2AX is among the earliest of substrates to become 
phosphorylated following DSB induction, achieving a plateau within 30 
min. This leads to a positive feedback amplification loop, in which γ-H2AX 
functions as a binding site for the BRCA1 C-terminal (BRCT) domains of 
the Mediator of DNA damage Checkpoint 1 (MDC1) protein (21), illus-
trated in Figure 3.3. Positioning of MDC1 at the DSB creates a docking 
site for additional repair proteins and recruits the MRN-ATM complex 
to the DSB site, where activated ATM phosphorylates a large number of 
‘mediator’ substrates, such as p53 binding protein 1 (53BP1) and Breast 
shown to phosphorylate hundreds of proteins, including proteins involved 
in checkpoint activation ( e.g. p53 and Chk2) and DNA-repair proteins 
(20). 
FIGURE 3.2 
Activation of ATM kinase. Under physiological conditions, ATM exists 
as a dormant dimer in association with PP2A. In response to DSB ATM 
autophosphorylates, resulting in the release of active ATM monomers, 
which phosphorylate H2AX (γH2AX). A positive feedback amplification loop 
arises, with γH2AX recruiting ATM to sites of DSB, where it phosphorylates 
substrates such as MDC1, 53BP1 and BRCA1. Data from (10).
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Cancer early onset-1 (BRCA1). MDC1 counteracts the dephosphorylation 
of γ-H2AX by PP2A and possible other phosphatases. γ-H2AX serves as 
a platform for signalling onto which DDR proteins are concentrated to 
amplify the initial signal (22). It is illustrated in Figure 3.2 that the phos-
phorylation of H2AX orchestrates the retention of many DDR proteins at 
sites of DSBs. This cascade of reactions spreads H2AX phosphorylation 
over a distance of a few megabase-long domains (23). This clustering of 
DDR proteins is commonly referred to as irradiation-induced foci (IRIF). 
The modified mediator proteins then amplify the DNA damage signal and 
transduce the signals to downstream effectors such as Rad51, Artemis, 
Chk2 and p53 (24).
FIGURE 3.3
Model of MDC1-regulated phosphorylation of H2AX. In the first 
step, the MRN complex binds at the DNA ends and recruits 
ATM, which phosphorylates H2AX. Afterwards, MDC1 binds 
proximal phosphorylated H2AX and recruits more MRN-ATM, 
which phosphorylates more distal H2AX. This cascade of events 
contributes to the spreading of γ-H2AX to more distal chromatin 
regions. Figure from (23).
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3.1.2
DNA damage effectors
As described above, the induction of DNA DSBs leads to the activation 
and integration of a diverse network of proteins. This culminates in the ac-
tivation of effector pathways, including cell cycle checkpoint responses to 
allow DNA repair or, in certain cases, the initiation of apoptotic programs 
(25). The overall function of cell cycle checkpoints is to detect damaged or 
abnormally structured DNA, and to coordinate cell-cycle progression with 
DNA repair. Typically, cell-cycle checkpoint activation slows or arrests 
cell-cycle progression, thereby allowing time for appropriate repair mech-
anisms to correct the radiation-induced lesions before they are passed on 
to the next generation of daughter cells.
3.1.2.1
Cell cycle checkpoints
The control of the mammalian cell cycle division is subjected to numer-
ous cyclin-dependent kinase (cyclin-Cdk) complexes, which regulate the 
movement through the cell cycle (see Figure 3.4). To ensure fidelity of 
DNA replication and chromosome segregation, cell cycle checkpoint arrest 
ensures the activation of surveillance mechanisms to prevent progression 
through the cell cycle until critical processes have been completed (26). 
The cell possesses several checkpoints, namely the G1/S, intra-S-phase and 
FIGURE 3.4
Control of the cell division cycle by cyclin-Cdks and their regulation by 
cell cycle checkpoints In the early G1 phase of the cell cycle, Cdk4/6–
Cyclin D complexes are active. Subsequently, entry into and progression 
through S phase are regulated by Cdk2–Cyclin E and Cdk2–Cyclin A, 
respectively, while the onset of mitosis is governed by Cdk1 (Cdc2)–
Cyclin B. Figure from (28).
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G2/M restriction points. When a cell arrives at a cell cycle checkpoint, it 
must assess whether its genome is fit for division, or whether it must allow 
time for DNA repair (27). Checkpoint activation is based in the inhibition 
of the cyclin-Cdk complexes, which regulate the movement through cell 
cycle. 
In the presence of DNA damage, the G1/S checkpoint prevents replica-
tion of cells that were in G1 at the time of DNA damage to progress into 
S-phase. The checkpoint is mediated by two distinct signal transduction 
pathways, the Chk1/Chk2-Cdc25A-Cdk2 pathway (29) and a second path-
way centred on tumour suppressor p53. The G1 arrest is a consequence of 
the inhibition of Cdk2, repressing the release of the G1/S phase-promoting 
E2F transcription factor (28, 30, 31).
During the S-phase, damaged DNA inhibits replicative DNA synthe-
sis, which is referred to as an intra-S-phase checkpoint. Downregulation 
of CDC25A subsequently causes inactivation of the S-phase-promoting 
Cdk2 –cyclinE and prevents loading of Cdc45 on replication origins (29).
The G2/M checkpoint prevents the cells from entering into mitosis and 
transducing DNA damage to daughter cells. The checkpoint is subject to 
the Chk1/Chk2-Cdc25c-Cdk1 pathway. The arrest is achieved through 
Cdk1-cyclinB kinase inhibition of the Cdc25c phosphatase (28, 29).
3.1.2.2
DNA repair pathways
IR can induce different types of DNA lesions, which require different 
repair pathways. Base damage and DNA SSBs can be repaired by ‘base-
excision repair’ (BER). Other excision repair mechanisms are ‘nucleotide 
excision repair’ (NER) and ‘mismatch repair’ (MMR), however the latter 
repair pathways are less important in the framework of IR induced DNA 
damage. DNA DSBs are the most serious and lethal types of DNA damage, 
since a single DSB is sufficient to kill a cell or disturb its genomic integrity. 
In the following paragraphs, we will focus on the two major repair path-
ways for DSBs in mammalian cells: homologous recombination (HR) and 
non-homologous end-joining (NHEJ). The HR pathway is error free but 
requires an intact homologous template, while the error prone NHEJ is 
the most prominent pathway for DSB repair in mammalian cells and does 
not require a homologous sequence to guide the repair (19, 30) (see Figure 
3.5).
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Homologous recombination (HR): HR-mediated repair is characterized 
by deriving the correct sequence from a homologous strand of intact DNA, 
which allows high-fidelity repair of DSBs. Thus, HR is typically error-free 
and occurs without loss of genetic information. Because HR depends on 
the existence of sister-chromatids to provide repair templates, it must 
occur during the late S-phase and G2-phase. The production of ssDNA 
requires the initial nuclease activity of the CtlP-MRN complex. DNA le-
sions are recognized by the MRN complex, and transmits the signal to 
mediators such as ATM and ATR. These mediators phosphorylate repair 
factors including H2AX and CtIP-interacting protein (CtIP), BRCA1 and 
exonuclease 1 (EXO1). HR requires the phosphorylation of CtIP at serine 
327 by Cdk, for the recruitment of BRCA1 and commitment to HR (27). 
Endonucleolytic cleavage by the MRN complex allows resection, which is 
mediated by CtIP and EXO1 in the presence of BRCA1 and Bloom’s syn-
drome helicase (BLM). The single-stranded DNA generated by resection is 
rapidly coated by RPA and subsequently replaced by Rad51 in the presence 
of BRCA2. Rad 51 and its paralogs, such as XRCC3, are critical in homol-
ogy searching to identify a homologous sequence and mediate invasion of 
the sister chromatid. When a homologous sequence is found, the invaded 
strand is extended by DNA polymerase and ligated to form D-loop struc-
tures. There is an exchange of the damaged strands, such that each strand 
is now paired with a homologous template. The damaged strands are then 
extended and ligated, restoring the original double strand (23).
Non-homologous end-joining (NHEJ): In contrast to the HR pathway, 
DNA repair through NHEJ is thought to occur rapidly throughout the cell 
cycle. The Ku70/80 heterodimer binds with high affinity to broken DNA 
termini in a non-sequence-dependent manner. Binding of Ku to the DNA 
recruits the catalytic subunit of DNA PKcs to the DSB site, leading to the 
activation of DNA PKcs serine-threonin kinase activity by binding to the 
DNA. ATM-mediated phosphorylation of H2AX and the recruitment of 
53BP1 protects DSB ends from being resected. It is noteworthy that in the 
absence of Ku, DNA-PKcs bind to DNA termini, albeit with a 100-fold 
lower affinity (31). The activated DNA PKcs facilitate then the recruit-
ment of other repair factors to the DSB site, such as Artemis, the XRCC4/
DNA ligase 4 complex and XRCC4-like factor (XLF). Artemis facilitates 
end processing and, subsequently, DNA ligase 4 (LIG4), XRCC4 and XLF 
ligate the broken DNA termini to complete repair (32). It has been suggest-
ed that in mammals, the MRN complex, which possesses nuclease and hel-
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icase activities and localizes at nuclear foci that are associated with DSB, is 
involved in the processing of the broken DNA ends in both HR and NHEJ 
(33). Although NHEJ efficiently rejoins the DSB ends, it often causes a loss 
of genetic information due to the loss of a few nucleotides at each broken 
end. NHEJ is the most common pathway in higher eukaryotes, and pre-
dominates in most stages of the cell cycle, particularly in G0 and G1 (34). 
How cells regulate the choice between HR and NHEJ repair pathways 
is not well understood, although both the 53BP1 and BRCA1 proteins can 
play a key role in this choice (20). Over the past decade, a number of al-
ternative DSB repair mechanisms were identified. These include alterna-
tive end joining pathways, also known as backup NHEJ, which operate 
independently of factors such as DNA-PKcs, XRCC4 and LIG4 (35). They 
are suspected to be more error-prone than the classical NHEJ pathway. 
Furthermore, single-strand annealing and break-induced replication were 
recently observed in mammalian cells where they may contribute to DSB 
repair (36, 37), especially in association with replication. 
FIGURE 3.5
Illustration of DNA double-strand break (DSB) repair pathways in mammals. DSBs are 
predominantly repaired by either an error-prone pathway - non-homologous end-
joining (NHEJ), or an error free pathway - homologous recombination (HR) (32).
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3.1.2.3
Apoptosis
Apoptosis is known as a ‘programmed cell death’ and represents an ordered 
suicidal process that results in the destruction and removal of damaged 
cells. Apoptosis plays a major role in the maintenance of tissue homeosta-
sis and the removal of cells during certain developmental processes, such 
as during lymphocyte development and differentiation. Moreover, it ap-
pears to be exploited by the damage response to specifically remove cells 
containing a threshold level of DNA damage. Thereby apoptosis limits the 
potential for the damaged cells to accumulate mutations that might lead 
to carcinogenesis and to prevent the transfer of defective genetic material 
to daughter cells. Apoptosis is is often viewed as a mechanism for elimi-
nating severely damaged cells that might otherwise threaten the health of 
the organism in which the threshold level of damage required to trigger 
apoptosis seems to be highly cell type–dependent (38). There are various 
experimental systems, which show that defects in the execution of apopto-
sis increase cancer incidence (39, 40). 
Apoptosis is characterised by morphological changes, including plasma 
membrane blebbing, peripheral condensation of the nuclear DNA without 
disassembly of the nuclear envelope, chromatin condensation and cleav-
age of the nucleus into membrane-enclosed structures, known as apoptotic 
bodies (41). These changes distinguish apoptosis from necrotic cell death, 
which can also result from DNA damage. Necrosis is considered as “un-
controlled” cell death, resulting in a loss of membrane integrity, swelling 
of cellular organelles and disrupture of the cells. During necrosis, the cel-
lular contents are released uncontrolled into the cell’s environment which 
can result in a strong inflammatory response in the surrounding tissue 
(42) Apoptosis is a complex process that can proceed through at least two 
main pathways (extrinsic and intrinsic), each of which can be regulated at 
multiple levels (43).
The primary regulators of apoptosis are proteins belonging to a group 
known as the B-cell CLL/lymphoma 2 (Bcl-2) family, including both pro- 
as well as anti-apoptotic molecules (44). The ratio between pro- and anti-
apoptotic family members determines whether or not a cell will undergo 
apoptosis. Apoptosis regulators also include death receptors on the cell 
surface which bind to death signalling molecules, as part of the extrin-
sic apoptotic pathway. Apoptosis is characterized by the activation of the 
members of a specialised family of cysteine aspartyl proteases, the cas-
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FIGURE 3.6
Model of the intrinsic and extrinsic 
apoptotic pathways (45).
pases. Active caspases are heterodimeric, consisting of large and small 
subunits generated by caspase-mediated cleavage. Sequential activation of 
caspases plays a central role in the execution-phase of cell apoptosis, with 
a potential for amplification of apoptotic signals through caspase cascades. 
In human cells caspases 8 and 9 play key regulatory roles in these cascades, 
whereas other members of the family perform effector roles downstream 
(40).
A brief overview of the extrinsic and intrinsic apoptotic pathways can 
be found in Figure 3.6. In the extrinsic pathway, death signals from the 
surrounding environment of the cell bind to death receptors on the surface 
of the cell membrane. This causes the conversion of inactive pro-caspase-8 
into active caspase-8. Caspase-8 then goes on to activate caspase-3, which 
begins the caspase cascade that leads to apoptosis. 
In addition to its cell cycle regulatory functions, p53 serves as a regu-
lator of the apoptosis and plays a key role in both extrinsic and intrin-
sic pathways. In the intrinsic pathway, typically initiated by DNA dam-
age, p53 is activated, escapes degradation and enables the activation of its 
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target genes involved in apoptosis; e.g. pro-apoptotic Bcl-2-associated X 
(Bax), Bcl-2 homologous antagonist killer (Bak), p53 up-regulated modu-
lator of apoptosis (Puma), Noxa, and apoptotic protease activating factor 
1 (Apaf1). The activation of the pro-apoptotic protein Bax by p53, initi-
ates the release of cytochrome c from the mitochondria. Apaf-1 and the 
released cytochrome c combine to form a complex known as the apopto-
some. This apoptosome causes the conversion of inactive pro-caspase-9 
into active caspase-9. Caspase-9 then goes on to activate caspase-3 in a 
similar manner to the extrinsic pathway. 
Thus, once activated, initiator caspases 8 and 9 in turn activate the ex-
ecutioner caspases: caspases-3, -6, and -7 (46). Caspase-3 and the other 
executioner caspases are required for initiating the hallmarks of the deg-
radation phase of apoptosis, and are indispensable for apoptotic chroma-
tin condensation and DNA fragmentation. Thus, caspase-3 is an essential 
executioner caspase that initiates a caspase cascade, necessary for certain 
processes associated with the dismantling of the cell and the formation of 
apoptotic bodies (47).
3.2
Chromatin structure 
and DNA repair
One of the striking features of the eukaryotic cell nucleus, which carries 
and reads the genetic information, is its functional and structural com-
plexity. The human genome contains some 35 000 genes and 3.2 billion 
base pairs of DNA (48). The packing of the human DNA into chromatin is 
an extremely efficient way to store the DNA within the nucleus of approxi-
mately 5 to 10 μm (see Figure 3.7). The primary protein components of 
chromatin are histones that compact the DNA into a nucleosome. The nu-
cleosome core particle represents the first level of chromatin organization 
and is composed of two copies of each of histones H2A, H2B, H3 and H4 
(the core histones) (49). Nucleosome cores are separated by linker DNA 
of variable length and are associated with the fifth histone H1, which is 
bound to the DNA as it enters each nucleosome core particle. This forms a 
chromatin subunit known as a chromatosome. The next level of chromatin 
organization is the 30-nm fibre, which is composed of packed nucleosome 
arrays arranged as a two-start helical model, and mediated by core histone 
internucleosomal interactions (50). 
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The organization of DNA into chromatin is not only important for re-
solving spatial and organization problems, but it is also essential for the 
functional utilization of the DNA and the proper coordination of its meta-
bolic activities (51). Several chromatin states are likely to be regulated and 
maintained in a tissue-specific manner, making the DNA accessible to the 
transcription machinery during specific periods of the cell cycle and at 
precise locations. During interphase, the chromatin is structurally decon-
densed and distributed throughout the nucleus to allow gene transcription 
and DNA replication in preparation for cell division. Most of the euchro-
matin in interphase nuclei appears to be in the form of 30-nm fibers, or-
ganized into large loops. About 10% of the euchromatin, containing the 
FIGURE 3.7
Illustration of DNA packing into chromatin and 
chromosomes. DNA wraps around proteins called 
histones to form units called nucleosomes. These units 
condense into a chromatin fibre, which condenses 
further to form a chromosome. Figure from (53).
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genes that are actively transcribed, is in a more decondensed state (the 10-
nm conformation) that allows transcription. In contrast to euchromatin, 
about 10% of interphase chromatin (called heterochromatin) is in a very 
highly condensed state that resembles the chromatin of cells undergoing 
mitosis. Heterochromatin is transcriptionally inactive and contains highly 
repeated DNA sequences, such as those present at centromeres and telom-
eres (52).
DDR takes place within the complex organization of the chromatin, 
and it is clear from work in many model systems that chromatin struc-
ture and nucleosome organisation represent a significant barrier to the ef-
ficient detection and repair of DSBs (20). The structure of the chromatin 
in eukaryotic cells affects the accessibility of DNA and therefore has con-
sequences for all cellular activities, including DNA repair (3). A more open 
and accessible chromatin should facilitate both the generation of DNA 
modifications by endogenous and exogenous agents and the initiation of 
the repair, while more condensed and compact chromatin might protect 
against damage generation, but at the same time hinder and retard the 
detection by repair enzymes.
The influence of the chromatin structure on damage generation and re-
pair was demonstrated for DNA DSBs induced by ionizing radiation (54). 
Furthermore, chromatin condensation by hypertonic shock was shown to 
impede the repair of oxidative generated DNA base modifications (55). In 
the last years, several small-molecule modulators of the chromatin struc-
ture have been identified and tested for therapeutic applications in tumour 
therapy. An example of these compounds is ‘resveratrol’ (3,5,4’-trihydrox-
ystilbene) that induces a more condense chromatin compaction and there-
fore potentially decreases the accessibility of the DNA (56). The influence 
of resveratrol on damage generation and repair has not been studied in 
detail, but primary studies show that resveratrol decreases the repair rates, 
while damage generation remained unchanged (57). The influence of the 
chromatin status on DNA repair will be further explored in the discussion 
section (see chapter 11). 
 
PA
RT
 I 
78
Children are the most important target group in mediCal radiation proteCtion
3.3
Detection of x-ray effects 
at DNA level
A variety of tests can be applied to determine the initial radiation-induced 
DNA damage, its repair, the cellular outcome and the associated ‘radio-
sensitivity’. There are several endpoints that can be used as radiosensitiv-
ity markers, depending on the assay that is used: radiation-induced DNA 
damage, cell survival, chromosomal aberrations, direct and late effects af-
ter in vivo exposure. The kind of assay that should be used, will depend 
on the study design such as the time window after exposure, the required 
sensitivity and specificity and the available biological material. The hae-
matopoietic system contains some of the most radiosensitive and easily 
sampled cells in the human body. Furthermore, circulating lymphocytes 
are a synchronous G0 population with a relatively long life span to preserve 
the DNA damage. Therefore, peripheral blood lymphocytes have been 
widely used for the detection of radiation-induced DNA damage. Cytoge-
netic analysis of lymphocytes as a biomarker of IR exposure, covers a set of 
long-established techniques. To this group of assays belong the dicentric 
assay, the scoring of stable chromosome aberrations such as translocations 
with chromosome ‘painting’ and the micronucleus (MN) assay. Another 
group of biomarkers comprise DNA damage and repair assays, such as 
the comet assay, pulsed-field gel electrophoresis (PFGE) and the γ-H2AX 
foci assay. Other assays, representing the effect on cell survival, apoptosis 
and epigenetic processes can also be used. In the following sections, the 
main focus is on the cytokinesis-block micronucleus assay (CBMN) and 
the γ-H2AX foci assay, as these two assays were used as biomarker for this 
PhD research.
3.3.1
Mutagenic effects: cytogenetic assays
Cytogenetics focus on the study of chromosomes and several cytogenetic 
biomarkers have been routinely used as biomarkers of exposure (58). The 
fact that most established human carcinogens, such IR, are genotoxic and 
capable of inducing chromosomal damage is the primary rationale of us-
ing these assays. Furthermore, epidemiological studies suggest that a high 
frequency of chromosome aberrations (CAs) is predictive for an increased 
cancer risk which supports the link between increased frequency of cy-
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togenetic alterations and cancer risk (59). CAs are structural aberrations 
resulting from un- or misrepaired radiation-induced DSBs, comprising 
chromosome- and chromatid-type breaks and rearrangements, usually 
analysed by transmitted light microscopy of Giemsa-stained metaphase 
slides or by fluorescence microscope using fluorescence in situ hybrid-
ization (FISH) techniques. The dicentric assay is considered as the ‘gold 
standard’ for biological dosimetry and is based on the analysis of dicentric 
chromosomes in metaphase cells. In addition to its application in biologi-
cal dosimetry, cytogenetic analysis is also used to determine chromosomal 
sensitivity. The concept that genetic susceptibility to cancer development 
is related to genomic instability was initially supported by rare disorders, 
such as Ataxia Telangiectasia and Xeroderma Pigmentosum. Several stud-
ies showed that both disorders are associated with in vivo and in vitro chro-
mosomal instability and defective DNA repair capacity (60). The extend of 
genetic damage reflects critical events for carcinogenesis, such as an im-
paired ability to remove damaged DNA or failure to correctly rejoin DNA 
breaks, which have the potential to be cytogenetically detectable (60, 61).
The G0 or the cytokinesis-block MN assay in human lymphocytes is 
one of the most commonly used methods for measuring chromosom-
al damage and sensitivity. The assay is based on the in vitro culturing of 
peripheral blood lymphocytes, that are stimulated to divide with phyto-
haemaglutinin (PHA) after irradiation. After the completion of one nu-
clear division, cells are blocked from performing cytokinesis by the addi-
tion of cytochalasin B and will consequently appear as binucleated (BN) 
cells. Cytochalasin B is an inhibitor of the microfilament ring assembly 
required for the completion of cytokinesis (62). MN originate from chro-
mosome fragments or whole chromosomes that fail to engage with the 
mitotic spindle and therefore lag behind when the cell divides (60). Sev-
eral studies demonstrated that radiation-induced MN are predominantly 
derived from acentric fragments (63) and the observed MN in PBL are 
mainly the result of un- or misrepaired DSBs by the NHEJ repair pathway 
(64). Compared to other cytogenetic assays, the quantification of MN has 
several advantages, including speed and ease of analysis, no requirement 
for metaphase cells and reliable identification of BN cells which completed 
only one nuclear division. The latter prevents confounding effects caused 
by differences in cell division kinetics because expression of the genetic 
damage end points is dependent on completion of nuclear division (65). 
Over the past 20 years, the CBMN assay has evolved into a comprehensive 
method for measuring several outcomes, such as chromosome breakage, 
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DNA misrepair, chromosome loss, apoptosis, gene amplification through 
nuclear buds (NBUDs) and nucleoplasmic bridges (NPBs) as biomarker 
of dicentric chromosomes resulting from telomere end-fusions or DNA 
misrepair (66) (see Figure 3.8). The CBMN assay requires BN cells, so in 
principle, MN can be detected in all types of cells, as long as they are capa-
ble to divide after in vitro stimulation. In the framework of this PhD, a new 
method to perform the CBMN assay in HSPCs was developed.
FIGURE 3.8 
A. The various possible fates of the CBMN assay following exposure to 
cytotoxic/genotoxic agents such as IR: the measurement of chromosome 
breakage and loss (MN), dicentric chromosomes (NPB) gene 
amplification (NBUDs), necrosis and apoptosis. Microscopic images 
of B. binucleated (BN) cell; C. BN cell containing one MN; D. BN cell 
containing a NPB and a MN; E. BN cell containing NBUDs and a MN. 
Figure from (66).
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3.3.2
The γ-H2AX foci assay to detect DNA 
DSB damage and repair
The phosphorylation of the histone variant H2AX at the site of DNA DSBs, 
as described in 3.1.1, leads to the formation and accumulation of γ-H2AX 
foci in the cell nucleus within a few minutes after IR exposure. The maxi-
mum yield of foci is detected within 0.5 - 1h after irradiation, depending 
on the dose and cell type, and after this time point, the number of foci usu-
ally decreases to baseline levels within days (67). The scoring of γ-H2AX 
foci can be used as a direct endpoint to assess the formation of damage 
after IR exposure, whereas its persistence with time in irradiated samples 
can be used to evaluate DNA repair kinetics. Application of the γ-H2AX 
foci assay for both endpoints was used in this PhD research.
3.3.2.1
The role of γ-H2AX in the DDR
The histone variant H2AX was the first and most prominent protein for 
which foci formation at the site of a DSB was described. Phosphorylation 
of H2AX at its C-terminal Ser-139 residue is mediated by DNA damage 
activated protein kinases ATM, ATR and DNA-PKcs to form γ-H2AX (see 
also 3.1.1) (37). This phosphorylation event is restricted to a chromosomal 
region surrounding an unrepaired DSB however, it involves hundreds to 
thousands of histone modifications within this region, resulting in a mi-
croscopically detectable distinct spot or ‘focus’ of several hundred nano-
metres diameter following immunostaining against γ-H2AX (68). As de-
scribed in previous paragraphs of this chapter, phosphorylation of histone 
H2AX is critical for facilitating the assembly of specific DNA-repair com-
plexes on damaged DNA. This was supported by experiments in targeted 
H2AX mice in which H2AX-/- mice were radiation sensitive and showed a 
reduced capacity to repair DSBs (69). A short summary of the biological 
functions that have been suggested for H2AX, based on (70):
•	 Concentration of DNA damage signalling and repair proteins at DSBs, 
such as MDC1, resulting in the positive feedback loop that extends 
H2AX phosphorylation over a megabase region around the DSB (37, 
51, 71). 
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•	 Signal amplification and transduction to enhance the sensitivity of the 
DNA damage-induced G2 cell cycle checkpoint. The γ-H2AX depend-
ent recruitment of 53BP1 could facilitate the activation of the cell 
cycle checkpoint in situations with low levels of DNA damage when 
checkpoint effectors (Chk1/Chk2 ) are not sufficiently activated (72). 
•	 Implementation of an Artemis-dependent pathway required for the re-
pair of a subset of radiation-induced DNA DSBs with slow kinetics dur-
ing the G1-phase of the cell cycle by NHEJ. Since Artemis interacts with 
53BP1; γ-H2AX and 53BP1 may act as scaffolds to maintain Artemis 
at the DSB site (73). 
•	 Recruitment of cohesin to promote sister chromatid-dependent HR. 
Rapid phosphorylation of H2AX results in a large zone of modified 
chromatin surrounding the DNA DSB, to which cohesin can be re-
cruited to hold the broken chromatin in close proximity to its undam-
aged sister (74).
•	 Chromatin remodelling to assist DSB processing, by recruiting the chro-
matin remodelling complexes INO80 and SWR1 (75).
•	 γ-H2AX functions as a chromatin anchor to prevent the separation of 
break ends and enhance repair fidelity (72).
When repair is completed, γ-H2AX should be reverted to H2AX. The 
molecular mechanism of this elimination remains to be established, cur-
rently it is not clear wether dephosphorylation takes place directly in the 
nucleosome, or whether it requires removal of γ-H2AX from chromatin 
(reviewed in (76)). In contrast to γ-H2AX foci formation, the elimination 
is much slower. It is known that about 60% of initial IR-induced DSBs 
are transient with rejoining half-lives of the order of minutes, whereas the 
other 40% are persistent with rejoining half-lives of the order of hours (4). 
In principle, the elimination of γ-H2AX in mammalian cells can be done 
either directly by dephosphorylation of γ-H2AX or indirectly by replacing 
γ-H2AX in the nucleosome with H2AX followed by rapid dephosphoryla-
tion of H2AX protein after its displacement from chromatin (51, 76). 
3.3.2.2
Technical aspects of γ-H2AX 
foci detection
There is a close correlation between the number of DNA DSBs and γ-H2AX 
foci, and between the rate of foci loss and DSB repair, resulting in a sensi-
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tive assay to monitor DSB formation and repair in individual cells after IR 
exposure. The demonstration of precise γ-H2AX localization to the sites 
of DNA DSBs was achieved by the means of a laser scissor experiment, 
where DSBs were introduced through a pulsed laser microbeam. Subse-
quent immunocytochemistry showed that γ-H2AX forms precisely along 
this track of DSBs (68). The formation of γ-H2AX foci has been detected 
in fibroblasts and peripheral lymphocytes following radiation doses as low 
as 1 mGy, and the increase in foci yields is strongly dose-dependent (65, 
72). Each individual γ-H2AX spot represents one (or more) DNA DSB. 
Although γ-H2AX foci are observed by 3 min post irradiation in G0/G1-
phase cells (e.g. lymphocytes), their detection is difficult at this time due to 
the small size of the spots. The best time point for foci scoring is probably 
30 min post exposure, when most of the induced foci are still present and 
have reached a size and intensity that allow reliable scoring (5, 70). How-
ever, there exists considerable variation among the time points of maximal 
γ-H2AX foci formation (70) and it is important to note that the levels of 
foci may vary substantially between different cell types and also techni-
cal differences can play an important role. Differences in immunostaining 
protocols and reagents may produce differences in signal to noise ratios. 
Furthermore, differences in magnification and the optical resolution of the 
microscope and camera used for foci scoring can affect the detection of 
small spots. Furthermore, the sensitivity of the technique depends largely 
on the variability of foci levels in unirradiated cells, which points again to 
the fact that the technique is cell type dependent (70). 
In general, lymphocytes have several advantages that make them 
most suitable for evaluating γ-H2AX foci formation. First, a considerable 
amount of cells can be easily obtained within a short time frame before 
and after exposure. Second, the use of lymphocytes avoids cell cycle ef-
fects, since unstimulated lymphocytes are a synchronous populations of 
non-cycling cells (G0). Third, the percentage of nucleosomal H2AX vari-
ant was reported to be small in lymphocytes, resulting in a low γ-H2AX 
background (77).
The most frequently used techniques to score foci are immunofluores-
cence microscopy and intensity-based assays, such as flow cytometry. Mi-
croscopic foci quantification can be performed by manual scoring through 
the eye piece of the microscope, manual scoring of digital microscope 
images or by automated scoring using image analysis software (37). The 
main disadvantage of manual foci scoring by fluorescence microscopy 
is its time-consuming character. Furthermore, it requires some training 
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and to avoid subjectivity slides have to be coded. There is an ongoing in-
tensive development of high throughput γ-H2AX foci scoring systems to 
automate microscopic evaluation. Automatic scoring could exclude the 
scorer-subjectivity together with the time-consuming character of manual 
scoring. In all cases of microscopic scoring, it is important to define and 
maintain strict scoring criteria and this requires an extensive optimisation 
of spot counting when scoring software is used.
Analysis by flow cytometry may be quicker. However, it is not as sensi-
tive as microscopy, which has the advantage to discriminate objects such 
as foci from background staining spots (78). Certainly for the detection of 
DNA damage after low dose exposure as in diagnostic radiology, where 
foci signals can be elusive, a sensitive scoring method is more appropriate. 
Furthermore, attempts have been made to quantify DSB formation using 
H2AX by Western blotting. However, Western blotting techniques are, just 
like flow cytometry, hampered by the inherent background staining that 
arises from S- phase cells, which can differ between cell types and can be 
affected by the activation of cell cycle checkpoint arrest following radiation 
exposure (79).
Recently, live cell imaging of cells expressing fluorescent fusion pro-
teins that are recruited to the sites of DSB has enabled detailed studies of 
the spatio-temporal dynamics of foci formation (80). 
3.3.2.3
Double immunostaining 
of 53BP1/γ-H2AX foci
Since H2AX is phosphorylated following activation of the DDR, γ-H2AX 
provides a powerful tool to monitor the presence of DNA damage. How-
ever, artefactual foci formation in the absence of a DSB can occur by non-
specific staining or aggregate formation of the primary or secondary anti-
body. A possible cause for these artefacts could be the non-specific binding 
of the γ-H2AX antibody (Ab) with parts of the endoplasmic reticulum 
and/or Golgi vesicles (67). During S-phase, ATR activation occurs at ss-
regions of DNA and γ-H2AX can be observed during normal replication, 
suggesting that phosphorylation of H2AX is not exclusively DSB depen-
dent (25, 81). However, the γ-H2AX staining that arises in S-phase cells is 
more diffuse and pan nuclear compared to the discrete foci at DSBs after 
IR exposure (5). Furthermore, early apoptotic DNA breakage can also give 
rise to foci patterns that may sometimes be scored as residual IRIF (81). 
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Besides the before mentioned limitations, the γ-H2AX foci assay is a 
reliable and sensitive monitor of DSB formation and repair if careful op-
timisation of the immunostaining conditions is performed. Furthermore, 
the use of a double immunostaining for two foci-forming markers could 
validate the signal and reduce strongly the impact of artefacts, which en-
hances the sensitivity of the technique. Radiation-induced γ-H2AX foci 
co-localise very reliably with 53BP1 foci (83, 84), the latter DDR protein 
can be used as an alternative or, in situation where accuracy is of crucial 
importance, as an additional marker of DSBs through double immu-
nostaining. 
FIGURE 3.9
Different functions of 53BP1 in the DNA damage response. First, 53BP1 recruits 
additional DNA double-strand break (DSB) signalling and repair proteins to the 
site of DNA damage. Second, 53BP1 promotes ATM-dependent checkpoint 
signalling, especially at low levels of DNA damage. Third, it is a key player in 
DSB repair pathway choice. Fourth, 53BP1 promotes the synapsis of distal DNA 
ends during NHEJ. Figure from (85).
Hence, 53BP1 represents a second, highly useful IRIF marker. In un-
damaged cells, 53BP1 is present as pan-nuclear staining, which is low in 
intensity since the protein is distributed diffusely throughout the nucle-
us (79). The latter can cause higher background 53BP1 foci levels, when 
53BP1 is not quantified in combination with another IRIF marker. Fol-
lowing radiation exposure, 53BP1 concentrates at DSBs, where it becomes 
visible as defined IRIF (86, 87). 53BP1 acts as a mediator and effector of 
the DSB response and is recruited to damaged chromatin and protects 
genomic instability by regulating DSB repair pathway choice by mutual 
antagonism with BRCA1 (85) (see Figure 3.9). 53BP1 can be advantageous 
over single γ-H2AX foci scoring for DSB repair analysis since it is not, 
or only weakly, retained at the ssDNA regions generated during replica-
tion (78). MRN and MDC1 can also be used for IRIF analysis but the foci 
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are less obvious either because they take longer to form (as in the case of 
MRN) or the currently available antibodies are sub-optimal (as in the case 
of MDC1) (78). 
As already mentioned in the first paragraph, soon after the discovery 
of γ-H2AX, Rogakou et al. reported the induction of apoptotic γ-H2AX 
(82). The subcellular distribution of γ-H2AX in apoptotic cells was fur-
ther investigated by Solier and Pommier, leading to the identification of 
the ‘apoptotic ring’ which contains γ-H2AX as an early chromatin modi-
fication during apoptosis (82). This γ-H2AX apoptotic ring appears in an 
early phase of apoptosis and follows a progression that we can subdivide in 
three phases: (1) the ‘ring staining’ that occurs only in a fraction of the cell 
without alteration of nuclear size, (2) the ‘ring’ is followed by a panstaining 
of the nucleus, which retains its overall morphology and size, (3) the pan-
staining persists within apoptotic bodies. An important finding of Solier 
et al. was that 53BP1 does not co-localize with γ-H2AX in the apoptotic 
ring (88). This suggested molecular and mechanistic differences between 
γ-H2AX induction after primary DNA damage and during apoptosis. In a 
subsequent study, the same research group could demonstrate that the ap-
optotic H2AX response does not recruit the DDR factors, because MDC1 
(which normally binds to γ-H2AX in response to DNA DSB induction and 
amplifies the DDR, see 3.1.1) is cleaved by caspase-3 (89). The decrease of 
MDC1 during apoptosis and the fact that is not recruited to γ-H2AX could 
explain why 53BP1 does not co-localize with apoptotic γ-H2AX. However, 
the functional relevance of γ-H2AX formation during apoptosis remains 
unknown. The scoring of co-localising 53BP1/γ-H2AX foci can rule out 
the misclassification of early apoptotic DNA breakage as residual IRIF.
3.4
Ethical considerations for 
biomarker studies in children
Biomarker studies in children raise a number of particular ethical consid-
erations related to the collection of biological samples, informed consent, 
and how to convey information about low-dose cancer risk to the par-
ents, as the level of scientific knowledge is inadequate to quantify the risk 
(90). The ethics of research involving children has a long and profound 
history including important debates that made compelling arguments for 
and against (91). Current statements on the ethical conduct of research 
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issued by various national and professional bodies generally include a sec-
tion outlining the special requirements for the inclusion of children in re-
search, with the following three general protection guidelines (90):
 
•	 Sound justification - the presumption that children should not be in-
cluded in research unless there is a compelling reason to do so.
•	 Informed consent - Only adults are presumed to have the capacity 
to act autonomously, whereas children are not presumed to have this 
capacity. In general, consent is given on their behalf by parents or le-
gal guardians, usually supplemented by the positive affirmation of the 
child where possible (92).
•	 Prior ethics review.
For a paediatric patient population, the subject of this PhD research, 
there are a number of barriers to cross compared to studies on adult sub-
jects, such as: fewer study subjects (only 1-2% of the CT examinations are 
performed in children), unique ethical challenges, difficulties in sample-
collection methods, and small tissue-sample volumes. Biomarker studies 
require the use of biological samples. In case of the γ-H2AX foci assay, 
preferably peripheral blood lymphocytes are used. The problem of repeat-
ed blood sampling in children before and after CT exposure can be ad-
dressed by using the catheter for contrast agent administration (flushed) to 
collect the blood samples, eliminating the need for additional venepunc-
ture. Efforts have been made to optimize the assay on exfoliated buccal 
cells which can be obtained by commercially available kits or a mouth-
wash technique (93). However, pilot studies are warranted to prove the 
applicability of this technique in the dose range relevant to CT procedures 
and the collected cells originate only from one anatomical site. This makes 
them currently only appropriate for the assessment of DNA damage re-
lated to high-dose x-ray exposure to the head and neck region (93, 94). 
Furthermore, buccal cells are likely to have higher background levels of 
DNA DSBs as they are more directly exposed to other environmental, nu-
tritional and life-style factors (70, 95). 
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Aim of the research
During the past decades, computed tomography has revolutionized the 
world of medical imaging. The CT usage in the US and the UK increased 
a 20-fold and a 12-fold respectively, over the past two decades (1). The 
increase in CT usage in Belgium is comparable, approximately 2 million 
CT examinations are performed annually (2). However, the high x-ray 
doses associated with CT usage have raised health concerns (3). This is of 
particular importance for the paediatric patient population, recognized as 
one of the most important target groups in medical radiation protection. 
Children have a higher sensitivity compared to adults regarding radiation-
induced malignancies and the associated risk for exposure induced death 
(4). Moreover, children have a longer life expectancy in which they can de-
velop radiation-related cancer and they can receive higher radiation doses 
than necessary if CT settings are not adjusted according to their smaller 
body size. 
The results of several ongoing epidemiologic studies on paediatric CT 
imaging have recently been published. Pearce et al. estimated the leukae-
mia and brain tumour risk associated with childhood CT imaging (5). The 
bottom line in this study was that there were significant linear associa-
tions between the radiation dose to the brain and the brain tumour excess 
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relative risk, and between the bone marrow dose and the leukaemia excess 
relative risk. Although the individual risks were small, in view of the high 
number of CT scans the radiation risk associated with paediatric CT im-
aging is a public health issue. Unfortunately, the limitations of epidemiol-
ogy inherent to low dose exposure, make it extremely difficult to directly 
quantify health risks from low-dose CT exposure (6). For the extrapola-
tion of radiation risks to very low doses (≤1mGy) and to substantiate the 
epidemiological evidence for radiation effects at low doses of the order of 
20 mGy, we are forced to rely on radiobiological evidence and biophysical 
arguments. An alternative approach to estimate the dose response rela-
tionship after low dose CT exposure, can be based on cellular and molecu-
lar biomarker studies of the biological mechanisms underlying the health 
effects of radiation exposure. Therefore, a first aim of this PhD project was 
to assess the in vivo biological effects and estimate cancer risks associated 
with paediatric CT imaging. Biomarker studies in children raise a number 
of ethical constraints, therefore, technical issues can be equally challenging 
as well. Therefore, a prior in vitro study was set-up in order to overcome 
the practical constraints and to adapt and optimise the existing protocols 
for paediatric CT settings.
As indicated by several epidemiological studies on high dose and high 
dose rate exposure (e.g. LSS cohort), there is a clear age-at-exposure effect 
which makes children considerably more sensitive compared to adults re-
garding radiation-induced malignancies. The UNSCEAR committee dedi-
cated a special volume on the paediatric target group in their 2013 report, 
showing that for at least 25% of tumour types, children are clearly more 
sensitive (4). A second aim of this PhD project was to get more insight in 
the intrinsic higher radiosensitivity of children compared to adults. The 
most prominent malignancy is leukaemia with a latency period of only 
2 to 3 years. Together with the positive association reported by Pearce et 
al. (5) between radiation dose from CT scans and leukaemia in children, 
it is of particular importance to study the radiation sensitivity of HSPCs. 
As HSPCs cells self-renew throughout life, accumulation of DNA damage 
can compromise their genomic integrity, which makes these cells a major 
target for radiation-induced carcinogenesis.
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Outline of the research
The use of sensitive biomarkers for the assessment of direct x-ray effects 
in patients gives valuable information on dose-effect relationships for di-
agnostic x-rays. Earlier work has demonstrated that the γ-H2AX foci assay 
is a sensitive technique to determine the effects of CT exposure at molecu-
lar level, namely the induction of DNA DSBs (1-3). DSBs are considered to 
be the most deleterious cellular effects of radiation exposure, because they 
can result in loss or rearrangement of genetic information, leading to cell 
death or carcinogenesis. 
Before the start of a biomarker study on a paediatric patient population, 
in vitro feasibility studies were required to optimise the γ-H2AX foci assay 
as a biomarker of DNA damage to investigate the effects of CT x-rays in 
children in a multicentre setting. The application of biomarkers to this end 
implies a critical evaluation of a number of technical issues: the logistics 
of biological sample collection in a paediatric radiology setting, processing 
and storing of blood samples, the validity and reliability of the biomarker 
γ-H2AX for DNA DSBs in the low-dose range, as well as the impact of po-
tential confounding factors, such as contrast agent administration. The re-
sults of this feasibility study are presented in the first paper: EPI-CT: IN VITRO 
ASSESSMENT OF THE APPLICABILITY OF THE γ-H2AX FOCI ASSAY AS CELLULAR MARKER 
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FOR EXPOSURE IN A MULTICENTRE STUDY OF CHILDREN IN DIAGNOSTIC RADIOLOGY. 
This paper is part of Workpackage 5 ‘Biological Mechanisms’ of the EU 
funded FP7 EPI-CT (Epidemiological study to quantify risks for paediatric 
computerised tomography and to optimise doses) project. 
In order to determine the number of x-ray induced DNA DSBs in chil-
dren’s lymphocytes undergoing a CT examination, a prospective multicen-
tre study was set up in Belgium. Herein, the γ-H2AX foci assay was used as 
an in vivo effect biomarker for radiation-induced DSBs. Individual blood 
dose estimates were obtained for every patient by creating patient-specific 
3D voxel models based on the CT images of the paediatric patients by us-
ing ImpactMC simulation software 1.3.1. Organ volumes were segmented 
in the original CT images and organ dose deposition was calculated based 
on the Monte Carlo dose distribution. BEIR VII age and gender specific 
risk models (4) were used to assess the lifetime attributable risk (LAR) 
of cancer incidence and mortality associated with the CT examination of 
every individual patient. The results of this study are presented in a second 
paper: γ-H2AX FOCI AS IN VIVO EFFECT BIOMARKER IN CHILDREN EMPHASIZE THE 
IMPORTANCE TO MINIMIZE X-DOSES IN PAEDIATRIC CT IMAGING.
In a last part of this PhD project, we investigated further the higher 
radiosensitivity of children compared to adults, by comparing the DNA 
repair and chromosomal radiosensitivity at a cellular level in T-lympho-
cytes from newborns and adults. Furthermore, the high radiosensitivity 
of children with respect to radiation-induced leukaemia, warrants studies 
on the response of HSPCs to DNA damage induced by IR as well as on the 
mutagenic consequences of DNA misrepair. In order to evaluate the chro-
mosomal radiosensitivity of HSPCs, we developed a micro-culture CBMN 
assay for purified CD34+ cells. The results of these in vitro studies are pre-
sented in the third paper: RADIATION SENSITIVITY OF HUMAN CD34+ CELLS VER-
SUS PERIPHERAL BLOOD T-LYMPHOCYTES. 
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EPI-CT: in vitro assessment 
of the applicability of the 
γ-H2AX-foci assay as cellular 
biomarker for exposure in a 
multicentre study of children in 
diagnostic radiology
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EPI-CT: in vitro assessment of the applicability of the 
γ-H2AX-foci assay as cellular biomarker for exposure 
in a multicentre study of children in diagnostic 
radiology 
ABSTRACT
Purpose: A feasibility study on the application of the γ-H2AX foci assay as an exposure 
biomarker in a prospective multicentre paediatric radiology setting. 
Materials and methods: A set of in vitro experiments was performed to evaluate technical 
hurdles related to biological sample collection in a paediatric radiology setting (small blood 
sample volume), processing and storing of blood samples (effect of storing blood at 4°C), the 
reliability of foci scoring for low-doses (merge γ-H2AX/53BP1 scoring), as well as the impact 
of contrast agent administration as potential confounding factor. Given the exploratory nature 
of this study and the ethical constraints related to paediatric blood sampling, blood samples 
from adult volunteers were used for these experiments. In order to test the feasibility of pool-
ing the γ-H2AX data when different centres are involved in an international multicentre study, 
two intercomparison studies in the low-dose range (10-500 mGy) were performed.
Results: Determination of the number of x-ray induced γ-H2AX foci is feasible with one 2 
ml blood sample pre- and post- computed tomography (CT) scan. Lymphocyte isolation and 
fixation on slides is necessary within 5h of blood sampling to guarantee reliable results. The 
possible enhancement effect of contrast medium on the induction of DNA DSB in a patient 
study can be ruled out if radiation doses and the contrast agent concentration are within diag-
nostic ranges. The intercomparison studies using in vitro irradiated blood samples showed that 
the participating laboratories, executing successfully the γ-H2AX foci assay in lymphocytes, 
were able to rank blind samples in order of lowest to highest radiation dose based on mean 
foci/cell counts. The dose response of all intercomparison data shows that a dose point of 10 
mGy could be distinguished from the sham irradiated control (p = 0.006).
Conclusions: The results demonstrate that it is feasible to apply the γ-H2AX foci assay as 
a cellular biomarker of exposure in a multicentre prospective study in paediatric CT imaging 
after validating it in an in vivo international pilot study on paediatric patients.
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INTRODUCTION
Epidemiological data of the atomic bomb sur-
vivors (Life Span Study) and medically exposed 
populations summarized in the UNSCEAR report 
clearly indicate that high doses of ionizing radia-
tion (IR) enhance cancer risks in humans (Pres-
ton et al., 2007, Thompson et al., 1994, Ron et al., 
1998, Richardson and Hamra, 2010, UNSCEAR 
2008). These studies have laid the foundation of 
the linear non-threshold (LNT) model, used in 
radiological protection for risk estimations at 
low-dose exposure, implying a linear relation-
ship between dose and biological effect without 
a dose threshold. Although the LSS has provided 
valuable insights into the quantitative effects of 
exposure to IR at higher dose ranges, consider-
able uncertainties remain about the health effects 
of exposure at low-dose and/or low-dose rates. 
As described by Brenner et al. (Brenner et al., 
2003), extraordinarily large population cohorts 
would be required to determine low-dose can-
cer risks in epidemiological studies. In order to 
obtain adequate statistical precision and power, 
the required sample size increases approximately 
as the inverse square of the dose. Other factors 
influencing power in epidemiological radiation 
effect studies include variability of the data - that 
can create background noise - and the frequency 
of the health outcomes (cancer and non-cancer 
diseases) to be observed (Motulsky, 2010). 
The health risks of low-dose IR exposure are 
relevant for a broad range of medical, environ-
mental and occupational exposed populations 
and are therefore of societal importance. For 
an average person worldwide, diagnostic x-ray 
applications represent the largest portion of ra-
diation exposure coming from man-made ir-
radiation sources and remain a topic of concern 
in the medical world and public press (Brenner 
and Hall, 2007, Lin, 2010, UNSCEAR, 2013). The 
growing use of CT scans for paediatric patients 
over the past two decades is an important issue 
(Brenner, 2003), since the lifetime cancer risk es-
timates might be a factor of 2 to 3 times higher 
for children compared to a population of all ages. 
This estimation is based on a lifetime risk pro-
jection model combining the risks of all tumour 
types together (UNSCEAR, 2013). The increased 
sensitivity for children is due to a number of 
factors including the higher number of rapidly 
dividing cells, smaller body dimensions leading 
to less tissue shielding towards external expo-
sure and their longer life expectancy to develop 
radiation-induced cancer. Concomitantly, the in-
creased sensitivity of children and adolescents to 
IR might potentiate and reveal more clearly the 
effects of IR at low doses than in adults. Recently 
a number of studies were published dealing with 
the long-term risk of radiation-induced cancer 
following CT scans in childhood (Mathews et al., 
2013, Pearce et al., 2012, Huang et al., 2014). De-
spite some study limitations, the results reported 
by the UK cohort study and the Australian link-
age study were consistent with the LSS results. 
However, it remains very difficult to assess the 
potential of small radiation-induced changes in 
cancer risk in the low-dose range. 
For the extrapolation of radiation risks to very 
low doses (≤1mGy) and to substantiate the epi-
demiological evidence for radiation effects at low 
doses of the order of 10 mGy, we are forced to 
rely on radiobiological evidence and biophysical 
arguments (Brenner, 2009, Pernot et al., 2012). 
IR can induce a variety of DNA damage either 
directly or indirectly through ionization events 
produced by radiation-induced reactive oxygen 
species (ROS). Double strand breaks (DSB) are 
considered as the most deleterious DNA lesions 
induced by IR exposure. Prior studies in the low-
dose range have demonstrated effects of CT expo-
sure at molecular level, including the induction of 
DNA DSB (Rothkamm et al., 2007, Beels et al., 
2012, Geisel et al., 2012, Löbrich et al., 2005). The 
phosphorylation of the histone variant H2AX at 
the site of a DNA DSB leads to the formation and 
accumulation of γ-H2AX foci in the cell nucleus 
within three minutes after DNA damage (Rogak-
ou et al., 1998, Su, 2006). γ-H2AX foci induced in 
peripheral T-lymphocytes by interventional x-ray 
exposure were used as a biomarker of DNA dam-
age in a group of paediatric patients who under-
went cardiac catheterization (Beels et al., 2009). 
Low-dose hypersensitivity was observed for this 
paediatric patient group, which challenges the 
LNT hypothesis and stresses the importance of 
non-targeted effects as the bystander effect at low 
doses (Beels et al., 2009). 
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In the framework of the EU funded FP7 pro-
ject EPI-CT (Epidemiological study to quantify 
risks for paediatric computerised tomography 
and to optimise doses), a multi-national large 
scale epidemiological cohort study was set up 
with the aim to investigate possibly late health 
effects associated to CT scan exposure in child-
hood and adolescence in a population of 1 mil-
lion paediatric CT patients (http://epi-ct.iarc.fr/). 
Using Picture Archiving and Communication 
Systems (PACS) national cohorts were assembled 
retrospectively and prospectively, until 2013, in 
nine European countries. The indications for CT 
scan are being reviewed to identify scans related 
to the diagnosis of cancer, in order to rule out po-
tential reverse causation. Patients will be followed 
over time to ascertain information on leukaemia 
and cancer incidence. In addition to the extensive 
epidemiological and dosimetric efforts undertak-
en in this project, one of the goals of the project 
is to perform pilot tests for different biomarkers 
of exposure and to assess their sensitivity in the 
low-dose range in order to clarify the biological 
mechanisms behind low-dose hypersensitivity 
reported in some paediatric patients. It is antici-
pated that significant insights will emerge from 
the integration of epidemiological and biological 
research, made possible by molecular epidemiol-
ogy studies incorporating biomarkers and bioas-
says (Pernot et al., 2012). Biomarkers of exposure, 
effects and susceptibility could be integrated into 
epidemiological studies in order to improve do-
simetry, health outcome diagnosis and homoge-
neity of the population, respectively, leading to an 
increased study power and accuracy of the risk es-
timates. In this paper, we present the results of in 
vitro feasibility studies to use the γ-H2AX foci as-
say as a biomarker of DNA damage to investigate 
the effects of CT x-rays in children in a multicen-
tre setting. The application of biomarkers to this 
end implies a critical evaluation of a number of 
technical issues: the logistics of biological sample 
collection in a paediatric radiology setting, pro-
cessing and storing of blood samples, the validity 
and reliability of the biomarker γ-H2AX in the 
low-dose range, as well as the impact of poten-
tial confounding factors, such as contrast agent 
administration, mentioned in Figure 1. Further-
more, in order to test the feasibility of pooling the 
γ-H2AX data when different centres are involved 
in an international multicentre study, we per-
formed two independent intercomparison stud-
ies in the low-dose range among the participants 
of the EPI-CT project. In this paper we report on 
the results of the experiments performed to solve 
the technical issues of using the γ-H2AX foci 
assay as a molecular epidemiology biomarker in 
a paediatric radiology setting and the results of 
the low-dose intercomparison studies.
FIGURE 1
Logistical and technical questions related to the use of γ-H2AX 
foci in blood samples as biomarkers of exposure in a multicentre 
molecular epidemiology study assessing the health effects of CT 
scans.
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TABLE I
Overview of the different γ-H2AX protocols 
used by the various partners of the 
project.
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MATERIALS AND METHODS
Blood samples
Although the main goal of this study was to 
validate the use of the γ-H2AX foci assay for large 
paediatric studies, we used samples from adult 
donors in the first instance to assess inter-labo-
ratory and methodological issues. This choice is 
justified by ethical considerations (Edwards and 
McNamee, 2005) given the exploratory nature of 
this study regarding blood volume, sample col-
lection, storage and analytical conditions, that 
do not necessarily require samples from children. 
Informed consent was obtained from all healthy 
adult volunteers, in accordance with local ethical 
guidelines.
γ-H2AX foci analysis
All participating research centres followed 
their own protocol of lymphocyte isolation, 
fixation, γ-H2AX foci staining and scoring tech-
niques. Details of the different protocols used by 
the various partners can be found in Table I. Most 
of the partners had experience with γ-H2AX foci 
analysis in purified blood lymphocytes, except 
for Lab 4, who used γ-H2AX foci analysis up to 
now only for cell lines.
Adaptation of the γ-H2AX foci protocol 
for multicentre paediatric studies in 
diagnostic radiology
Reduction of blood sample volume
In a previous study from Beels et al. (Beels et 
al., 2012), two consecutive blood samples were 
collected after CT examination through the cath-
eter used for contrast agent administration to 
avoid an additional venepuncture. After the CT 
scan, the first blood sample was not used because 
of possible dilution of the blood with contrast 
agent and to avoid stagnation. Because of the 
small blood volume of very young children, the 
local Ethical Committee restricts blood sampling 
for biomarker studies of effects of CT x-rays in 
children to a single small blood sample of 2 ml 
before and after the CT examination. Blood cir-
culation is faster in children compared to adults, 
which ensures a lower risk of getting stagnated 
blood. We collected one blood sample before CT 
and two consecutive (interval of 5 min) blood 
samples of 2 ml - a small sample volume aimed 
at mimicking the limited volume that would be 
available from children - from two adult patients 
5 min after their CT examination through the 
catheter used for contrast agent administration 
(after flushing). The blood samples were kept for 
30 min at 37°C in a water bath, followed by 15 
min in ice water (0°C). Afterwards, the γ-H2AX 
foci protocol as described for Lab 3 in Table I was 
applied.
Effect of storing blood samples at 4°C
First, we investigated the effect of storing 
whole blood samples at 4°C for several hours be-
fore blood separation, on the foci yield in a set 
of in vitro experiments using blood samples from 
four healthy donors. For every time point, one 
blood sample was sham-irradiated. Blood sam-
ples were irradiated with 100 mGy Co-60 γ-rays 
at a dose rate of 170 mGy/min, incubated at 37°C 
for 30 min and arrested on iced water (0°C) for 
15 min. Afterwards, the blood samples were kept 
at 4°C for 0, 5 and 24h before the start of the T-
lymphocyte isolation according to the γ-H2AX 
foci protocol of Lab 3 (Table I). Afterwards, a sec-
ond set of in vitro experiments was set up in order 
to mimic the shipping conditions in case blood 
samples need to be transported to another labo-
ratory in the framework of a multicentre study. 
For these experiments, blood samples of three 
adult healthy volunteers were irradiated under 
the same conditions as in the first set of experi-
ments, incubated at 37°C for 30 min and arrested 
on ice water (0°C) for 15 min. Part of the whole 
blood was kept at 4°C for 24h before lymphocyte 
isolation was started, while the other part under-
went T-lymphocyte isolation directly after the ice 
water arrest. Half of the isolated T-lymphocytes 
were stored in cRPMI with 10% foetal calf serum 
(FCS) at 4°C for 24h. Afterwards the γ-H2AX 
foci protocol of Lab 3 was applied (see Table I).
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Validation of the γ-H2AX foci 
immunostaining and scoring
Discrimination between artefacts and DNA 
damage induced γ-H2AX foci remains a critical 
point especially in the low-dose range. To vali-
date the γ-H2AX foci data obtained by manual 
scoring with an Olympus BX60 fluorescence mi-
croscope, a double staining of the microscopic 
slides was performed. In the standard protocol 
of Lab 3, the γ-H2AX protein is stained with a 
secondary antibody conjugated with the red fluo-
rophore Tetramethyl Rhodamine Isothiocyanate 
(TRITC) (Sigma-Aldrich, Diegem, Belgium). For 
the double immunostaining a second protein, the 
p53 binding protein 1 (53BP1) (Abcam, Cam-
bridge, UK), is stained with the green fluores-
cent marker Fluorescein Isothiocyanate (FITC) 
(Sigma-Aldrich, Diegem, Belgium). The 53BP1 
protein acts, together with MDC1, as mediator/
adaptor protein that promotes DNA repair and 
regulates cell cycle checkpoints (Markova et al., 
2007, Solier and Pommier, 2014) and the co-lo-
calisation of 53BP1 and γ-H2AX foci will allow 
to distinguish artefacts from real DNA DSB. For 
this validation experiment, we irradiated blood 
samples of four donors with 25 mGy and 500 
mGy Co-60 γ-rays at a dose rate of 170 mGy/
min, incubated at 37°C for 30 min and arrested 
on 0°C (ice water) for 15 min. For each irradiated 
sample, a sham-irradiated control sample was 
taken into account.
Effect of contrast agent
A venepuncture for blood sampling is a very 
distressing experience for children. As described 
earlier (Beels et al., 2012), pre- and post-CT 
blood samples are needed in order to determine 
the induced number of DNA DSB by CT x-rays. 
In order to limit the number of venepunctures, 
blood samples can be collected through the cath-
eter for contrast agent administration. An in vitro 
experiment was set up to investigate the possible 
interference of iodinated contrast agent and the 
corresponding emission of secondary radiation 
in CT imaging on the induction of DNA DSB. 
Blood samples from three healthy volunteers 
were mixed with 4 different concentrations of 
a frequently used contrast agent (Ultravist 300, 
Bayer Schering Pharma, Mijdrecht, The Neth-
erlands), resulting in concentrations of 0, 5, 10, 
20 mg iodine per ml blood. Samples were sub-
sequently irradiated in vitro with 100 kV x-rays 
(dose rate of 20 mGy/min) at different dose levels 
(5, 10, 50 mGy). A radiation quality of 100 kVp 
with 2 mm Al filtration was used generated by 
a Philips MG420 x-ray generator coupled to a 
MCN420 tube (Philips Medical Systems, Ander-
lecht, Belgium). One blood sample was sham-ir-
radiated for every condition. The iodine concen-
trations used in the experiment were calculated 
based on the volumes used in clinical practice. Af-
ter irradiation, blood samples were kept at 37°C 
in a water bath for 30 min to allow DNA damage 
signalling. Afterwards, DNA repair was arrested 
by cooling the samples at 0°C (iced water) for 15 
min.
In vitro intercomparison of different 
γ-H2AX foci protocols for a molecular 
epidemiological study in diagnostic 
radiology
A first intercomparison was organised in or-
der to investigate whether the existing γ-H2AX 
protocols (blood separation technique, fixation, 
immunostaining and scoring) of different EPI-
CT partners would produce similar foci fre-
quencies. In a second intercomparison study, the 
aim was to test the feasibility of sending isolated 
lymphocytes in an overnight shipment and to 
evaluate the ability of the different participants 
to quantify DNA damage induced by low-dose 
x-ray exposure. 
First intercomparison study
We performed the first intercomparison at 
Ghent University and four different partner re-
search centres participated: Bundesamt fuer 
Strahlenschutz, Germany (BfS), Institut Curie, 
France (IC), Radiation and Nuclear Safety Au-
thority, Finland (STUK) and Ghent University, 
Belgium (UGent). Blood samples from the same 
adult healthy donor were irradiated with 100 
mGy and 500 mGy Co-60 γ-rays with a dose rate 
of 170 mGy/min at Ghent University. After ir-
radiation, blood samples were incubated at 37°C 
for 30 min and arrested on ice water (0°C). Each 
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participant followed in Ghent its own protocol of 
lymphocyte isolation and γ-H2AX foci protocols 
as presented in Table I. All participants evaluated 
their samples on their own scoring platforms at 
home, using an automated microscope system 
and/or manual scoring. 
Second intercomparison study
For the second intercomparison study, irra-
diation experiments were performed at STUK 
(Finland). Blood from an adult healthy donor 
was collected and lymphocytes were isolated with 
Histopaque density gradient separation (Sigma–
Aldrich Co., St Louis, MO, USA). Four biologi-
cal replicates from the same donor were set up 
per dose point and cells remained in pure FCS 
(Sigma–Aldrich, St Louis, MO, USA) through-
out the irradiation and shipment (each labora-
tory obtained approximately 5 x 105 cells per 
replicate). Irradiation was performed with 135 
kV x-rays (generator: Isovolt 320HS, Seifert; X-
ray tube: MB 350/1, Thales; filters: 2.203 mmAl 
and 0.232 mmCu) at 37 °C with 10, 30, 50, 100 
mGy (dose rate: 35.3 mGy/min). One sample 
served as control and was sham irradiated. Af-
ter irradiation, cells were kept at 37°C for 30 
min, put on iced water (0°C) for 15 min and kept 
cooled until and during shipment. For shipment, 
samples were packed together with Styrofoam 
boxes containing frozen cool packs in order to 
keep the temperature below 6°C in order to di-
minish foci loss during transportation. Care was 
taken to avoid freezing of samples. Each pack of 
blood samples also contained a temperature log-
ger to control the temperature during transport. 
Samples were coded before sending and decod-
ing was performed after evaluation. Upon ar-
rival of samples, each laboratory performed the 
γ-H2AX assay according to its own protocol. In 
case of manual scoring it was intended to evalu-
ate 100 cells/dose/replicate, in total 400 cells/dose 
for all 4 replicates. For the automated scoring, 500 
cells/dose/replicate, in total 2000 cells/dose for all 
4 replicates had to be evaluated. In this set-up a 
biological replicate meant four independent irra-
diated lymphocyte samples from the same donor 
per dose point. Lab 1 applied two classifiers with 
different sensitivity settings for the automated 
scoring with the Metafer scoring system.
Statistical analyses
Differences between two datasets were tested 
for significance with a Mann-Whitney U test for 
unpaired datasets, while a Wilcoxon signed-rank 
test was used for paired datasets. For experimen-
tal data including more than two variables, a 
Kruskal-Wallis test was used. The slopes of lin-
ear regression fit of different scoring methods 
was compared by using the F-statistics. Statisti-
cally significance was considered for p < 0.05. 
Coeffients of variation were calculated from the 
dispersion of the frequency distribution of the 
γ-H2AX foci scoring and the arithmetic mean of 
the distribution. All statistical calculations were 
performed with the SPSS program, version 22 
(SPSS Inc., USA), GPower version 3.1.5 (Uni-
versität Düsseldorf, Germany) for power calcu-
lations, R Studio 3.1.2 and Microsoft Excel 2010 
(Microsoft Corporation, USA). 
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RESULTS
Adaptation of the γ-H2AX foci protocol 
for multicentre paediatric studies in 
diagnostic radiology
Reduction of blood sample volume
To investigate the feasibility of using one small 
blood sample for the γ-H2AX foci assay instead 
of a consecutive sampling as reported by Beels et 
al. (Beels et al., 2012), one blood sample of 2 ml 
before CT and two blood samples of 2 ml were 
taken from two adult patients after a CT exami-
nation (DLP (Dose Length Product) patient 1: 
1090 mGycm; DLP patient 2: 374 mGycm). Ro-
setteSep T-lymphocyte separation resulted in a 
yield of approximately 106 cells/ml of blood. For 
every replicate, foci were manually scored in at 
least 240 cells over two microscopic slides. To 
rule out the possible dilution with contrast agent 
or the effects of stagnation the number of foci of 
the first and second 2 ml blood sample after CT 
were compared: patient 1: 1.46 foci/cell (95% CI: 
1.29-1.63) and 1.34 foci/cell (95% CI: 1.14-1.54) 
post-CT versus 0.90 foci/cell (95% CI: 0.78-1.02) 
pre-CT, patient 2: 0.88 foci/cell (95% CI: 0.71-
1.05) and 0.83 foci/cell (95% CI: 0.72-0.94) post-
CT versus 0.57 foci/cell (95% CI: 0.48-0.66) pre-
CT. Based on the overlapping 95% confidence 
intervals in the two consecutive post-CT blood 
samples, it can be concluded that determination 
of the number of x-ray induced γ-H2AX foci in 
patients is feasible with one 2 ml blood sample 
before and 5 min after CT scan. 
Effect of storing blood samples at 4°C
In most in vivo γ-H2AX foci studies, blood 
separation was performed almost directly after 
blood sampling and incubation. However, in the 
framework of large multicentre studies, direct ac-
cess to an on-site laboratory for blood separation 
is not always feasible immediately after CT expo-
sure. Therefore, the effect of storing the samples at 
4°C (in the refrigerator) over a certain period was 
investigated. For the different time points at least 
400 cells were scored over 2 slides for each donor. 
Results are presented in Figure 2-a. Compared 
to direct isolation the average foci yield induced 
by 100 mGy γ-rays in the blood of four healthy 
donors has not changed significantly after 5h ap-
plying the Wilcoxon signed-rank test (p = 0.180). 
On the contrary, an incubation period of 24h in-
duced a statically significant decrease in the aver-
age number of foci (38%, p = 0.032). The results 
show that keeping a blood sample at 4°C (e.g. in a 
refrigerator) for a few of hours (up to 5h) has no 
significant effect on the number of γ-H2AX foci. 
However, leaving a whole blood sample overnight 
in the refrigerator reduces the foci yield signifi-
cantly. For a multicentre study we can conclude 
that lymphocyte isolation is necessary on the 
day of the blood sampling to guarantee reliable 
results. In a second set of experiments the influ-
ence of storing blood samples for 24h at 4°C was 
investigated for both isolated lymphocytes and 
whole blood samples to test if the shipment of 
purified lymphocytes to other laboratories would 
provide better results with respect to foci yields 
compared to whole blood samples (Figure 2-b). 
The storage of whole blood samples for 24h at 
4°C results again in a significant reduction in the 
average number of foci, while the experiments 
on isolated lymphocytes provide similar results 
compared to the protocol with direct assessment 
of γ-H2AX foci.
Validation of the γ-H2AX foci immunos-
taining and scoring
The validation experiments show that 
γ-H2AX-TRITC foci co-localise with 53BP1-
FITC foci, as illustrated in Figure 3. Scoring 
of sham-irradiated samples results in a mean 
value of 0.86 γ-H2AX-TRITC foci/cell (95% CI: 
0.75-0.97), 1.05 53BP1-FITC foci/cell (95% CI: 
0.87-1.23) and 0.71 co-localised foci/cell (95% 
CI: 0.56-0.85). An in vitro radiation dose of 25 
mGy γ-rays gives a mean value of 1.53 γ-H2AX-
TRITC foci/cell (95% CI: 1.31-1.74), 1.86 
53BP1-FITC foci/cell (95% CI: 1.62-2.09) and 
1.34 co-localised foci/cell (95% CI: 1.16-1.52), 
while a radiation dose of 500 mGy results in 7.34 
γ-H2AX-TRITC foci/cell (95% CI: 7.05-7.63), 
7.24 53BP1-FITC foci/cell (95% CI: 6.98-7.50) 
and 6.57 co-localised foci/cell (95% CI: 6.31-
6.83) (Figure 3-d). When taken all data together, 
86.4% (95% CI: 81.6% - 91.2%) of γ-H2AX foci 
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FIGURE 2
A: The mean induced number of γ-H2AX foci after in vitro irradiation of blood 
samples of four donors with 100 mGy, 30 min at 37°C and then storing at 4°C for 0, 
5 and 24h. Error bars represent standard deviations for the inter-individual variation 
among the four donors.
B: Three different methods were tested after 30 min incubation at 37°C and arrest on 
ice water (0°C): 1) the full γ-H2AX protocol was applied directly after incubation, 2) 
lymphocytes were isolated and stored at 4°C for 24h, 3) whole blood was stored at 
4°C for 24h. The corresponding mean numbers of γ-H2AX foci among three different 
donors for 0mGy, 100mGy and the induced yield are presented. Error bars represent 
standard deviations.
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were confirmed by 53BP1-foci scoring and repre-
sent real DNA DSB. This indicates that γ-H2AX 
foci scoring is a sensitive and reliable technique 
for the visualisation of DNA DSB after low-dose 
exposure. However, the added value of using a 
double γ-H2AX-53BP1 immunostaining should 
be further explored in the future. The scoring of 
merged foci reduces to a certain extent the rate 
of false positives, but increases the reliability that 
the observed spots are indeed DNA DSB and en-
hances the sensitivity of foci scoring in the low-
dose range by reducing the impact of artefacts.
Effect of contrast agent
The iodine contrast agent concentrations used 
in this experiment were based on the physiologi-
cal concentrations after administration to patients 
in clinical practice. The blood samples containing 
the contrast agent were exposed to x-ray doses in 
the diagnostic range for CT scans. We observed 
no enhancement of γ-H2AX foci as a function 
of the concentration of iodinated contrast agent 
(Figure 4). At least 400 cells were scored over 2 
slides for every experimental condition. Kruskal-
Wallis analysis showed no statistical significant 
increase in γ-H2AX foci numbers with increasing 
FIGURE 3
Captured images of the Olympus BX60 fluorescence microscope (100x/1.30 
oil lens) of A) 53BP1-FITC staining, B) γ-H2AX-TRITC staining and C) merged 
in T- lymphocytes. The graph (D) illustrates the mean γ-H2AX-TRITC foci , 
53BP1-FITC foci and the merged foci of four different donors, error bars 
represent the corresponding standard deviations.
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FIGURE 4
Illustration of the in vitro γ-H2AX foci yield for different contrast agent 
concentrations (0, 5, 10, 20 mg/ml I) and different dose points (0, 5, 
10, 50 mGy), in the range of clinical practice. The error bars represent 
standard deviations derived from the statistical uncertainty on inter-
individual variation among three donors.
iodine concentrations for the different radiation 
doses. Thus the observed data do not indicate a 
possible enhancement effect of contrast medium 
on the induction of DNA DSB in a patient study 
if radiation doses and the amount of Ultravist 300 
contrast agent used are within those used for nor-
mal ranges for these procedures.
In vitro intercomparison study of 
different γ-H2AX protocols for a 
molecular epidemiological study
First intercomparison study
All the partner research centres used their 
own γ-H2AX foci assay protocol at Ghent Uni-
versity and the resulting slides were thereafter 
analysed in their own laboratory. One partner 
had no experience with γ-H2AX foci analysis in 
purified blood lymphocytes and their techniques 
optimised for use in cell lines did not produce 
satisfactory results in terms of number of cells/
slide and staining of foci and thus were excluded 
from subsequent comparisons. Figure 5 shows 
that all the other partners had a working γ-H2AX 
protocol appropriate for possible future collab-
orative multicentre studies to assess DNA DSB 
induced in vivo in purified lymphocytes from 
patients. Very similar levels of γ-H2AX foci were 
found after exposure to 100 and 500 mGy accord-
ing to the standard protocol and preferred scor-
ing technique of each laboratory. The histograms 
in Figure 5 represent the mean number of foci 
for at least 350 cells in case of automated scor-
ing (Laboratories 1 and 2) and at least 200 cells 
in case of manual score (Laboratories 1 and 3). 
An analysis of the foci frequency distributions of 
the irradiated samples showed no systematic dif-
ferences in the coefficient of variation between 
the participating laboratories and between the 
115
PA
RT
 II
ORIgInAl ReseARch
results of automated and manual scoring: 0.1 Gy 
1.71-2.53 versus 1.43-3.26; 0.5 Gy 0.53-1.12 ver-
sus 0.52-0.60.”
Second intercomparison study
The three institutes that succeeded in the 1st 
intercomparison study also participated in the 
2nd intercomparison study using the same experi-
mental γ-H2AX protocol (Table 1). The set-up 
for the 2nd intercomparison study was different: 
isolated lymphocytes in pure FCS were irradiated 
by one partner (STUK) and sent as overnight 
shipments to the other participants for process-
ing and scoring. In this set of experiments the re-
sponse in the low-dose range, as used in diagnos-
tic radiology, was further explored (10-100 mGy 
x-rays). The laboratory at STUK kept the samples 
in the cold room (5-6 °C) until next day to mim-
icking the shipment circumstances. The other two 
laboratories received the samples within 24h and 
the temperature loggers showed profiles ranging 
from 0.5 to 6 °C during shipment. Figure 6 shows 
the γ-H2AX foci yields obtained by the different 
partners of the project. Per dose point, on the av-
erage 360 cells were evaluated in case of manual 
scoring and 1600 cells in case of automated scor-
ing. A power analysis was performed based on 
mean values of 0.34 and 0.56 foci/cell for 0 and 
10 mGy respectively. This power analysis result-
ed in a required scoring sample size of 205 cells 
per dose point to be able to discern a dose of 10 
mGy from background levels, when considering 
a power of 0.80 (α=0.05 ,β=0.20 ).
One of the major differences with the first 
intercomparison is that isolated lymphocytes 
in pure FCS were irradiated for the second in-
tercomparison study instead of whole blood 
samples. Indeed, a blood separation after 24h to-
gether with the shipment conditions results in an 
inferior quality of lymphocyte separation. Fur-
thermore the second intercomparison study was 
FIGURE 5
The number of γ-H2AX foci obtained by three different partners as 
a function of radiation doses of 0, 100 and 500 mGy. The error bars 
represent the standard error of the mean (SEM) of three different slides 
scored per condition.
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performed in the diagnostic x-ray dose range, 
instead of the higher 0.1 and 0.5 Gy doses used 
in the first intercomparison study. The different 
laboratories were able to rank the blind samples 
in order of lowest to highest radiation dose based 
on mean foci/cell counts over the four replicates, 
except Lab 2 was not able to distinguish 10 mGy 
from the sham irradiated control. However, the 
results of Lab 2 were impaired to a certain degree 
by equipment failure during sample processing. 
The γ-H2AX foci levels averaged over the four 
replicates obtained with different protocols and 
scoring methods of the three participating labs 
show a statistical significant difference between 
sham irradiation and the dose of 10 mGy (Mann 
Whitney U test: p = 0.001).
The data collected by participant 1 allowed 
comparing manual against automated scoring on 
a Metafer4 scoring platform. Comparison of the 
linear regression fits (presented in Fig 7) with F-
statistics shows good accordance between classi-
fier 1 and manual scoring (p = 0.371), while the 
foci yields obtained with classifier 2 with higher 
sensitivity were clearly too high compared to the 
manual scoring (p < 0.05). This illustrates the im-
portance of careful optimization of Metafer clas-
sifier settings for automated scoring of γ-H2AX 
foci.
Although the four data sets presented in Fig-
ure 6 show a similar dose dependence the re-
sults obtained by the different laboratories and 
scoring method are significantly different ex-
cept for the 30 mGy dose point when applying 
a Kruskal-Wallis analysis. The results of the in-
tercomparison study highlight the importance of 
standardization of γ-H2AX assay protocols and 
application of quality assurance procedures to 
obtain foci yields, which can be shared in a mul-
ticentre setting.
The induced γ-H2AX foci levels obtained by 
averaging the results of the participants for every 
dose point are presented in Figure 8. Regression 
analysis shows a linear relationship between the 
radiation dose and the number of γ-H2AX foci 
induced in the isolated lymphocytes (R² =0.998) 
in the dose range from 0 mGy to 100 mGy.
FIGURE 6
Number of γ-H2AX foci yields scored as a function of low 
radiation doses (0, 10, 30, 50 and 100 mGy) obtained by 
the different partners of the project. Error bars represent 
the standard deviations among the four different replicates 
per dose point.
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FIGURE 8
Linear regression of the dose response curve of all participating labs. 
The error bars represent the standard deviations on the mean among 
the three laboratories.
FIGURE 7
The γ-H2AX foci yields of the four replicates obtained with automated 
scoring by using 2 different classifiers and with manual scoring on 
Metasystems Metafer4 scoring platform. The lines are the result of a 
linear least squares fit to the data of Lab 1. R² values are based on the 
γ-H2AX foci yields of the four replicates, to illustrate the dispersion of 
the data points around the fit.
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DISCUSSION
One of the aims of the EU FP7 project EPI-CT 
is to investigate the feasibility of using biomark-
ers of exposure in a multicentre molecular epi-
demiological study in order to better understand 
mechanisms underlying the response to low-dose 
irradiation effects in paediatric patients undergo-
ing CT imaging. Many studies have already dem-
onstrated the relevance and sensitivity of using 
the formation and persistence of γ-H2AX as a 
surrogate endpoint to detect and quantify DNA 
damage after low-dose radiation exposure. The 
post-translational modification of the histone 
protein H2AX in response to the formation of 
DSB can be detected by a number of immunologi-
cal approaches including immune-coupled FACS 
analysis (Haddy et al., 2014) or as in this study 
immunofluorescence microscopy. The γ-H2AX 
foci assay is currently the most sensitive assay to 
investigate low-dose exposure induced DSB after 
CT x-ray exposure. Rothkamm et al. demonstrat-
ed a detection sensitivity of manual γ-H2AX foci 
scoring by fluoresence microscopy to radiation 
doses as low as 1 mGy (Rothkamm and Lobrich, 
2003) and recently Halm et al. (Halm et al., 2014) 
described a dose dependent increase in γ-H2AX 
foci in a pilot study of three CT exposed children 
to blood doses of 0.22 – 1.22 mGy.
The use of biomarkers in multicentre molecu-
lar epidemiology studies is limited by access to 
appropriate biological samples. In many situa-
tions there is only a small time window of oppor-
tunity to collect the samples as the study subject 
may no longer be available or conditions may 
have changed (Pernot et al., 2012). Particularly 
in children, the study population in the EPI-CT 
project, an additional desirable characteristic is 
the possibility of using non-invasive procedures 
to collect biological samples. Currently we still 
depend on blood sampling to perform a highly 
sensitive γ-H2AX foci assay. Efforts have been 
made to optimize the assay on exfoliated buc-
cal cells which can be obtained by commercially 
available kits or a mouthwash technique (Gonza-
lez et al., 2010) and γ-H2AX has been measured 
in eye-brow hair root bulbs in the context of phar-
mocodynamic studies involving PARP inhibitors 
(Fong et al., 2009). However neither of the above 
mentioned biological samples have been proven 
to be informative in the dose range relevant to CT 
procedures and these samples are only appropri-
ate for the assessment of DNA damage related to 
high-dose x-ray exposure to the head and neck 
region.
In the present paper, the problem of repeated 
bloodsampling was addressed by using the cath-
eter for contrast agent administration (flushed) 
to collect the blood samples, eliminating the 
need for additional venepuncture. However, the 
catheter for blood collection in young children is 
not a perfect solution as it can be occluded after 
administration of contrast agent. Moreover, it is 
important that the possible influence of contrast 
agent administration on DNA DSB formation 
can be ruled out, which is still subject of debate 
(Grudzenski et al., 2009, Jost et al., 2009, Joubert 
et al., 2005, Deinzer et al., 2014). Iodine-con-
taining contrast agents strongly attenuate x-rays 
and are commonly used in CT imaging to better 
delineate anatomical structures from their sur-
rounding tissue. Our results show no significant 
increase in γ-H2AX foci numbers with increas-
ing iodine concentration. These findings confirm 
the results of Jost et al. (Jost et al., 2009) showing 
no biological dose-enhancing effect when both 
radiation and contrast dose were in the diagnos-
tic range (0.025, 0.05 and 0.1 Gy). However, a sta-
tistically significant increase in γ-H2AX foci and 
dicentrics was reported by these authors when a 
dose of 50 mg I/ml blood (outside the local io-
dine concentration range used for CT) and a high 
dose of 1 Gy (outside the diagnostic imaging dose 
range) were used. 
Performing clinical studies in children is chal-
lenging and limited by low consent rates from 
parents, the small amount of blood volume and 
the difficulties associated with blood sampling. 
In many countries, an informed consent has to 
be signed by one of the parents for children be-
low the age of 12 years, which requires detailed 
explanations of study aims and protocols. The 
limited blood volume in small children (0.27 l – 
4.5 l as published in ICRP 89 (Valentin, 2002)) 
obliged us to carry out the γ-H2AX foci assay in 
a small blood volume. Our results demonstrate 
that it is technically feasible to perform the assay 
with only 2 ml of blood taken before and after 
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the CT examination. This is in accordance with 
the sample volumes used the recent pilot study 
of Halm et al. (Halm et al., 2014) in which 2 ml 
blood samples were collected from children be-
fore and 1h after CT.
One of the major drawbacks of using γ-H2AX 
foci in a molecular epidemiological study, is the 
limited persistence of the signal after irradiation. 
This problem was also adressed by Roch-Lefèvre 
et al. (Roch-Lefevre et al., 2010) as a critical issue 
for the application of the γ-H2AX assay for bio-
logical dosimetry in case of an accidental expo-
sure. They reported an inhibition of γ-H2AX sig-
nal loss up to 24h when the blood was incubated 
on ice after an irradiation with 500 mGy γ-rays. 
In contrast whilst we could demonstrate that 
there was no loss in γ-H2AX foci signal when 
the blood samples of four different donors after 
irradiation with 100 mGy γ-rays were kept at 4°C 
up to 5h after exposure, a significant decrease in 
γ-H2AX signal was noted after 24h incubation at 
4°C. Moreover, keeping the blood samples on ice 
for 24h can result in difficulties during blood sep-
aration due to extensive haemolysis (Olson et al., 
2011). The current results open up the possibil-
ity of transporting the blood samples at 4°C from 
the hospital to an equipped laboratory, keeping 
in mind that lymphocyte separation is required 
on the same day of blood sample collection. Af-
ter lymphocyte separation it is possible to ship 
the purified lymphocyte overnight (within 24h) 
at 4°C to another laboratory without γ-H2AX 
signal loss.
In case blood sampling is only possible a few 
hours and not within 5-30 min post-CT, the 
scored gamma-H2AX foci will be reduced due to 
the DNA DSB repair kinetics. To cope with this 
decrease, more information on the kinetics of 
gamma-H2AX foci after low-dose x-ray exposure 
is needed and a subject for future research.
In a large scale context a quick and objective 
quantification of the γ-H2AX signals in cells 
would be particularly interesting. There is an on-
going intensive development of high throughput 
γ-H2AX foci scoring systems to automate mi-
croscopic evaluation. Automated scoring would 
exclude the scorer-subjectivity together with the 
time-consuming character of manual scoring, 
which are the major limitations of the γ-H2AX 
foci scoring to date. Sample size calculation 
based on the mean γ-H2AX foci yields obtained 
in the second intercomparison study, revealed 
that at least 200 cells per case should be scored 
in order to be able to discern a dose of 10 mGy 
from a sham-irradiated control. This is reason-
able considering the statistical resolution at low 
doses. However, many studies in literature count 
not more than 100 cells per sample. As discussed 
previously, analysis by flow cytometry may be 
quicker, however, it is not as sensitive as micros-
copy, which has the advantage of being able to 
discriminate objects such as discrete foci from 
background fluorescence (Redon et al., 2012). 
Certainly for the detection of DNA damage af-
ter low-dose exposure as in diagnostic radiol-
ogy, where the number of foci is small and the 
size of the biological sample is a limiting factor, a 
sensitive scoring method is more appropriate. In 
the intercomparison exercises, two participants 
performed manual scoring and two laboratories 
performed automated scoring. The results of 
the present study indicate a satisfactory agree-
ment between manual and automated scoring 
obtained in one of the participating laboratories 
(p = 0.093), suggesting an opportunity for auto-
mated γ-H2AX foci scoring in a low-dose mo-
lecular epidemiologal study. A carefully designed 
and well trained classifier is essential for a good 
correlation between manual and automated scor-
ing. The selection of the classifier depends on the 
microscope magnification and the quality of the 
samples and is therefore specific for the labora-
tory. However, an extensive optimisation of spot 
counting on the Metasystem scoring platforms 
and exchange of classifiers between laboratories 
is required to make automated scoring appli-
cable at a larger scale. It is recognised that there 
are several variables to consider when data col-
lected from different laboratories are compared 
(reagents and methods) and each laboratory has 
predetermined criteria for foci scoring (Barnard 
et al., 2014). By organising intercomparison stud-
ies and training, we can try to improve quality as-
surance, however some variation will be unavoid-
able in a multicentre context. 
As already mentioned, the presence of back-
ground and staining artefacts on the microscopic 
slides, can impede the foci quantification and 
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may affect the reproducibility of the assay. In this 
study in addition to γ-H2AX, 53BP1 was used 
as a surrogate marker for DNA DSB. 53BP1 is a 
well known DNA damage response (DDR) fac-
tor, which is recruited to nuclear structures at the 
site of DNA damage and forms readily visualised 
ionizing radiation-induced foci. Within the DNA 
damage response mechanism, 53BP1 is classified 
as an adaptor/mediator, required for processing 
of the DNA damage response signal and as a plat-
form for the recruitment of other repair factors 
(Gupta et al., 2014). We selected this protein, be-
cause 53BP1 foci are formed very quickly in re-
sponse to IR, compared to MRE11/RAD50/NBS1 
and BRCA1 foci (Celeste et al., 2003). For a radia-
tion dose of 25 and 500 mGy in the present ex-
perimental set-up most of the radiation induced 
foci showed overlap in fluorescence images. An 
additional interesting characteristic of perform-
ing γ-H2AX/53BP1 double immunostaining, is 
the possibility to make a morphological distinc-
tion between DNA-repair and apoptosis as 53BP1 
is not present in the apoptotic ring as reported by 
Solier and Pommier (Solier and Pommier, 2014). 
By scoring ‘merged’ γ-H2AX/53BP1 foci in G0 
lymphocytes one can be sure that the observed 
spot represents a DNA DSB attributable to the 
radiation exposure (Chua et al., 2011, Rothkamm 
et al., 2007, Horn et al., 2013). Our results vali-
dated that the ‘conventional’ γ-H2AX foci scor-
ing method is a reliable technique to score DNA 
DSB after low-dose exposure. However, further 
research is needed to test if the scoring of merged 
foci within a multicentre study would increase 
the uniformity in scoring results among the part-
ners.
In the last few years, several laboratory in-
tercomparison studies were organised in order 
to compare laboratories’ dose-assessment per-
formances of the γ-H2AX foci assay as a triage 
tool in biological dosimetry (Ainsbury et al., 
2014, Rothkamm et al., 2013a, Rothkamm et al., 
2013b). These intercomparison studies provided 
valuable input for the shipment and processing of 
the samples in the current study. For shipment, 
lymphocytes were packed together with frozen 
cool packs in order to keep the temperature below 
10°C and each package contained a temperature 
logger and dosemeter, as described in the Mul-
tibiodose Guidance (www.multibiodose.eu). The 
initial experiments of Rothkamm et al. (Roth-
kamm et al., 2013a) showed that several laborato-
ries encountered difficulties in sample processing 
due to extensive haemolysis when whole blood 
was irradiated, incubated and shipped. This was 
also observed in the current experiments after 
storing blood samples at 4°C for 24h. For this 
reason, we used freshly isolated lymphocytes in 
the second intercomparison study. In addition, 
we should keep in mind that radiation doses used 
in diagnostic radiology are much lower than the 
doses used in these emergency excercises. We 
show here for the first time in an intercompari-
son exercise in the low-dose range that laborato-
ries with highly optimized protocols can detect a 
damage response at least down to 10 mGy. This is 
essential for a large scale multicentre molecular 
epidemiological study, in particular when using 
biomarkers of exposure at very low doses. 
In the context of large international studies, 
it is crucial to organise intercomparison studies 
to investigate whether existing γ-H2AX proto-
cols would produce similar foci freqencies and to 
test the feasibility of sending samples in an over-
night shipment. The first intercomparison study 
showed comparable results for radiation doses 
of 100 and 500 mGy when every partner applied 
its own protocol. In the second intercomparison, 
the transport of samples exposed to doses in the 
diagnostic range was further explored and dem-
onstrated the feasibility of the foci assay to dis-
tinguish low-dose diagnostic x-ray exposures in 
a multicentre setting. In the first intercomparison 
foci yields were systematically lower compared to 
the other data obtained in this study. A possible 
explanation could be differences in experimental 
condititions between the UGent laboratory and 
partner sites or related to variation in radiosensi-
tivity among the donors involved in the different 
experiments. 
DNA DSB are considered to be the most del-
eterious cellular damage of x-rays because misre-
paired DNA DSB are the principal lesions of im-
portance in the induction of gene mutations and 
chromosomal rearrangements, including translo-
cations, which are linked to genomic instability 
and tumorigenesis (Richardson and Jasin, 2000). 
However, before the γ-H2AX foci assay can be 
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widely applied to obtain cancer risk estimations 
after low-dose exposure the link between the 
repair of ionizing radiation-induced DNA DSB 
and carcinogenesis needs to be further explored 
(Haddy et al., 2014).
In conclusion, we have shown that it is feasible 
to apply the γ-H2AX foci assay as a potential cel-
lular biomarker of exposure in a multicentre pro-
spective study of the effects of paediatric CT im-
aging if the γ-H2AX foci results can be validated 
in an in vivo pilot study on paediatric patients. 
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γ-H2AX foci as in vivo effect biomarker in children 
emphasize the importance to minimize x-ray doses in 
paediatric CT imaging
ABSTRACT
Objectives: Investigation of DNA damage induced by CT x-rays in paediatric patients versus pa-
tient dose in a multicentre setting.
Methods: From 51 paediatric patients (median age, 3.8 years) who underwent a CT abdomen or CT 
chest examination in one of the five participating radiology departments, blood samples were taken 
before and shortly after the examination. DNA damage was estimated by scoring γ-H2AX foci in pe-
ripheral blood T-lymphocytes. Patient-specific organ and tissue doses were calculated with a validated 
Monte Carlo program. Individual lifetime attributable risks (LAR) for cancer incidence and mortality 
were estimated according to the BEIR VII risk models.
Results: Despite the low CT doses, a median increase of 0.13 γ-H2AX foci/cell was observed. Plot-
ting the induced γ-H2AX foci versus blood dose indicated a low-dose hypersensitivity, supported also 
by an in vitro dose-response study. Differences in dose levels between radiology centres were reflected 
in differences in DNA-damage. LAR of cancer mortality for the paediatric chest CT and abdomen CT 
cohort was 0.08 and 0.13 ‰ respectively. 
Conclusion: CT x-rays induce DNA damage in paediatric patients even at low doses and the level of 
DNA damage is reduced by application of more effective CT dose reduction techniques and paediatric 
protocols.
Key Points:
1. CT induces a small, significant number of DNA DSBs in children.
2. More effective CT dose reduction results in less DNA damage.
3. Risk estimates according to the LNT hypothesis, may represent underestimates
Abbreviations and Acronyms:
DNA: deoxyribonucleoside acid
LSS: lifespan study
LNT: linear-no-threshold
γH2AX: phosphorylated histone subtype H2A isoform X
DSB: double-strand break
BEIR: biological effects of ionizing radiation
LAR: lifetime attributable risk
ATCM: automatic tube current modulation
RPMI: Roswell Park Memorial Institute
PFA: paraformaldehyde
RAM-TRITC: rabit-anti-mouse tetramethyl rhodamine isothiocyanate
DAPI: 4’,6-diamidino-2-phenylindole
53PB1: p53 binding protein 1
ICRP: international commission on radiological protection
DLP: dose-length product
DRL: dose reference level
CTDIvol: computed tomography dose index (volume)
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INTRODUCTION
The introduction of computed tomography 
(CT) has tremendously improved diagnostic im-
aging. However, the high x-ray doses associated 
with CT procedures have raised health concerns 
[1]. This is of particular importance for the pae-
diatric patient population, recognized as one of 
the most important target groups in medical ra-
diation protection. Technological developments 
in CT have substantially increased diagnostic 
applications and accuracy in paediatric patients. 
Children have a higher radiosensitivity compared 
to adults regarding x-ray induced malignancies 
and the associated risk for exposure induced 
death [2]. Therefore, optimisation and justifica-
tion of CT protocols for children is a topic of 
high importance in daily clinical practice [3]. 
An initiative worth mentioning in this context, 
is the Image Gently campaign of the Alliance for 
Radiation Safety in Paediatric Imaging, that tries 
to change practice by increasing awareness of the 
opportunities to reduce radiation dose in the im-
aging of children [4]. Several studies have shown 
that the use of CT dose reduction techniques in 
paediatric CT imaging lowers the physical radia-
tion dose [5, 6]. However it remains unexplored 
if they also have an impact on the DNA damage 
induced by CT x-rays in children.
A recent study in the United Kingdom has 
linked the exposure from x-rays in CT scan-
ning during childhood with the development of 
brain tumours and leukaemia [7]. However, the 
risk assessments at low doses remain subject of 
active debate. The lifespan study (LSS) of atomic 
bomb survivors showed a roughly linear relation-
ship between cancer mortality and high doses 
of high dose rate radiation for an adult popula-
tion [8]. This resulted in the linear-no-threshold 
(LNT) hypothesis, implying a linear relationship 
between dose and biological effect without a dose 
threshold. Despite the considerable uncertainties 
and divergent views regarding the health effects 
and applicability of the LNT theory at low doses, 
the model is used for risk estimation by the in-
ternational radiation protection community and 
referred as the main paradigm of radiation pro-
tection [9]. 
The use of sensitive biomarkers for the assess-
ment of early x-ray effects in patients gives valu-
able information on dose-effect relationships for 
diagnostic x-rays. Earlier work has demonstrated 
that the γ-H2AX foci assay can be used to deter-
mine the effects of CT exposure at molecular lev-
el, namely the induction of DNA double-strand 
breaks (DSBs) [10-13]. DSBs are considered to 
be the most deleterious cellular effects of x-rays, 
because they can result in loss or rearrangement 
of genetic information, leading to cell death or 
carcinogenesis [14]. The phosphorylation of the 
histone variant H2AX is one of the earliest stages 
in the cellular response to DSBs and one γ-H2AX 
focus represents one DNA DSB, which can be 
quantified by immunofluorescence microscopy 
[15]. 
A prospective multicentre study was set up in 
order to determine the number of x-ray induced 
DNA DSBs in children undergoing a CT chest or 
CT abdomen examination. Herein, the γ-H2AX 
foci assay was used as an effect biomarker for 
radiation-induced DSBs. Blood doses were deter-
mined by a patient specific full Monte Carlo dose 
simulation in order to correlate the induced DNA 
damage with the individual blood dose. BEIR VII 
age and gender specific risk models were used to 
assess the lifetime attributable risk (LAR) of can-
cer incidence and mortality associated with the 
CT examination of every individual patient. 
MATERIALS AND METHODS
A. Assessment of DNA DSBs in 
pre- and post-CT blood samples of 
paediatric patients 
Study Population
The study population consisted of 51 children 
undergoing a CT exam of the chest (41) or abdo-
men (10) in one of the five participating radiolo-
gy centres (March 2012 through July 2013) (Table 
1). The small number of CT abdomen patients is 
caused by the fact that magnetic resonance imag-
ing (MRI) was the preferred imaging modality of 
the majority of participating radiologists for ab-
domen investigations, to avoid ionizing radiation 
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exposure. Exclusion criteria were present or past 
leukaemia or lymphoma and radiochemotherapy 
within the last year. The median age of the pa-
tient group was 3.8 years (range 0.1 - 12.5 years). 
Before blood sampling, an informed consent was 
signed by one of the parents of the children. The 
prospective multicentre study was approved by 
the local review boards of the participating hos-
pitals and the institutional review board of Ghent 
University Hospital acted as central Ethical Com-
mittee.
state-of-the-art CT systems with dose reduction 
techniques and adapted paediatric protocols re-
sulted in low- or even ultra-low CT doses.
Sample collection 
Blood samples (2 mL) were collected through 
the catheter for contrast agent administration. 
One blood sample was taken before CT, to deter-
mine the baseline level of DSBs, and one approxi-
mately 5 min after the examination (the catheter 
was always flushed before sampling). Due to oc-
TABLE 1
Demographic data of the paediatric patients 
included in the study. 
CT Equipment and acquisition protocols
All the participating radiology departments 
used contemporary state-of-the-art low dose CT 
systems. The following CT scanners were used in 
this study: Siemens Somatom Definition Flash 
and Sensation 64 (Siemens Medical Solutions, 
Germany), Toshiba Aquilion (Toshiba Medical 
Systems, Japan) and three centres used the GE 
Discovery CT750 HD (GE Healthcare, USA). 
Every radiology department used his own, opti-
mized paediatric CT protocol with low kVp set-
tings (median values; CT chest 80 kV: range 80-
120 kV; CT abdomen 100 kV: range 100-120 kV), 
low fixed tube currents or automatic tube current 
modulation (ATCM), adapted pitch values and 
scan lengths restricted to the region of interest. 
Iterative reconstruction technology was applied 
in two of the institutions, resulting in ultra-low 
doses (VEO reconstruction from GE Healthcare). 
Individual CT parameters for the patients of the 
study are presented in Table 2 and 3 for CT chest 
and abdomen respectively. The combination of 
clusion, blood sampling through the catheter was 
not possible for more than half of the patients, 
especially very young children. For these patients 
an additional venepuncture after the CT exam 
was necessary. The blood samples were kept at 
37°C for 30 minutes to allow DNA damage sig-
nalling. Afterwards, DNA repair was arrested by 
cooling the samples at 0°C for 15 minutes. Blood 
was transported at 4°C, with an elapsed time no 
longer than 3h from collection to processing. 
Before processing, samples were coded allowing 
blind scoring later on.
Detection of DNA DSBs
The method is based on the phosphorylation 
of the histone variant H2AX after DSB forma-
tion and follows previously published protocols 
[11, 16, 17]. In order to be able to work with a 
homogeneous cell population, T-lymphocytes 
were isolated from the blood with the RosetteSep 
Human T-Cell Enrichment Cocktail (StemCell 
Technologies, France) and resuspended in com-
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TABLE 2
Individual CT parameters 
for all paediatric 
patients of present study 
undergoing a CT chest 
examination.
TABLE 3
Individual CT parameters 
for all paediatric 
patients of present study 
undergoing a CT abdomen 
examination. 
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plete RPMI cell culture medium (84% RPMI-
1640, 15% Foetal Calf Serum, 1% L-glutamine, 
50U/mL penicillin and 50µg/mL streptomycin; 
Life Technologies, Belgium). For immunofluo-
rescence staining, 250 µL of the resuspended T-
lymphocytes was centrifuged onto poly-L-lysine 
coated slides (VWR International, Belgium). The 
slides were fixed in 3% paraformaldehyde (PFA) 
(Sigma-aldrich, Belgium) for 20 minutes and 
stored overnight in 0.5% PFA. Fixation should 
immobilize antigens while retaining the lym-
phocytes as close to their natural state as possi-
ble. The next day, slides were permeabilised by 
dropping 100 µL of 0.2% Triton-X-100 (Sigma-
Aldrich, Belgium). This permeabilisation step 
is required because the anti-γ-H2AX antibody 
binding requires intracellular access to detect 
the γ-H2AX protein. The immunofluorescence 
staining was performed with an unlabelled pri-
mary mouse monoclonal anti-γ-H2AX antibody 
(1:500; Biolegend, Belgium) which specifically 
binds to the target γ-H2AX protein, followed by 
a secondary Rabbit Anti-Mouse (RAM) - TRITC 
antibody (1:1000; DakoCytomation, Denmark). 
This secondary antibody carries the (TRITC) 
fluorophore, recognizes the primary anti-γ-
H2AX antibody and binds to it. Subsequently, 
the lymphocyte nucleus was counterstained with 
-6,›4  %2diamidino-2-phenylindole (DAPI) in 
slow-fade mounting medium (Sigma-Aldrich, 
Belgium). DAPI is a blue fluorescent stain specific 
for DNA. Microscopic scoring was performed 
manually with an Olympus BX60 fluorescence 
microscope with an Olympus 100x/1.30 oil 
lens. The images were viewed using Cytovision 
software and captured with a digital camera 
(Applied Imaging, USA). Ten optical sections 
were obtained for each field of vision (Z-stack 
sections of 1.03 µm). Different images of one 
blinded slide were stored and on average 250 cells 
were scored manually for γ-H2AX foci. More 
than 250 cells were scored for every condition 
and the number of γ-H2AX foci induced by 
CT x-rays was obtained by subtracting the pre-
scan foci yield from the post-scan foci yield after 
decoding. The scoring procedure was validated 
by double immunostaining for both γ-H2AX and 
p53 binding protein 53)  1BP1), to discriminate 
between background artefacts and small γ-H2AX 
foci. The experiments demonstrated that the 
γ-H2AX-TRITC foci coincide with 53BP-1FITC 
foci, resulting in a statistical significant agreement 
between the number of double stained foci 
(merge) and the number of individual γ-H2AX-
TRITC foci (results not shown).
B. In vitro dose response study on 
umbilical cord blood samples
For the validation of the in vivo results, a set 
of in vitro experiments was performed. Unfor-
tunately, it was not possible to have access to 
blood samples with a larger volume than 2 mL 
from young children, due to ethical constraints. 
Since umbilical cord blood is physiologically and 
genetically part of the foetus, we can consider this 
as blood of a newborn [18]. Therefore, umbilical 
cord blood samples were irradiated in vitro in or-
der to compare the γ-H2AX foci dose response 
after in vivo and in vitro exposure. Cord blood 
samples from three healthy donors were exposed 
to 1, 2, 4, 6, 8, 10, 15, 20 and 500 mGy and one 
blood sample was sham-irradiated. A radiation 
quality of 100-kVp x-rays and 2 mm Al filtration 
was used, with a Philips MG420 x-ray generator 
coupled to a MCN420 tube. The irradiation was 
carried out in a 37°C water bath. Calibration was 
performed with an NE2571 Farmer ionization 
chamber (Thermo Electron, Altrincham, UK). 
The irradiated blood samples were kept for 30 
minutes at 37°C, followed by 15 minutes on ice 
water to simulate the situation of patient blood 
samples after in vivo exposure. The same γ-H2AX 
foci protocol and scoring method as described 
for the in vivo study was applied. The use of cord 
blood for in vitro experiments was approved by 
the institutional review board.
C. Patient dosimetry
Calculation of blood and organ doses 
induced by CT x-rays by full Monte Carlo 
simulation
The blood dose was calculated as a weighted 
sum of doses to the largest blood containing or-
gans with the percentage of blood pool as weight-
ing factor, namely lungs (12.5%), heart (10%), liv-
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er (10%) and remainder (67.5%) [19]. In order to 
obtain individual organ dose estimates, an indi-
vidualized full Monte Carlo patient dose simula-
tion was set up using ImpactMC simulation soft-
ware 1.3.1 (CT Imaging GmbH, Germany). In the 
latter software, patient-specific 3D voxel models 
are created based on the CT images acquired 
during CT examination [20]. For the simulation 
of the CT scan, actual scan parameters such as 
tube voltage (kV), tube current - exposure time 
product (mAs) and pitch, are retrieved from the 
DICOM header of the CT images. The individual 
mA values of all the reconstructed CT slices were 
used in order to take into account the tube cur-
rent modulation of the CT scanner. More than 
1010 photons were simulated in order to minimize 
the uncertainty in the Monte Carlo results. The 
patient specific dose distribution was determined 
by multiplying the air-kerma normalized dose 
distribution from the simulations with the actual 
air-kerma value (mGy) measured free-in-air in 
the iso-center of the scanner by using a pencil 
ionization chamber (RaySafe Xi CT detector, Un-
fors RaySafe, Sweden). In addition to the organ 
doses needed for the blood dose evaluation, doses 
to other organs and tissues of interest according 
to the BEIR VII risk models were also calculated 
with this Monte Carlo patient dose simulation. 
Organ volumes were segmented in the original 
CT images and organ dose deposition was calcu-
lated based on the Monte Carlo dose distribution. 
For the bone marrow, all bony structures in the 
field of view were segmented and the bone mar-
row dose was calculated as the weighted sum of 
the doses to these structures with the percent-
age of bone marrow in these compartments as 
weighting factor [21]. To account for differences 
in photon absorption in bone and bone marrow, 
the obtained value was corrected for the ratio of 
mass absorption coefficients in soft tissue and 
bone [22]. 
Calculation of effective dose
To compare the dose levels of the CT proce-
dures in the current study with similar proce-
dures in different hospitals and countries, the 
effective dose was calculated for the total group 
of CT chest and CT abdomen patients. Effective 
dose is a quantity reflecting the stochastic risk as-
sociated with an exposure to ionizing radiation 
at a population level. The effective doses of the 
paediatric populations under study were derived 
from the individual DLP values by using the con-
version factors published by Deak et al. as func-
tion of kVp, imaging region and age for ICRP 
publication 103 recommendations [23].
D. Risk estimation
Individual LAR of cancer incidence and mor-
tality related to a chest or abdomen CT scan were 
calculated according to the BEIR VII risk mod-
els for different cancer types, taking into account 
age-dependent incidence and mortality rates 
within the Euro-American population [24]. Input 
for these risk assessments were the simulated or-
gan doses and the age of the individual patients. 
The LAR data from BEIR VII were adapted for 
a dose and dose-rate effectiveness factor of 2 as 
proposed by the ICRP [25].
E. Statistical Analysis
Statistical analysis was performed with 
Microsoft Office Excel 2010 (Microsoft 
Corporation,USA) and Statistical Package for 
Social Sciences software version 22 (SPSS Inc., 
USA). Poisson statistics were applied to calculate 
the statistical accuracy of the number of x-ray 
induced γ-H2AX foci. The differences between 
the pre- and post-CT data sets were evaluated 
for significance with the paired sample Wilcoxon 
signed-rank test (95% confidence level). Linear 
regression analysis was applied to evaluate age 
dependence. A p-value less than 0.05 was consid-
ered as statistically significant.
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RESULTS
A. Assessment of DNA DSBs in 
pre- and post-CT blood samples of 
paediatric patients
An increase in DNA DSBs was observed for 
every patient, except for one CT chest patient 
with a very low blood dose of 0.14 mGy. The me-
dian pre-exposure level was 0.56 foci/cell (range 
0.23 - 1.20 foci/cell) and the post-exposure level 
was 0.72 foci/cell (range 0.31 - 1.44 foci/cell). The 
pre- and post- CT exposure foci levels are pre-
sented in Figure 1 for every individual patient. 
The median number of induced foci represent-
ing DNA DSBs induced by CT was 0.13 foci/
cell (range -0.07 - 0.49 foci/cell) and the median 
blood dose 0.94 mGy (range 0.14 - 8.85 mGy). 
Present study shows that nearly every CT pro-
cedure induces DNA DSBs in T-lymphocytes of 
paediatric patients. A Wilcoxon signed-rank test 
showed a statistically significant difference in the 
mean level of DNA DSBs pre-CT and the mean 
level post-CT per patient (p<0.001). Moreover, 
the number of induced DSBs is strongly blood 
dose dependent as illustrated in Figure 2. 
To investigate the intrinsic higher radiosensi-
tivity of children decreasing with age, the num-
ber of induced γ-H2AX foci was divided by the 
calculated blood dose and plotted versus age of 
the paediatric patient. The linear fit in Figure 3 
indicates a diminishing trend of the foci-over-
dose ratio versus age, however regression analysis 
showed that the decrease of the foci-over-dose 
ratio versus age was not statistically significant 
(p=0.204).
B. In vitro dose response study on 
umbilical cord blood samples
The results of the in vitro irradiation of um-
bilical cord blood, repeated for 3 different donors, 
are also presented in Figure 2. The in vivo and in 
vitro dose response curves show both an initial 
sharp increase with dose and appear not linear 
at all. The dashed line in Figure 2 represents an 
extrapolation according to the LNT hypothesis of 
the in vitro dose response of γ-H2AX foci in cord 
blood at higher doses (5.68 γ-H2AX foci/cell for 
0.5 Gy) to zero. This shows clearly that the foci 
numbers in the low-dose range are much higher 
than expected from the LNT extrapolation of 
high dose behaviour. 
FIGURE 1
Comparison of γ-H2AX-foci levels pre- and post- CT x-ray 
exposure for every individual patient of the study. Error 
bars represent standard deviations on foci yields calculated 
following Poisson statistics.
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FIGURE 2
(a) The mean number of γH2AX-foci per cell induced by in vivo x-ray exposure 
plotted versus the Monte Carlo calculated blood dose for every paediatric patient 
undergoing a CT chest or CT abdomen (in blue). The whiskers represent standard 
deviations derived from the statistical accuracy of the scored number of foci in 
the blood samples taken before and after CT examination (Poisson statistics). The 
dose-response curve after in vitro x-ray irradiation of cord blood is also shown (in 
green). The whiskers of the in vitro study represent SDs among the three different 
donors. The dashed line represents a linear extrapolation based on the γ-H2AX 
foci induced in cord blood after an in vitro dose of 0.5 Gy, based on the LNT 
hypothesis. Since a large part of the data are clustered in 0-2 mGy range, this 
range is presented as a separate figure (b).
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C. Patient dosimetry
Monte Carlo calculations resulted in a median 
blood dose for CT chest patients of 0.86 mGy 
(0.14 – 2.84 mGy) and for CT abdomen patients 
of 1.62 mGy (0.66 - 8.85 mGy). The median ef-
fective dose value for the CT chest patient cohort 
was 1.14 mSv (range 0.17 mSv - 3.10 mSv). For 
the CT abdomen patient cohort, the median ef-
fective dose value was higher, namely 2.82 mSv 
(range 1.18 mSv - 10.55 mSv). A comparison of 
these values with literature data confirms that in 
present study patient doses were low [26, 27]. All 
participating centres used state-of-the-art low 
dose equipment and specific paediatric protocols, 
resulting in very low CTDIvol and DLP values of 
the patients compared with the national dose ref-
erence levels (DRLs) (Table 4). Reference levels 
are typically set at the 75th percentile of the dose 
distribution from a conducted survey. The me-
dian CTDIvol and DLP values in the current study 
are below the 75th percentile values and close to 
the 25th percentile, which represents good clini-
cal practice. However, substantial differences in 
dose sparing equipment and imaging protocols 
for children resulted in differences in patient 
doses and corresponding DNA damage. Figure 
4 shows a clear correlation between both param-
eters when comparing the data for the different 
participating hospitals. This figure emphasizes 
that the use of more powerful dose reduction 
techniques and protocols involving a lower pa-
tient dose, results also in less radiation effects for 
paediatric patients according to the DNA damage 
effect biomarker. 
D. Risk estimation
Based on the Monte Carlo calculated organ 
doses, individual lifetime attributable risk val-
ues for cancer incidence and mortality according 
to the BEIR VII risk models were calculated for 
every patient. The BEIR VII report provides a 
method to estimate LAR of cancer incidence and 
mortality based on the organ doses associated 
with the radiation exposure and a patient’s age at 
FIGURE 3
The number of	γ-H2AX foci normalized to blood dose, as a 
function of age of the paediatric patients. The dashed line is 
the result of a linear fit.
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FIGURE 4
The mean γ-H2AX foci per cell induced by CT x-rays plotted against the mean patient blood dose for participating 
centres. The CT equipment used by the participating centres was as follows: hospital A - GE Discovery CT750 HD, 
hospital B - GE Discovery CT750 HD (VEO), hospital C – Siemens Somatom Definition Flash and Toshiba Aquilion, 
hospital D – GE Discovery CT750 HD (VEO), hospital E - Siemens Somatom Definition Flash and Sensation 64. Whiskers 
represent the standard deviation on the mean of foci numbers and blood doses.
TABLE 4
Comparison of the median CTDIvol 
(mGy) and DLP (mGycm) values of the CT 
chest and CT abdomen investigations in 
this study with the national DRLs (75th 
percentile) in Belgium. As an indication 
of good clinical practice, also the 25th 
percentile is presented.
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the time of exposure. Table 5 represents the medi-
an LAR values of cancer incidence and mortality 
related to leukaemia and different types of solid 
cancer of organs in the field of view based on the 
simulated organ doses. The range of LAR values 
over the patient cohorts is indicated between 
brackets. For the total patient cohort undergoing 
a CT chest examination the LAR values for can-
cer incidence and mortality are respectively 0.17 
per thousand and 0.08 per thousand. For the total 
group of paediatric patients undergoing a CT ab-
domen examination the LAR incidence and mor-
tality are respectively 0.32 per thousand and 0.13 
per thousand.
TABLE 5
LAR of cancer incidence and mortality following the BEIR VII model, associated 
with x-ray exposure from CT chest and CT abdomen examinations for the cohort 
of paediatric patients included in the study. Values are median (range), based on 
the individual simulated organ doses and the age of the individual patients.
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DISCUSSION
Our study provides evidence that CT induces 
DNA damage in paediatric patients, even at low 
doses (blood doses in the range of 0.15 - 8.85 
mGy). Several studies reported γ-H2AX foci in-
duction by CT x-ray exposure in adult patients 
[10-13, 28]. However none of them investigated 
the DNA damage induced by CT radiation ex-
posure in paediatric patients, nor the ultra-low 
dose region evaluated in current study. There 
was already a small scale pilot study with blood 
samples from ten paediatric patients undergoing 
CT examinations, in which chromosome analysis 
in lymphocytes showed a significant increase in 
dicentric frequencies and excess acentric frag-
ments [29]. However, the mean blood dose of 
the cohort of ten children in the study of Stephan 
et al. was 12.9 mGy compared to the low mean 
blood dose of 1.35 mGy for the 51 patients in the 
current study. 
Currently, the vast majority of publications 
use the concept of effective dose to assess CT 
radiation burden. However, effective dose calcu-
lations can never be linked to an individual pa-
tient exposure, as reference phantoms need to be 
used and the quantity effective dose is designed 
for risk estimation in a population. To interpret 
the in vivo γ-H2AX foci data, it is very impor-
tant to have an accurate blood dose calculation 
for every patient, which takes into account the 
patient’s anatomy, different types of CT scanners, 
dose reduction technologies and various types of 
CT protocols. However, the latter analysis can-
not be performed by using effective dose. This 
was accomplished by a Monte Carlo simulation 
of radiation transport in patient specific 3D voxel 
models derived from the CT images. For dosim-
etry of paediatric patients the use of voxel models 
is a substantial improvement compared to dose 
calculation based on anthropomorphic paediat-
ric standard phantoms, as the full Monte Carlo 
simulation takes into account the real anatomy of 
the patient.
In addition the results of present study show 
that lower patient doses related to more effec-
tive CT dose reduction strategies for paediatric 
patients result also in a similar decrease in DNA 
DSBs as effect biomarker. It is internationally rec-
ognized that CT dose optimization is essential, es-
pecially for children taking into account not only 
dose reduction but also diagnostic image quality. 
A number of CT dose surveys showed substantial 
differences between practices for the same type 
of examination, suggesting that not all institu-
tions have suitably optimized their CT protocols 
[30, 31]. Dose saving strategies are continuously 
evolving in terms of imaging techniques as well 
as dose management and the result of the pres-
ent study, stress the importance of dose reduction 
in paediatric CT imaging. As already shown by 
the values of the calculated blood doses and the 
comparison of DLP and CTDIvol values with na-
tional DRLs, paediatric CT radiation doses were 
substantially low in all participating radiology 
departments. One of the institutions (hospital D 
in Figure 4) achieved very low doses (mean blood 
dose, 0.71 mGy) by using iterative reconstruction 
for all CT examinations, however only CT chest 
patients were recruited in this institution. For the 
patient cohort of institution D, a very low mean 
level of induced γ-H2AX foci per cell (0.10 foci/
cell) was recorded. Hospital E achieved a mean 
blood dose of 0.95 mGy corresponding with 0.13 
induced foci/cell and the data for this hospital 
are a mixture of CT chest and CT abdomen in-
vestigations. For both types of examination DLP 
values in this hospital were very low compared to 
the DRL (reported in Table 4). The median DLP 
value for CT abdomen patients in hospital E was 
60.00 mGycm (range, 33.00 - 87.20 mGy), which 
is lower than the 25th percentile of 100 mGycm.
When the number of induced γ-H2AX foci 
is plotted versus blood dose, the data point to 
a low-dose hypersensitivity. The observed low-
dose hypersensitive response in paediatric CT 
is in agreement with the data of a previous study 
on paediatric patients undergoing a cardiac cath-
eterization [17]. The in vitro dose response curve 
on umbilical cord blood shows the same behav-
iour in the low-dose range and supports the in 
vivo results. 
The observed low dose hypersensitivity chal-
lenges the LNT hypothesis, assuming less DNA-
damage, and can be explained by the “bystander 
effect” [32]. Genetic/epigenetic changes occur 
not only in cells hit by the ionizing particles but 
also in non-irradiated cells that are neighbouring 
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directly-hit cells. The bystander effect amplifies 
the effects of radiation by increasing the number 
of affected cells, due to cell-cell communication 
or soluble factors released by irradiated cells. By-
stander effects are observed after co-cultivation 
of irradiated and non-irradiated cells and trans-
fer of medium from irradiated to non-irradiated 
cells [33, 34]. For cells in direct contact, bystand-
er signalling can occur through gap-junctional 
intercellular communication [35, 36]. A second 
route by which bystander responses are medi-
ated is through the release of soluble factors from 
cells that have been irradiated. These factors have 
been extensively studied and several of these key 
molecules are central players involved in stress 
responses and cell-cell signalling, which are not 
generally specific to radiation exposure [35]. 
Moreover, many aspects of bystander mediated 
response have close parallels to inflammatory 
responses. This was recently shown in a gene set 
enrichment analysis, that highlighted different 
gene expression profiles in whole blood samples 
irradiated with low and high doses of x-rays. 
Functional analysis of genes differentially ex-
pressed at 0.05 Gy showed the enrichment of che-
mokine and cytokine signalling [37]. In a study 
of Mancuso et al., DNA damage, apoptosis and 
tumour induction were observed in the shielded 
cerebellum of mice heterozygous for Patched af-
ter partial-body irradiations [38]. This indicates 
that bystander effects in vivo have carcinogenic 
potential. 
A possible confounder in present study could 
be the increase in DSB levels due to the adminis-
tration of contrast agent and the corresponding 
emission of secondary radiation in CT imaging. 
However, previous studies showed that there 
was no biological dose enhancing effect if radia-
tion and contrast agent are within the diagnostic 
range [11,39]. 
Epidemiological data indicate a higher relative 
risk of cancer per unit of radiation dose for chil-
dren compared to adults and children have also 
a longer lifetime for radiation-related cancer to 
occur [2]. We observed a non-significant age-de-
pendency in our present study of x-ray induced 
DNA DSBs. To study age dependence, the study 
population should be broadened and a more uni-
form distribution of the ages is required. 
Using the calculated organ doses, the LAR for 
cancer mortality in the paediatric patient popu-
lation undergoing a low dose chest or abdomen 
CT was of the order of 0.1‰ according to the 
BEIR VII data assuming the LNT hypothesis. 
The thyroid gland, breast tissue and gonads are 
structures that have an increased sensitivity to 
radiation in growing children. Some of these re-
gions, as thyroid and breast tissue, are routinely 
involved in CT chest scanning. Miglioretti et al. 
[27] calculated radiation exposure and LAR for 
cancer incidence from a random sample of pae-
diatric CT scans. The calculated lifetime attrib-
utable risks reported in this paper are an order 
of magnitude higher than those reported in the 
current study: CT abdomen 1-4 ‰ versus 0.3 ‰ 
(median), CT chest 2-3 ‰ versus 0.1-0.4 ‰ (me-
dian boys-girls). The main reason for the lower 
risk estimates in the current study are lower pa-
tient doses compared to the work of Miglioretti 
et al. [27]. They reported a mean ED of 12.5 mSv 
for CT abdomen and 6.3 mSv for CT chest, where 
in present work median ED values were 2.8 mSv 
and 1.1 mSv respectively. The lower doses and 
corresponding risk estimates in current work 
reflect the use of contemporary state-of-the-
art low-dose CT equipment and the successful 
implementation of dose reduction strategies for 
paediatric CT imaging by the participating radi-
ology departments (as illustrated in Table 4). 
Large uncertainties are associated with the 
risk estimates summarized in Table 5. The BEIR 
VII committee estimates that the excess cancer 
mortality due to radiation can be estimated with-
in a factor of two (at 95% confidence level). For 
leukaemia the corresponding factor is four. The 
LNT model applied by the BEIR VII committee is 
based mainly on epidemiological data for radia-
tion induced cancers in the atomic bomb survi-
vors in the dose range of about 100 mSv to 2.5 
Sv [8]. For lower doses involved in diagnostic ra-
diology epidemiological data are not available to 
support the LNT model mainly owing to the nec-
essary sample size [40]. Application of the LNT 
hypothesis in the low dose range may lead to an 
overestimation of the risk in case of the existence 
of a dose threshold or an underestimate in case 
of cooperative multicellular radiation effects such 
as bystander effects. It is anticipated that signifi-
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cant insights in dose response and cancer risks in 
the low dose range will emerge from molecular 
epidemiology studies incorporating biomarkers 
and bioassays [41]. The low dose hypersensitiv-
ity observed in the γ-H2AX foci dose response of 
present study indicates that LAR estimates based 
on the LNT model may potentially underestimate 
the risks of paediatric CT imaging. 
For conclusions with respect to the risk of 
stochastic effects of x-rays present study has limi-
tations. Biological damage in T-lymphocytes re-
flects only the damage in one tissue, namely the 
blood. However, we may assume that DNA dam-
age and repair in peripheral blood lymphocytes 
is representative for other normal tissues [42]. 
Using the γ-H2AX foci assay, only DNA DSBs 
induced by CT x-rays are detected but not the 
outcome of the DNA repair process. DNA DSBs 
are considered to be particularly biologically im-
portant because their repair is more difficult than 
other types of DNA damage. Cells have evolved 
mechanisms to monitor genome integrity and 
they respond to DNA damage by activating a 
complex DNA damage response pathway. Erro-
neous repair of DNA DSBs can result in chromo-
somal rearrangements, including translocations, 
which are associated with tumorigenesis [43]. An 
increase in chromosomal aberrations, due to a 
defect in DNA repair as observed in Ataxia Tel-
angiectasia (AT) patients, leads to genetic insta-
bility, which in turn enhances the rate of cancer 
development [44]. In the framework of cancer 
risk, a direct assessment of mutations in DNA or 
chromosomal aberrations induced by CT x-rays 
in paediatric patient’s lymphocytes would pro-
vide added value taking into account the muta-
gen-carcinogen link. However, this kind of stud-
ies is not obvious in view of the low sensitivity of 
contemporary mutagenicity assays. 
Present study emphasizes the need to opti-
mize and minimize radiation exposure in paedi-
atric CT imaging: lower patient doses entail less 
DNA damage in children. This implies justifica-
tion of the indications for which medical imag-
ing involving ionizing radiation is used. From a 
patient’s perspective, the benefits of a medically 
necessary CT scan far exceed the small radia-
tion-induced cancer risk. However, some stud-
ies suggest that a third of paediatric CT scans 
are unnecessary [1]. This indicates that the refer-
ring physician and radiologist should consider 
whether the exam is truly clinically indicated and 
was not recently performed in another hospital. 
Furthermore, they should check if no alternative 
diagnostic procedure might be available, not in-
volving ionizing radiation such as ultrasound and 
MRI. When CT is indicated, great care should be 
taken to optimize radiation exposures in order to 
minimize the risk for carcinogenic effects later 
in life. Strategies to optimize radiation doses in 
paediatric CT imaging are: adjustment of the CT 
parameters to the child’s size (guidelines on in-
dividual size/weight parameters [45]), the scan 
length should be restricted to the region of in-
terest and dose reduction techniques should be 
implemented taking into account the required 
image quality (ATCM, iterative reconstruction 
and/or adaptive collimation). The observations 
of present work should encourage medical prac-
titioners to maximize the benefit-to-risk ratio of 
CT imaging in paediatric radiology.
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Radiation sensitivity of human CD34+ cells versus 
peripheral blood T-lymphocytes of newborns and adults: 
DNA repair and mutagenic effects
ABSTRACT
As haematopoietic stem and progenitor cells (HSPCs) self-renew throughout life, accumulation of 
genomic alterations can potentially give rise to radiation carcinogenesis. In this study we examined 
DNA double-strand break (DSB) induction and repair as well as mutagenic effects of ionizing radia-
tion (IR) in HSPCs (CD34+) and T-lymphocytes from the umbilical cord of newborns. The age depen-
dence of these DNA damage repair endpoints was investigated by comparing newborn T-lymphocytes 
with adult peripheral blood T-lymphocytes. As umbilical cord blood (UCB) contains T-lymphocytes 
that are practically all phenotypically immature, we examined the radiation response of separated 
naive (CD45RA+) and memory lymphocytes (CD45RO+). The number of DNA DSB was assessed by 
the microscopic scoring of γ-H2AX/53BP1 foci 0.5 h after low-dose exposure, while DNA repair was 
studied by scoring the number of residual γ-H2AX/53BP1 foci 24 h post-exposure. Mutagenic effects 
were studied by the cytokinesis block micronucleus (CBMN) assay. 
Both HSPCs and newborn T-lymphocytes showed statistically significant lower endogenous levels 
of DNA DSBs and MN compared to adult T-lymphocytes. No significant differences in the number of 
DNA DSB induced by low-dose (100-200 mGy) exposure were observed between the three different 
cell types. However, residual γ-H2AX/53BP1 foci levels 24 h post IR were significantly lower in HSPCs 
compared to newborn T-lymphocytes, while newborn T-lymphocytes showed significant higher foci 
yields than adult T-lymphocytes. No significant differences in the level of radiation-induced micro-
nuclei at 2 Gy were observed between CD34+ cells and newborn T-lymphocytes. However, newborn 
T-lymphocytes showed a significantly higher number of MN, compared to adult T-lymphocytes. These 
results confirm that HSPC quiescence promotes mutagenesis after ionizing radiation exposure. Fur-
thermore, we can conclude that the peripheral T-lymphocytes from newborns are significantly more 
radiosensitive than peripheral T-lymphocytes of adults. Using the results of the comparative study of 
the radiation-induced DNA damage repair endpoints in naive (CD45RA+) and memory T-lympho-
cytes (CD45RO+), we could demonstrate that the observed differences between newborn and adult 
T-lymphocytes can be explained by the immunophenotypic change of T-lymphocytes with age, which 
is presumably linked with the remodelling of the closed chromatin structure of naive T-lymphocytes. 
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INTRODUCTION
The paediatric patient population is recog-
nized as one of the most critical target groups in 
medical radiation protection. Epidemiological 
study data, summarized in the UNSCEAR 2013 
report, show clearly that for a given dose the risk 
for a radiation-induced malignancy and especial-
ly for leukaemia is seriously higher in children 
than in adults : 2-3 times for solid tumours (how-
ever, not all solid cancers show age-at-exposure 
effects) and 3-5 times for haematological malig-
nancies (1). These observations are thought to be 
linked to the fact that children are in a phase of 
active development of organs and tissues. This 
variance of cancer risk with age-at-exposure was 
also observed in a series of animal studies (2).
A recent study in the United Kingdom has as-
sessed the risks of leukaemia and brain tumours 
after CT scans in childhood and young adulthood 
(3). These malignancies are considered as end-
points of great concern during childhood, due 
to the high radiosensitivity of red bone marrow 
and brain at young ages. Especially red marrow, 
which contains haematopoietic stem and pro-
genitor cells (HSPCs), is of critical interest owing 
to the well-documented induction of a range of 
leukaemia types by ionizing radiation, especially 
myeloid leukaemia’s (AML and CML) (4). Stem 
cells are a major target of radiation-induced carci-
nogenesis. As HSPCs cells self-renew throughout 
life, accumulation of DNA damage can compro-
mise their genomic integrity. In this way, proper 
regulation of DNA damage responses in HSPCs 
is crucial to avoid bone marrow failure and pre-
vent malignant transformation, resulting in leu-
kaemia. Furthermore, appropriate regulation of 
the cell cycle is essential for homeostasis. Under 
steady-state conditions, stem cells are mainly in 
dormancy to avoid exhaustion, known as a qui-
escent state (5). A hierarchical model has been 
proposed for blood, where tissue homeostasis re-
quires continual replenishment of mature blood 
cells from a rare population of marrow residing 
quiescent cells, which are vastly outnumbered by 
the dividing progenitor population which lead to 
the differentiated cells. The finding that leukemic 
stem cells can also be quiescent like normal hae-
matopoietic stem cells adds additional support 
to the notion that some types of AML may arise 
from the primitive cell compartment, before full 
lineage commitment has occurred. Alternatively, 
it is also possible that AML could arise from com-
mitted progenitors if stem cell self-renewal pro-
grams are established during the leukemogenic 
process (6). 
The high radiosensitivity of children with re-
spect to radiation-induced leukaemia warrants 
studies on the response of HSPCs to DNA dam-
age induced by ionizing radiation as well as on 
the mutagenic consequences of DNA misrepair. 
However only limited data are currently avail-
able (7-9). HSPCs are usually characterized by 
their CD34 antigen and specified as CD34+ cells, 
which are present in bone marrow (BM), umbili-
cal cord blood (UCB) and in low amounts in the 
peripheral blood (PB) (10). They have emerged 
as a model system for studying stem cell biology 
since they can be purified based on the unique 
CD34+ cell surface marker. 
Whether cellular responses to ionizing radia-
tion change with age remains largely unknown. 
A recent study of Bakhmutsky et al., showed that 
peripheral blood lymphocytes (PBL) from new-
borns (UCB samples) showed a statistically sig-
nificant increased number of radiation-induced 
chromosome aberrations compared to adult 
PB (APB) T-lymphocytes (11). However, UCB 
or newborn T-lymphocytes differ from APB T-
lymphocytes in their immunophenotypic pro-
file. In particular, UCB contains T-lymphocytes 
that are phenotypically immature and express 
the naive RA isoform of the CD45 molecule 
(CD45RA+), while APB contains a higher num-
ber of CD45RO+ memory cells (12). 
In present study, induction and repair of 
DNA double-strand breaks (DSBs) after in vitro 
exposure to ionizing radiation were evaluated 
by scoring the radiation-induced and residual 
γ-H2AX/53BP1 foci 24 h post-irradiation for 
HSPCs (CD34+) compared to newborn T-lym-
phocytes, both isolated from UCB. In addition, 
the mutagenic effect of ionizing radiation on UCB 
CD34+ and newborn T-lymphocytes was evalu-
ated with the cytokinesis-blocked micronucleus 
(CBMN) assay. To investigate if there exists an 
age dependency in radiation-induced DNA dam-
age, repair and mutagenic effects in T-lympho-
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cytes, the γ-H2AX/53BP1 foci and CBMN assays 
were also applied to PB T-lymphocytes of adults. 
In order to find an explanation for the observed 
age dependence, the immunophenotypic differ-
ence of T-lymphocytes with age was examined 
by flow cytometric analysis of the composition of 
the UCB and APB T-lymphocyte subpopulations 
with respect to naive CD45RA+ and memory 
CD45RO+ subsets. Furthermore, we were able 
to evaluate for the first time radiation-induced 
residual DNA DSBs and mutagenic endpoints in 
separated human naive CD45RA+ and memory 
CD45RO+ subpopulations to allow interpreta-
tion of the observed age dependent difference in 
radiosensitivity of T-lymphocytes between new-
borns and adults.
MATERIALS AND METHODS
Sample collection and isolation of cells
Human CD34+ HSPC were isolated from UCB 
following the guidelines of the Ethical Commis-
sion of Ghent University Hospital (Belgium). 
UCB (70-90 ml) was collected from full-term 
newborns through the umbilical cord at time of 
delivery. Afterwards, mononuclear cells were ob-
tained by density gradient centrifugation (Den-
sity: 1.077 g/ml, Lymphoprep, Axis-Shield) and 
HSPCs were purified by using CD34+ immuno-
magnetic beads (human CD34 MicroBeadKit, 
Miltenyi Biotec) to achieve a purity > 95%.
Adult peripheral blood samples were collected 
from healthy volunteers from whom informed 
consent was obtained prior to the experiments. 
Donors were non-smokers and had no history of 
radiotherapy treatment within the last ten years. 
CD3+ T cells were isolated from UCB and APB 
using the RosetteSep™ Human T Cell Enrichment 
Cocktail (Stemcell Technologies) by negative 
selection after density gradient centrifugation 
(Density: 1.081 g/ml, RosetteSep™ Density Me-
dium, Stemcell Technologies). Unwanted cells are 
targeted for removal with Tetrameric Antibody 
Complexes recognizing CD16, CD19, CD36, 
CD56, CD66b and glycophorin A on red blood 
cells (RBCs), resulting in a highly enriched popu-
lation of CD3 T-lymphocytes (purity > 98%). 
Since umbilical cord blood is physiologically and 
genetically part of the foetus, we can consider this 
as blood of a newborn (13). For simplicity we will 
refer to the UCB T-lymphocytes as “T newborns” 
and APB T-lymphocytes as “T adults”.
CD4+ T-lymphocyte subsets were isolated 
from the peripheral blood (50 ml) of healthy 
adult donors by using first RosetteSep™ Human 
CD4+ T Cell Enrichment Cocktail (Stemcell 
Technologies) to obtain CD4+ T-lymphocytes 
from whole blood by negative selection (purity 
> 95%). Afterwards, the isolated CD4+ cells were 
labelled with CD45RO and CD45RA immuno-
magnetic beads (human CD45RO MicroBeadKit 
and human CD45RA MicroBeadKit, Miltenyi 
Biotec) to obtain naive (CD45RA+) and memory 
(CD45RO+) CD4+ cells (purity > 85%).
Flow cytometric immunophenotyping
T-lymphocyte subpopulations of newborns 
and adults were determined by means of flow cy-
tometry using the following panel of monoclonal 
antibodies: CD45RA-FITC/CD45RO-PE/CD3-
PerCP/CD8-PC7/CD4-APC (BD Biosciences). 
Briefly, 50μl of whole blood was simultaneously 
stained with 5μl of the mAb panel and incubated 
for 20 minutes at room temperature, in dark. 
After incubation, the red blood cells were lysed 
(BD Pharm Lyse™, BD Biosciences) and washed 
with Cellwash (BD Biosciences) before the sam-
ples were analysed. Data were acquired on a 
BD FACSCantoTM II flow cytometer (BD Bio-
sciences) and at least five thousand T-lymphocyte 
events were scored.
In vitro irradiation
For the assessment of the number of 
γ-H2AX/53BP1 foci induced by low-dose x-
irradiation, isolated T-lymphocyte populations 
of UCB (n=6) and adult PB (n=7) were resus-
pended in cRPMI (Gibco) + 10% FCS (Gibco) 
and CD34+ cells (n=7) in cIMDM (Gibco) + 
10% FCS and exposed to 100 or 200 mGy x-rays. 
In every experiment, one cell sample served as 
a sham irradiated control sample. The samples 
were kept for 30 min at 37°C in a humidified 5% 
CO2 atmosphere incubator (Thermo Scientific) 
after irradiation to obtain the maximum number 
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of γ-H2AX/53BP1 foci, followed by an arrest on 
ice water (0°C) for 15 min.
A repair time of 24 h was considered to study 
the residual number of γ-H2AX/53BP1 foci in 
the different cell types. To this end, after isolation, 
CD34+ cells (n=6), newborn (n=6) and adult 
(n=6) T-lymphocyte populations were suspended 
in appropriate medium as described in previous 
paragraph and irradiated with 4 Gy x-rays. Again, 
one sample served as a sham irradiated control. 
After irradiation, the cells were kept in a humidi-
fied 5% CO2 atmosphere incubator at 37°C for 
24h, followed by an arrest on ice water (0°C). 
One of the most frequently used tests for the 
assessment of in vitro chromosomal radiosensi-
tivity is the CBMN assay. For this set of experi-
ments, isolated cells (n=7, for all cell types) were 
resuspended in appropriate medium as described 
above and irradiated with 2 Gy x-rays, while one 
sample served as a sham irradiated control sam-
ple in every experiment. 
In all the irradiation experiments, a radiation 
quality of 100 kVp x-rays with 2mm Al filtration 
was used generated by a Philips MG420 x-ray 
generator coupled to a MCN420 tube (Philips 
Medical Systems). All irradiations were carried 
out in a water bath at 37°C (Lauda GMBH & Co) 
and calibration was performed with a NE2571 
Farmer ionization chamber (Thermo Electron). 
The dose rate was 20 mGy/min for doses up to 
200 mGy and 0.6 Gy/min for the higher doses (2 
and 4 Gy). 
γ-H2AX/53BP1 Foci Assay
After irradiation and incubation, cells were 
centrifuged on poly-L-lysine coated slides (VWR 
International) in a concentration of 600,000 cells/
ml. The slides were fixed in PBS (Sigma-Aldrich) 
containing 3% paraformaldehyde (PFA) (Sigma-
Aldrich) for 20 min and stored overnight in PBS 
containing 0.5% PFA. The next day, slides were 
washed with PBS for 10 min and treated with 
0.2% Triton X-100 (Sigma-Aldrich) solution in 
PBS for 10 min. Thereafter, cells were blocked 
by washing them three times for 10 min in PBS 
containing 1% Bovine Serum Albumin (BSA) 
(Roche). Immunohistochemistry staining was 
performed using primary antibodies (Ab) against 
γ-H2AX (1:500, Mouse mAb, Biolegend) and p53 
binding protein 1 (53BP1) (1:500, Rabbit pAb, 
Abcam). Slides were incubated with the primary 
Ab for 1 h at room temperature. After washing 
the cells three times in PBS containing 1% BSA 
the slides were incubated for 1 h at room tem-
perature with secondary antibodies, Tetramethyl 
Rhodamine Isothiocyanate (TRITC) goat-anti-
mouse Ab (1:1000, Sigma-Aldrich) for γ-H2AX 
staining and highly cross-adsorbed Alexa Fluor 
488 goat-anti-rabbit (1:1000, Invitrogen) for 
53BP1 staining. Afterwards, the slides were 
rinsed three times in PBS and mounted in a so-
lution of Fluoromount (Sigma-Aldrich) contain-
ing 2% 4’,6-Diamidino-2-Phenylindole (DAPI) 
(Sigma-Aldrich). 
Slides were stored in a cool and dark place 
before image capturing to allow the mounting 
medium to dry and to avoid fading of the fluo-
rescent signal. Slides were scanned by a Metafer 4 
System (Metasystems) equipped with a 63x/1.30 
oil objective. Images were obtained automatically 
by using MetaCyte software, however merged 
foci were scored manually on the raw train-
ing files. First, cells were selected as positives 
based on the nucleus morphology visible in the 
DAPI channel. Secondly, co-localizing foci were 
scored by projecting TRITC and Alexa Fluor 
488 sections on top of each other. The scoring of 
γ-H2AX/53BP1co-localized foci increases the re-
liability that the observed spots are indeed DNA 
DSB and enhances the sensitivity of foci scoring 
by reducing the impact of artefacts and false posi-
tives. In each experiment, at least 250 cells were 
scored over two slides in randomly selected fields 
of view.
‘96-well Plate’ Cytokinesis Block Micro-
nucleus Assay
It is difficult to obtain a sufficient number of 
CD34+ cells after immunomagnetic purification 
of one UCB sample in order to perform several 
CBMN cultures in parallel. To overcome this 
problem, we developed a micro-culture CBMN 
assay in which isolated cells were cultured in 
a small volume of 200 µl in a 96-well plate. The 
methodology is based on a protocol published by 
Fenech (14).
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After isolation and irradiation, T-lymphocytes 
and their corresponding subtypes were seeded in 
a concentration of 500,000 cells/ml in a F-bottom 
shape 96-well plate (CELLSTAR® Tissue Culture 
Plates, Greiner Bio-One). Isolated cells were cul-
tured in 200 µl RPMI supplemented with 0.5% an-
tibiotics (penicillin and streptomycin, Gibo), 1% 
L-glutamine (Sigma-Aldrich), 1% natrium pyru-
vate (100 mM, Gibo), 0.1% β-mercaptoethanol 
(50 mM, Gibco). In case of naive and memory 
T-lymphocytes, 50 µL/ml interleukin-2 (Roche) 
was added to the cultures. Mitotic division of T-
lymphocytes was stimulated by adding 10 µL/ml 
phytohaemagglutinin (PHA) (Gibo). Cells were 
incubated at 37°C with lids loose in a humidified 
incubator containing 5% CO2. Cytochalasin B 
(Sigma-Aldrich) was added to the cultures after 
23 h at a final concentration of 6 µg/ml and 50 
µl of fresh culture medium (pre-heated to 37 °C) 
was added to each well. CD34+ HSPCs were cul-
tured in a similar way, however, cIMDM contain-
ing 10% FCS was used as culture medium and a 
combination of recombinant hematopoietic cy-
tokines, 100 ng/ml stem cell factor (SCF), 100 
ng/ml FLT3 ligand (Flt3L) and 20 ng/ml throm-
bopoietin (TPO) (all cytokines from Peprotech), 
were used in order to stimulate the expansion of 
the HSPCs. Furthermore, CD34+ HSPCs were 
grown in a different well plate than the T cells, 
a U-shaped 96 well-plate (BD Biosciences). De-
termination of HSPC cycle stage by flow cytom-
etry after first stimulation showed a division rate 
comparable to that of T-lymphocytes (data not 
shown). Based on these findings cytochalasin B 
was added at the same time point of 23 h as for 
the T-lymphocyte cultures.
After 72 h total incubation time, the cul-
tures were resuspended gently to reduce cellular 
clumping and harvested for slide preparation. A 
cell suspension of 250 µl was applied to a slide 
by cytocentrifugation (Cellspin, Tharmac) at 
1000 rpm for 5 min. Slides were air dried hori-
zontally for 8 min, fixed in 10/1 methanol/acetic 
acid (Merck) for 12 min and again allowed to air 
dry. Thereafter, slides were stained in Giemsa’s 
Azur Eosin Methylene blue solution (Merck) and 
micronuclei were scored in binucleated (BN) cy-
tokinesis blocked cells under the microscope us-
ing a 400x magnification. At least 1000 BN cells 
were scored from various slides per condition by 
two independent readers. 
Statistical Analysis
The results from the individual experiments 
were averaged and the corresponding standard 
deviation of the mean (SEM) calculated. The 
2-tailed Mann–Whitney test was performed to 
investigate the significance of differences in bio-
marker scores. The results were considered as sig-
nificantly different at p < 0.05. Statistical analysis 
of the data was performed using the Statistical 
Package for Social Sciences (SPSS) version 22.0
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RESULTS
DNA DSB formation after low-dose 
x-ray exposure
γ-H2AX foci formation is a highly sensitive 
technique to evaluate DNA DSB formation and 
repair. Moreover, the γ-H2AX foci co-localize 
with other DNA repair factors such as 53BP1, 
which confirms that the observed focus is a DNA 
DSB and no staining artefact. In a first set of 
experiments the foci numbers induced in HSPCs 
and T-lymphocytes from newborns and adults by 
100 and 200 mGy x-rays were compared. The pre-
existing, endogenous DNA DSBs were analysed 
in all three cell types, illustrated in Figure 1. 
The number of endogenous γ-H2AX/53BP1 
foci levels was significantly lower in CD+34 cells 
(MWU, p < 0.05) and T newborns (MWU, p < 
0.05) compared to T adults. These data are in 
line with other studies that reported lower levels 
of endogenous DSBs in cord blood lymphocytes 
and HSPCs than in adult peripheral blood lym-
phocytes (7, 8, 15). Subsequently, the number of 
radiation-induced (RI) foci was determined by 
subtracting the endogenous foci levels from the 
foci counts in the irradiated samples. Figure 1 
shows that the induction of DSBs is dose depend-
ent, but for both doses the differences in induced 
foci levels among the different types of cells were 
not statistically significant (MWU, p > 0.05). 
FIGURE 1
Mean number of γ-H2AX/53BP1 foci per nucleus at 30 min in the 
sham-irradiated control samples and after irradiation with 100 and 
200 mGy x-rays. Radiation-induced (RI) foci levels were obtained by 
subtracting the number of endogenous γ-H2AX/53BP1 foci in the sham 
irradiated control samples from the γ-H2AX/53BP1 foci number scored 
in the irradiated samples. The number of endogenous γ-H2AX/53BP1 
foci was significantly different between CD34+ (n=7) and T newborn 
(n=5) compared to T adult (n=7) (* p < 0.05). No statistical significant 
difference could be observed in RI foci levels between CD34+ (n=4), 
T newborn (n=4) and T adult (n=5) at the two dose points. Error bars 
represent standard error of the mean of the different donors (SEM).
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Residual foci levels 24h post-irradiation 
in HSPCs, newborn and adult 
T-lymphocytes
The first set of experiments showed no detect-
able difference in the induction of γ-H2AX/53BP1 
foci between HSPCs, T newborn and T adult. 
However, to assess the number of residual DNA 
DSBs, which may mark unrepaired or misre-
paired sites, γ-H2AX/53BP1 foci were quantified 
at 24 h after irradiation with 4 Gy x-rays. A dose 
of 4 Gy was chosen for the DNA repair experi-
ments, as this dose is often used for the estima-
tion of radiosensitivity after in vitro irradiation 
of human lymphocytes (16). Again, co-localizing 
γ-H2AX and 53BP1 foci were scored to make 
sure that DNA DSBs were analysed (Figure 2). 
The sham-irradiated HSPCs and T-lymphocytes 
of newborns show again very low levels of foci 
compared to T-lymphocytes of adults (MWU, 
both p-values < 0.005) (Figure 3). At 24 h after 4 
Gy irradiation, the number of radiation-induced 
γ-H2AX/53BP1 foci in HSPCs (3.54 foci/cell) 
is significantly lower than in T-lymphocytes of 
newborns (7.13 foci/cell) (MWU, p < 0.005), in-
dicating more repair in the first 24 h after irra-
diation in HSPCs. This is in agreement with data 
previously published by other research groups (8, 
15). On the other hand, significantly higher foci 
levels of induced foci were observed 24 h post-ex-
posure in T-lymphocytes of newborns compared 
to adults (5.77 foci/cell) (MWU, p < 0.05). 
Residual foci levels 24h post-irradiation 
in CD45RA+ and CD45RO+ CD4+ 
T-lymphocytes
A possible explanation for the difference in in 
residual foci levels 24 h post-irradiation between 
T-lymphocytes of newborns and adults could 
reside in the immune system immaturity. There-
fore we performed an immunophenotypic study 
of the UCB and adult PB T-lymphocyte samples 
 Subpopulations
  
CD4+
CD45RO+
CD4+
CD45RA+ CD4
+ CD8+
CD45RO+
CD8+
CD45RA+ CD8
+
Donor 1
RI MN/1000 BN 213 346 259 274 379 360
Flow cytometry 48.2% 51.3% 21.0% 79.0%
“Estimated value” 280 357
Donor 2
RI MN/1000 BN 229 335 263 214 271 225
Flow cytometry 75.8% 25.2% 35.0% 65.0%
“Estimated value” 258 251
Donor 3
RI MN/1000 BN 322 395 334 392 412 393
Flow cytometry 66.7% 35.6% 22.0% 79.0%
“Estimated value” 355 412
Donor 4
RI MN/1000 BN 259 334 312 309 361 337
Flow cytometry 66.8% 36.4% 28.0% 70.0%
“Estimated value” 295 339
Group 
Mean
RI MN/1000 BN 256 353 292 297 356 329
Flow cytometry 64.4% 37.1% 26.5% 73.3%
“Estimated value” 296 339
FIGURE 2
Immunofluorescence staining of γ-H2AX (red), 53BP1 
(green) and the merged double-staining in CD34+, newborn 
and adult T-lymphocytes, 24h after 0 and 4 Gy irradiation.
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by means of flow cytometry. The data, presented 
in Table 1, show that CD4+ and CD8+ T cells of 
newborns predominantly (> 98%) co-express the 
CD45RA antigen, while adult PB T-lymphocytes 
are composed by both CD45RA+ and CD45RO+ 
subpopulations. A different distribution of the 
CD45 isoforms was observed on CD4+ and CD8+ 
T-lymphocytes, with the CD45RA+ phenotype 
more expressed in CD8+ T cell population and 
the CD45RO+ phenotype more expressed on 
CD4+ T cells, which is in agreement with other 
studies (12, 17). 
To evaluate whether the observed difference 
in residual DNA DSBs between newborn and 
adult T-lymphocytes could be explained by the 
composition of T-lymphocyte subsets, naive and 
memory CD4+ cells were isolated from adult pe-
ripheral blood samples of four donors in order 
to compare DNA repair of the two subsets. We 
selected the CD4+ subpopulation for this pi-
lot study as the results in Table 1 show the high 
prevalence of helper-inducer CD4+ in both UCB 
and adult PB samples and we want to avoid in-
terference of the results by possible differences 
among the CD4+ and CD8+ subpopulations. A 
difference in residual DNA DSBs was observed 
for CD4+CD45RO+ and CD4+CD45RA+ cells 
(MWU, p < 0.05), shown in Table 2. The percent-
age of CD4+ cells expressing the CD45RO+ and 
CD45RA+ phenotype was determined by flow 
cytometry and these values were taken into ac-
count to calculate an ‘estimated’ overall CD4+ 
residual γ-H2AX/53BP1 foci level 24 h post-ex-
posure. The calculated ‘estimate’ differs less than 
10% from the CD4+ γ-H2AX/53BP1 foci levels, 
determined experimentally on the total CD4+ 
population (Table 2). These results indicate that a 
change of immunophenotypic profile of lympho-
cytes with age has an effect on DNA DSB repair. 
FIGURE 3
Mean number of residual DNA DSBs in CD34+ (n=6), T newborn 
(n=6) and T adult (n=6) 24h after 4 Gy x-ray irradiation. Error 
bars represent the standard error of the mean (SEM) of the six 
different donors. At least 250 nuclei were scored for each donor 
at each time point (* p < 0.05, ** p < 0.005).
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Subpopulation T newborns T adults
CD4+
75.9 63.5
(68.2 - 81.5) (52.8 - 69.8)
CD4+RO+
1.7 66.0
(0.5 - 6.1) (33.2 - 75.4)
CD4+RA+
98.3 30.5
(92.8 - 99.9) (19.9 - 64.9)
CD8+
34.5 22.0
 (30.2 - 41.7)  (13.1 - 27.4)
CD8+RO+
0.2 36.0
 (0.0 - 0.9)  (19.8 - 56.8)
CD8+RA+
99.7 64.0
(99.1 - 100.0) (31.0 - 79.4)
TABLE 1
Expression of CD45RO and CD45RA 
on CD4 and CD8 T cell subsets. Data 
present median percentage values 
(with corresponding range).
TABLE 2
Distribution of memory and naive cells, expressed as percentage 
number of adult CD4+ cells. The experimentally determined 
radiation-induced γ-H2AX/53BP1 foci values were multiplied with the 
corresponding percentage of the CD45 isoform, to obtain an estimated 
induced	γ-H2AX/53BP1 foci yield for the overall CD4+ population of 
every adult donor. 
Subpopulation RI
γ-H2AX/53BP1 foci %
Estimate 
CD4+
Donor 1
CD4+RO+ 5.23 x 48.2
= 6.00
CD4+RA+ 6.78 x 51.3
CD4+ 6.66
Donor 2
CD4+RO+ 5.96 x 75.8
= 6.40
CD4+RA+ 7.47 x 25.2
CD4+ 6.83
Donor 3
CD4+RO+ 6.41 x 66.7
= 7.14
CD4+RA+ 8.04 x 35.6
CD4+ 7.04
Donor 4
CD4+RO+ 5.54 x 66.8
= 6.31
CD4+RA+ 7.18 x 36.4
CD4+ 6.75
Mean
CD4+RO+ 5.78 ± 0.25 x 64.4
= 6.46
CD4+RA+ 7.37 ± 0.26 x 37.1
CD4+ 6.82 ± 0.08
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Assessment of radiation-induced 
mutagenic effects in HSPCs, newborn 
and adult T-lymphocytes by the CBMN 
assay 
The CBMN is an effective method to detect 
chromosomal damage in peripheral blood lym-
phocytes of humans exposed to ionizing radia-
tion (18). However, no study reported the use of 
the CBMN assay to detect chromosomal damage 
in human CD34+ HSPCs after ionizing radiation 
exposure so far. For these experiments, isolated 
cells were irradiated with 2 Gy x-rays. Table 3 
presents the number of spontaneous and radi-
ation-induced MN in binucleated (BN) CD34+ 
HSPCs and T-lymphocytes of both newborns 
and adults for the different donors. Before irra-
diation, the cell cycle distribution of the HSPCs 
was determined by DNA flow cytometry analysis 
with propidium iodide (PI) and revealed similar 
distributions in HSPCs as in G0 T-lymphocytes, 
approximately 95% of the cells was in G1/G0, 
3.2% in S-phase and 1.8% in G2/M-phase (data 
not shown). The spontaneous MN expression 
was significantly lower in CD34+ HSPCs (mean 
11/1000 BN cells; MWU p < 0.005) and T-lym-
phocytes of newborns (mean 8/1000 BN cells; 
MWU p < 0.005) compared to adult T-lympho-
cytes (mean 18/1000 BN cells). No difference 
was observed between the MN yields induced 
by 2 Gy in HSPCs (mean 371/1000 BN cells) and 
newborn T lymphocytes (mean 351/1000 BN 
cells) (MWU, p > 0.05). However, MN yields were 
significantly lower in T-lymphocytes of adults 
(mean 275/1000 BN cells) compared to newborns 
(mean 351/1000 BN cells) (MWU p<0.05) after 2 
Gy irradiation. 
Assessment of radiation-induced 
mutagenic effects in CD45RO+ and 
CD45RA+ CD4+ T-lymphocytes
To evaluate whether the observed difference 
in MN yields between newborn and adult T-lym-
phocytes could be explained by the composition 
of T cell subsets as discussed in the paragraph on 
DNA repair kinetics, naive and memory CD4+ 
cells were isolated from adult peripheral blood 
samples of four donors in order to compare the 
number of MN induced by 2 Gy in the two sub-
sets. Results are presented in Table 4. A statisti-
cally significant difference was observed in the 
induced number of MN after 2 Gy x-rays between 
CD4+CD45RO+ cells and CD4+CD45RA+ cells 
(p < 0.05). An estimate of the expected number 
of MN for the CD4+ population was made based 
on the CD45RO+/CD45RA+ distribution of ev-
ery individual donor. The difference between 
the estimated MN value and the actual observed 
number of induced MN in the total population 
of CD4+ cells was less than 10% for every donor.
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Donor Cell Type
Dose (Gy)
0 2
UCB1
CD34+ 7 433
T newborn 9 347
UCB2
CD34+ 8 345
T newborn 9 316
UCB3
CD34+ 12 347
T newborn 7 332
UCB4
CD34+ 11 378
T newborn 7 335
UCB5
CD34+ 16 335
T newborn 10 265
UCB6
CD34+ 13 330
T newborn 6 414
UCB7
CD34+ 12 429
T newborn 6 447
Mean (±SEM)
CD34+ 11 (±1) 371 (±17)
T newborn 8 (±1) 351 (±23)
AB1 T adult 18 255
AB2 T adult 13 198
AB3 T adult 16 265
AB4 T adult 16 262
AB5 T adult 14 351
AB6 T adult 26 299
AB7 T adult 26 297
Mean (±SEM) T adult 18 (±2) 275 (±18)
TABLE 3
Number of micronuclei per 1000 BN cells in both the sham irradiated 
control samples and after 2 Gy x-ray irradiation, for 14 individual 
donors (7 UCB samples and 7 adult PB samples).
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Subpopulation RI MN/1000 BN % Estimate CD4+
Donor 1
CD4+RO+ 213 x 48.2
= 280
CD4+RA+ 346 x 51.3
CD4+ 259
Donor 2
CD4+RO+ 229 x 75.8
= 253
CD4+RA+ 335 x 25.2
CD4+ 263
Donor 3
CD4+RO+ 322 x 66.7
= 355
CD4+RA+ 395 x 35.6
CD4+ 334
Donor 4
CD4+RO+ 259 x 66.8
= 295
CD4+RA+ 334 x 36.4
CD4+ 312
Mean
CD4+RO+ 251 (±22) x 64.4
= 287
CD4+RA+ 352 (±15) x 37.1
CD4+ 292 (±17)
TABLE 4
Radiation-induced number of MN per 1000 BN cells after 2 Gy x-ray 
irradiation. Based on the percentage of CD45RO+ and CD45RA+ 
subpopulations, an estimate of the expected induced number of MN 
for CD4+ cells was made.
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DISCUSSION
Leukaemia is, with an incidence of 2.6% in 
Europe (both sexes combined) (19), a relatively 
rare disease, but the IR-induced risk of cancer 
development is high for the hematopoietic tissue 
especially in children (excess relative risk (ERR)/
Sv for childhood leukaemia of ~50) (20, 21). The 
bone marrow is likely to harbour HSPCs with ac-
quired mutations as a direct result of genotoxic 
insults such as IR exposure. During the long 
lifespan of stem cells DNA damage-induced mu-
tations accumulate and could initiate the leuke-
mogenic process (6, 9, 22). Up to now, there are 
only a very limited numbers of studies that evalu-
ate the DNA repair capacity and chromosomal 
radiosensitivity of human HSPCs. Most of the 
studies on the radiation sensitivity of HSPCs use 
colony formation in the framework of haemato-
logical recovery after ionizing radiation exposure 
(23, 24). The elimination of damaged HSPCs by 
apoptotic or necrotic death prevents long-term 
consequences of damage. The nonlethal DNA 
modifications which remain unrepaired or mis-
repaired can eventually lead to malignant disease 
(25). Therefore, the aim of this study was to char-
acterize the DNA damage response and the mu-
tagenic effects of IR exposure in HSPCs in com-
parison with T-lymphocytes from UCB and APB.
Present study shows that the number of re-
sidual DSBs 24 h post-exposure is significantly 
lower in HSPCs than in newborn T-lymphocytes 
pointing to more repair of DNA DSBs. This is 
possibly linked to differences in chromatin struc-
ture, which has a major influence on the cellular 
response to DNA damage (26). Indeed, intrigu-
ing evidence accumulates showing that stem cells 
use specific DDR mechanisms to ensure genomic 
integrity over lifetime and a possible defence 
mechanism could be their chromatin structure. 
For example, the nuclear organization of embry-
onic stem cells is globally open and permissive 
for gene expression, becoming more compact at 
different regions of the genome with differentia-
tion. The open configuration allows different pro-
teins to interact easily with chromatin, a very im-
portant process which could facilitate signalling 
of cell cycle arrest and DNA repair in damaged 
stem cells (9). 
In the current study, purified HSPCs en-
riched for the glycosylated transmembrane pro-
tein CD34 have been used, as the enrichment of 
CD34+ cells is current practice in haematopoietic 
stem cell transplantation and to date one of the 
most efficient cell separation methods to study in 
vitro haematopoiesis. However, CD34+ cells are a 
heterogeneous mixture of cells at various stages of 
differentiation which are hierarchically organized 
in primitive human HSCs (Lin-CD34+CD38-
CD90+CD45RA-), multipotent progenitors 
(MPP) (Lin-CD34+CD38-CD90-CD45RA-) and 
oligopotent progenitors (CD34+CD38+). Emerg-
ing evidence reveals that the radiation sensitivity 
of these three populations is different (10). Fur-
thermore, the long lasting dogma that primitive 
human HSCs are believed to be Lin-CD34+CD38- 
has recently been challenged by several groups 
who suggest that CD34+ HSCs originate from 
CD34- HSCs (27). If we want to compare the 
current results on radiation sensitivity of HSPCs 
with the existing literature on DNA repair of 
HSCs, it is important to take into account that 
a heterogeneous population of CD34+ cells was 
used in the current study. The majority of the ob-
served DNA damage response is attributable to 
the CD34+CD38+ progenitor fraction, since only 
a very small fraction as low as 3% of the enriched 
cells in this study will be CD34+CD38- (28-30).
Milyavsky et al. showed that the DDR 
of human quiescent HSC population (Lin-
CD34+CD38-CD90+CD45RA-) differs in mul-
tiple ways from more mature haematopoietic 
populations, such as progenitor/precursor cells 
(Lin-CD34+CD38+) (9). The authors observed 
significantly more residual γ-H2AX foci 12h after 
3 Gy irradiation in HSC compared to the pro-
genitor population, 7.1 versus 2.7 foci/nucleus 
respectively. These results are in line with our low 
residual foci level of 3.5 foci/cell 24h after 4 Gy 
in CD34+ HSPCs, from which the majority are 
progenitor cells (CD34+CD38+). Fast DNA re-
pair kinetics of HSPCs was observed in a murine 
model by Mohrin et al. using the alkaline COM-
ET assay (8). Furthermore, in a study of resid-
ual γH2AX/53BP1 foci level in human CD133+ 
HSPCs from UCB, Vasilyev et al. concluded en-
hanced DNA repair capacity in HSCs compared 
to mature lymphocytes. CD133 is, just as CD34, a 
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marker found both in human progenitor and hae-
matopoietic stem cells, which can be used alone 
or in combination with CD34 to enrich HSPCs 
(31, 32). Flow cytometer analysis of Becker et al. 
indicated that 80% of the purified CD34+ popula-
tion, co-express CD34+CD133+ (33).
Another interesting field where the DNA 
DSB repair of haematopoietic stem cells is widely 
studied, is the age-dependent decline in stem cell 
function. Several studies reported an age-depen-
dent accumulation of DNA damage in tissue stem 
cells leading to stem cell exhaustion (15, 34, 35). 
In particular, Rübe et al. studied the formation 
and loss of γ-H2AX foci in different stem and 
progenitor populations exposed to ionizing radi-
ation to gain insight into age dependent changes 
in DSB repair capacity (15). In both CD34+ and 
CD34- cells obtained from UCB the number of 
endogenous γ-H2AX foci was generally low, 
which is in line with the results obtained in the 
current study on background levels of co-localiz-
ing γ-H2AX/53BP1 foci. Furthermore, the study 
of Rübe et al. showed an increase of unrepaired 
DSBs with increasing donor age (newborns and 
healthy volunteers of 16-83 years old), which sug-
gests that unrepaired DSBs accumulate continu-
ously in CD34+ HSPCs and in the more mature 
CD34- cells during physiological cell aging. The 
higher endogenous foci levels observed in pres-
ent study in adult peripheral T-lymphocytes 
compared to HSPCs and T-lymphocytes of new-
borns support these findings. 
In present work a new culture method for the 
CBMN assay requiring culture volumes of only 
250 µl was worked out. Comparison of the CBMN 
results obtained with this new culture method 
for adult T-lymphocytes (mean 275 MN/1000 
BN cells for 2 Gy) shows a good agreement with 
previously published data obtained with the stan-
dard MN assay using 5 mL whole blood cultures 
(mean 277 MN/1000 BN cells for 2 Gy) (36). 
Fenech described in detail the standard method 
for the CBMN Cytome assay as applied to iso-
lated lymphocyte cultures (14). In this protocol 
isolated lymphocytes were cultured in 750 μl of 
culture medium in a density of 1 x 106 cells per 
ml and duplicate cultures were set up per subject 
and/or dose point. However, since the number 
of CD34+ cells isolated from one umbilical cord 
blood sample (70-90 ml) was approximately 1.5 x 
106 cells which had to be divided by two to obtain 
a sham-irradiated and 2 Gy dose sample, we had 
to work with smaller culture volumes of 250 μl. 
The same methodology was applied for isolated 
T-lymphocytes. 
The MN data obtained in present work in-
dicate that a 2 Gy exposure induces the same 
amount of mutagenic effects in HSPCs as in 
newborn T-lymphocytes. Under steady-state 
conditions, the majority of HSPCs and T-lym-
phocytes are maintained in a quiescent state, 
in which the major pathway for DSB repair is 
nonhomologous end joining (NHEJ), a rapid 
but error-prone pathway of DSB repair. It is well 
known that NHEJ-mediated repair can be muta-
genic and this was reflected in our CBMN results 
with high levels of radiation-induced MN (371 ± 
15 MN/1000 BN cells) in CD34+ HSPCs, which 
were comparable with newborn T-lymphocytes 
(351 ± 23 MN/1000 BN cells). Micronucleus 
analysis in CD34+ cells was already used to assess 
the genotoxicity induced by benzoquinone (37). 
However, to our knowledge, this is the first study 
in which the CBMN assay was used to assess the 
chromosomal radiosensitivity of CD34+ cells af-
ter ionizing radiation exposure. The lower levels 
of spontaneous MN yields observed for both the 
HSPCs as the newborn T-lymphocytes compared 
to adult T-lymphocytes reflect the increase of 
baseline genotoxic damage with age.
One of the major findings of this work is 
the observed difference in cellular chromo-
somal radiosensitivity between T-lymphocytes 
of newborns and adults, with T-lymphocytes of 
newborns being more radiosensitive than T-lym-
phocytes of adults. Bakhmutsky et al. could show 
that newborns as a group have an elevated sen-
sitivity for radiation-induced chromosome dam-
age in peripheral blood lymphocytes compared 
to adults by scoring chromosome aberrations at 
doses of 1, 2, 3 and 4 Gy (11). Another interesting 
finding in the study of Bakhmutsky et al. was that 
sensitivity to radiation-induced chromosome 
damage does not change with age among adults. 
This indicates that the change in sensitivity with 
age appears to occur between birth and young 
adulthood rather than gradually over the years 
from birth to senescence. Similarly, a study on 
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rodents didn’t show a difference in cancer suscep-
tibility between adult and elderly rodents, while 
there was a dramatically higher risk of cancer for 
rodents in fetal period up to the age of sexual ma-
turity compared to adult and elderly animals (2). 
This lack of an age effect among adult humans 
could be the result of the completion of growth 
and development. 
Most of the T-lymphocytes of newborns are 
immunologically immature, known as naive 
T-lymphocytes, and express the CD45RA cell 
surface marker (12, 38). The immune system 
maintains both naive and memory T cells, so that 
individuals can establish an immune response 
to a variety of new antigens while keeping ap-
propriate levels of memory T cells that recognise 
previously encountered pathogens. Naive and 
memory T cells can most simply be characterised 
by the reciprocal expression of the CD45RA or 
CD45RO isoforms. Once naive T cells encounter 
an antigen and become activated through the T 
cell receptor, they proliferate and generate effec-
tor T cells that are CD45RO+. A small propor-
tion of these effector cells persist as memory cells 
which give an accelerated response upon a future 
encounter with the specific antigen. As individu-
als age and encounter more new antigens, the 
proportion of naive T cells declines and that of 
antigen experienced memory cells increases (17, 
39). The proportion of the naive subpopulation in 
T cells gradually decreases from a high fraction 
(median of 89% in present study) at 0 to 3 months 
to about 50 % (median of 51% in present data) at 
12 to 18 years. The gradual shift is most compel-
ling in the CD4+ T cell subsets.
In this study, we studied for the first time the 
radiosensitivity of human CD4+CD45RO+ and 
CD4+CD45RA+ subpopulations of T-lympho-
cytes. We could demonstrate that the observed 
differences in foci 24 h post exposure and MN 
yields between newborn and adult T-lymphocytes 
are related to the immunophenotypic changes in 
T-lymphocyte composition with respect to naive 
and memory subsets. In agreement with our find-
ings, studies in murine models could also show 
that naive lymphocytes are more radiosensitive 
than their memory counterparts (40-42). The 
main reason for the observed difference is attrib-
utable to the chromatin structure of the cells. The 
organization of DNA into chromatin has a major in-
fluence on the cellular response to DNA damage (43). 
The ability of repair factors to detect DNA lesions and 
to be retained efficiently at breaks is determined by 
histone modifications around the DSBs and involves 
chromatin-remodelling events that facilitate repair 
by promoting chromatin accessibility (26). Closed 
chromatin formations impair DSB repair. The differ-
entiation of naive to memory T cells requires chro-
matin remodelling. Rawlings et al. demonstrated that 
Stat5 proteins, essential for peripheral T cell prolifera-
tion, cannot access DNA in naive T cells and acquire 
this ability only after T cell receptor engagement 
(44). This transition is not associated with changes 
in DNA methylation or global histone modifications, 
but rather chromatin decondensation. Furthermore, 
Pugh et al. showed that opening chromatin with the 
histone deacetylase inhibitor (HDACi) valproic acid 
(VPA) following radiation exposure improved sur-
vival of naive T cells to the levels observed in effector 
memory T cells (40).
This study has several restrictions, we were not 
able to evaluate the radiosensitivity of the different 
subsets of the heterogeneous CD34+ cell population, 
due to the restriction on the number of cells obtained 
after isolation of UCB samples. Future research is 
needed to elucidate the DNA damage response of the 
different subsets of the human HSPCs population. To 
confirm that the observed age-effect in T-lympho-
cytes is gradual and partly determined by the shift 
in immunophenotypic profile of the lymphocytes, a 
more extensive study would be required using blood 
samples from children of all ages. However, ethical 
constraints limit the feasibility of such studies. 
In conclusion, the obtained results confirm that 
HSPC quiescence promotes fast error prone DNA 
repair and mutagenesis after ionizing radiation ex-
posure, which may trigger leukaemia development. 
Furthermore, one of the major findings of this work 
is the difference in radiation sensitivity between na-
ive an memory T-lymphocytes, which sheds new 
light on our understanding of the radiation sensitiv-
ity of newborns compared to adults. Further work is 
required to provide better understanding on chro-
matin structures and the corresponding influence 
of chromatin remodelling on the radiation sen-
sitivity of human HSPCs, naive and memory T-
lymphocytes.
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CT is a valuable and essential imaging modality for children since it can 
provide rapid, consistent and detailed information about nearly any organ 
system (1). As already described in the Introduction of this PhD, children 
are more radiosensitive than adults and the high x-ray doses associated 
with CT procedures have raised serious health concerns (2). Recent epi-
demiological studies have linked CT x-ray exposure during childhood to 
elevated cancer risks, especially to the development of brain tumours and 
leukaemia (see chapter 2) (3). However, carcinogenic risk assessment at 
low doses based on the LNT hypothesis is still subject of debate and sev-
eral authors question the validity of the linear extrapolation down to low 
doses (4, 5). The assessment of low dose IR effects in humans is one of the 
major problems in radiation protection that remains to be clarified. In this 
respect, the development of sensitive biomarkers for assessment of x-ray 
effects can give valuable information on the low dose-effect relationship.
The latter methodology was applied in this PhD research to assess radi-
ation risks in children. We used the γ-H2AX foci assay to detect early x-ray 
effects at DNA level to get more insight into the dose-effect relationship for 
diagnostic CT x-rays in children. In an prospective multicentre study in 
Belgium, we determined the number of CT x-ray induced DNA DSBs in 
Radiation risks in 
paediatric CT imaging
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lymphocytes of children undergoing a chest or abdomen CT examination 
(paper 2). This study resulted in three key findings:
•	 CT induces a small, but statistical significant number of DNA DSBs in 
children’s T-lymphocytes
•	 Risk estimates based on the LNT hypothesis may represent underes-
timates
•	 More effective CT dose reduction results in less DNA damage
In the following sections, we will discuss these findings in more detail, 
describe the associated uncertainties and put the obtained results in the 
current concept of low dose risk estimates in paediatric CT imaging. 
9.1
Biomarker studies in paediatric 
diagnostic radiology
Children are a difficult study population for biomarker studies, since the 
use of biological samples of children raises a number of ethical issues. 
Therefore, only limited in vivo biomarkers studies of paediatric patients 
were published. These studies will be presented in the following para-
graphs, together with the findings of our own research group. 
Since its discovery, the γ-H2AX foci assay has been widely applied in 
fundamental and human population studies, because of the high sensitivi-
ty, efficiency and mechanistic relevance of the assay. It is generally accepted 
that one γ-H2AX focus represents one DNA DSB. DSBs are considered to 
be the most deleterious effect of x-ray exposure at DNA level, because they 
can result in loss or rearrangement of genetic information, chromosomal 
aberrations and gene mutations, which can eventually lead to carcinogen-
esis (6). In the framework of cancer risk assessment, detection of chro-
mosomal aberrations or MN induced by diagnostic x-rays would allow a 
more direct mutagen-carcinogen link. However, the γ-H2AX foci assay is 
currently the best we can do, due to the lack of sensitivity of contemporary 
mutagenicity assays.
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9.1.1
Behaviour of the γ-H2AX dose 
response in diagnostic studies 
on children 
The results of the in vivo γ-H2AX foci study on 51 paediatric patients (me-
dian age: 3.8 years) undergoing a CT examination (see paper 2), showed 
an increase in DNA DSBs for nearly every child except for one patient 
with a very low blood dose of 0.14 mGy (7). The initial sharp increase of 
the in vivo dose response was confirmed by in vitro γ-H2AX foci data on 
umbilical cord blood, representing blood of a newborn. The shape of the in 
vivo and in vitro dose response curves points to a low dose hypersensitiv-
ity, which is consistent with a previous study of our research group on 49 
paediatric patients (median age: 0.75 years) undergoing a cardiac catheter-
ization (8). Figure 1.1 combines the γ-H2AX data versus the blood doses 
of both studies. However, the blood doses of the paediatric CT study are 
much lower (average blood dose: 1.35 mGy) compared to the blood dose 
in the study of interventional cardiology of Beels et al. (average blood dose: 
11.3 mGy). The in vivo dose response allowed us to explore further the 
very low dose range in the paediatric CT study. The data of both in vivo CT 
and interventional x-ray studies are in good agreement and show that the 
in vivo foci yields observed in the paediatric patients are without any doubt 
higher than expected from the linear extrapolation of high dose behaviour 
(dashed line in Figure 9.1). The results indicate a higher risk for low dose 
exposure than expected using the LNT model, which will be further dis-
cussed in 1.1.2 of this chapter.
Until recently, it was not known whether the low doses from CT ex-
ams could induce γ-H2AX foci in vivo in young children. However, several 
studies already reported γ-H2AX foci induction by CT x-ray exposure in 
adult patients (9-11). Unfortunately, lack of blood dose calculations and 
different experimental conditions make it impossible to directly compare 
the results obtained in these adult patient studies with the results obtained 
for young children presented in paper 2. Around the same time of our 
study, a small pilot study was published by Halm et al. who also found a 
significant induction of γ-H2AX foci in lymphocytes of three very young 
children (3 – 21 months) post CT (12). The reported blood doses were in 
the same low dose range as our dose estimates (0.22 – 1.22 mGy), however, 
blood samples were taken 1h post CT exam. In view of the low statistical 
power, the results of this study are very preliminary and no wide-reach-
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ing conclusions can be drawn on the dose-response relationship between 
γ-H2AX foci and the corresponding radiation doses.
A few in vivo studies involving other biomarkers to determine low dose 
effects of diagnostic x-rays were already published. 
A first group of in vivo biomarker studies deals with CA and MN in-
duced by diagnostic RX examinations of children. Already in 1980, a signif-
icant increase in chromosomal aberrations was reported in a retrospective 
study of nine children exposed to high diagnostic x-ray doses for congeni-
tal skeletal anomalies compared to nine healthy control individuals (p = 
0.001) (13). The mean age of the children was 13.2 years (range 7 – 17 
years). The shorter the time since the last x-ray exposure, the higher was 
the frequency of chromosome type aberrations. Although the study popu-
lation was small, it was already clear at that time that exposure of children 
to diagnostic x-rays may cause chromosomal damage. Chest radiographs 
represent the basic radiological examination of the thorax providing diag-
nostic information on the status of lung, heart and the skeletal system; and 
are the most frequently performed radiological examinations in children 
(14). Effective doses from chest radiographs are also very small, typically 
less than 1 mSv. The CBMN assay was used in a study of Gajski et al. (15) 
to assess different types of chromosomal damage in twenty children with 
pulmonary diseases exposed to diagnostic x-ray procedures. The average 
age of the study population was 11.30 ± 2.74 years and absorbed doses 
were estimated by using thermoluminescence and radiophotolumines-
cence dosimetry systems. Almost all children exhibited higher frequency 
of CBMN parameters (MN, NPBs and NBUDs) compared with the levels 
before diagnostic examination. However, it should be noted that the ob-
served increase in MN, NPBs and NBUDs frequencies per 1000 BN cells is 
very low in this study; respectively 3.00 MN, 3.05 NPBs and 2.30 NBUDs 
per 1000 BN cells, and the increase was only statistically significant for a 
few of the patients. The results of this study suggest, together with a previ-
ous study from the same research group using the comet assay (16), that 
the radiation exposure of diagnostic chest RX may induce some damaging 
effects to the cell chromosome structure, even though the radiation doses 
in this type of procedure is very low. 
A second group of in vivo biomarker studies investigated mutagenic 
radiation effects in children with congenital heart diseases (CHD) under-
going intensive radiological exposure, who are theoretically at a relatively 
higher radiation risk due to their cumulative radiation exposure in the 
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early periods of life. Andreassi et al. (17) examined the frequency of CA 
and MN in patients with CHD. The mean frequency of CA and MN were 
higher in the exposed patients, showing that cardiac x-ray procedures are 
associated with a long lasting mark in the chromosomal damage of ex-
posed children with CHD. The same research group published in 2010 a 
new study in which the MN assay was used as a biomarker of DNA damage 
before and 2h after catheterisation procedures in a subset of 18 patients 
(mean age 5.2 ±5.7 years) (18). The micronucleated BN cell frequency 
was determined as the number of micronucleated cells per 1000 cells. The 
median micronucleus levels increased significantly after the procedure in 
comparison with the baseline (median effective MN value of 6‰ at base-
FIGURE 9.1
Comparison of x-ray induced γ-H2AX foci per cell versus calculated 
blood dose observed in the paediatric CT study (blue) (7) and the 
previous paediatric interventional cardiology study (orange) (8). The in 
vitro dose response curve is presented in black (■). Error bars are not 
shown in the overview figure, since they disturb the detail in the low 
dose region. The figure in the right corner zooms in on the low dose 
region, since most of the paediatric CT study data are clustered in this 
region (error bars are calculated based on Poisson statistics). The dashed 
line represents the behaviour according to the LNT hypothesis based on 
the γ-H2AX foci induced after an in vitro dose of 0.5 Gy (5.68 foci/cell). 
The error bars on the in vitro dose response curve represent SDs among 
three different donors. 
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line versus 9‰ 2h after the procedure), but the median dose-area product 
(DAP) value of the paediatric procedure was high, 20 Gy cm². 
A last study of cytogenetic biomarkers in children is of particular inter-
est for this PhD research. A small scale pilot study was set up by Stephan 
et al. to determine whether CT could enhance the chromosome aberra-
tion yield in paediatric patients (19). Blood samples were taken from 10 
children between 5 months and 15 years of age (median age: 8.4 years) 
before and after a CT scan. The mean blood dose of the 10 children was 
12.9 mGy. Based on more than 20 000 analysed cells it was found that 
the frequencies of dicentrics and acentric fragments were significantly in-
creased after CT examination. The results demonstrate that CT examina-
tions enhance the dicentric yields in peripheral lymphocytes of children. 
The detection of chromosomal anomalies induced by diagnostic x-rays in 
paediatric patients provides an interesting mutagen-carcinogen link. How-
ever, it should be noted that this kind of studies is not obvious in view of 
the low sensitivity of contemporary mutagenicity assays to detect the weak 
mutagenic effects induced by low dose exposure. The estimated blood dose 
of children after CT x-ray exposure is of the order of 0.1 - 10 mGy (based 
on our estimates in paper 2). To get meaningful results, chromosome and 
chromatid breaks should be analysed manually in 500 – 1000 metaphases/
per individual, which makes this kind of studies very labour intensive.
The observed low-dose hypersensitivity in both in vivo γ-H2AX foci 
studies in paediatric x-ray applications of our research group (7, 8) chal-
lenges the LNT hypothesis, which assumes less DNA damage than we ob-
served, and can be explained by the bystander effect. The studies of the 
atomic bomb survivors have provided risk estimates that increase linearly 
for moderate to high doses (>50–100 mGy). However, this linear dose-
response relationship based on the A-bomb data is very different in nature 
compared to the IR used in diagnostic radiology. The A-bomb survivors 
were mainly exposed to neutron and γ-rays, while 100 kV x-rays (cor-
responding to CT x-rays) were used through this PhD research. Estimates 
below this level are difficult to obtain directly from epidemiological data 
and BEIR VII indicates that “statistical limitations make it difficult to eval-
uate cancer risk in humans below this level” (20). However, for practical 
regulatory purposes, a linear model has been adopted for low doses and is 
used by the international radiation protection community. Nevertheless, 
this remains the main paradigm of radiation protection and as nicely de-
scribed by Brenner et al., a linear extrapolation could both underestimate 
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(hypersensitivity or bystander effect) or overestimate (adaptive response, 
threshold hypothesis or hormetic response) low-dose risks (21). Several 
radiobiological phenomena, challenge the assumption that the biological 
responses at high and low doses are proportional with radiation doses (22-
24). Furthermore, this low dose hypersensitivity was also observed in an 
in vitro study of our research group, however, only when whole blood was 
irradiated with x-rays (25). On the contrary, when isolated T-lymphocytes 
were irradiated or when γ-rays were used, a linear dose response was ob-
served. These findings suggest that biophysical differences in dose qualities 
and tissue environment might lead to a different radiation dose response. 
Nevertheless, the results of this PhD research support a hypersensitive re-
sponse that is able to signal very small changes above endogenous level 
of DNA DSBs (26). The mechanisms of the radiation-induced bystander 
effect will be further discussed in the next section.
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9.1.2
Low dose hypersensitivity indicates a 
bystander effect
Already in 1992, the dogma that radiation-induced DNA damage is re-
stricted to directly hit cells, has been challenged by the observation that 
similar effects can be seen in normal cells that were not directly traversed 
by the radiation track (27). In the following decades, evidence has built up 
for a novel biological phenomenon termed as bystander effect, in which 
genetic and biochemical changes not only occur in cells hit by ionizing 
particles but also in unexposed “bystander” cells, that are in close prox-
imity to the directly hit cells. The fact that IR would only induce direct 
biological effects and subsequent health consequences as a result of en-
ergy deposition in the cell nucleus, is likely true for higher radiation doses, 
but at lower doses (<100 mGy) non-targeted effects may play a significant 
role (28, 29). A key characteristic of the bystander response in contrast to 
direct irradiation effects, is the dose–response relationship. Instead of an 
increased response with increasing radiation dose, the bystander response 
has been shown to be induced at very low doses (in the mGy range) and 
a further increase in radiation dose did not increase the effect (30). How-
ever, this hypothesis remains controversial and at high doses the effects 
will likely be overwhelmed by direct damage to cells (28). Also, it has been 
proposed that a binary mode of action may occur, with a simple on–off 
response, the probability of which increases with radiation dose (31). By-
stander effects have been observed in a range of cell types and for several 
endpoints, such as sister chromatic exchanges, mutations, transformation, 
apoptosis, MN formation and genomic instability. 
Co-culture experiments of irradiated and non-irradiation cells (32, 33), 
as well as medium transfer experiments (34) demonstrated that cell popu-
lations exposed to IR respond as an integrated tissue rather than sepa-
rate individual cells, pointing to the role of the cellular communication. 
Microbeam irradiation could even demonstrate that gene mutations do 
occur following cytoplasmatic irradiation without crossing of the nucleus 
(28). The nature of the induced mutations in this study consisted mainly 
of base damage, suggesting the involvement of ROS. Several mechanisms 
have been assumed to mediate radiation-induced bystander effects, which 
are the result of cells receiving signals from irradiated cells through gap-
junction mediated intercellular communication or the secretion of solu-
ble factors (see Figure 9.2) (27). Several studies point to a crucial role of 
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membrane originating effects such as gap junctions and critical enzymes 
such as cyclooxygenase-2 (COX-2) (35, 36). Gap junction-mediated inter-
cellular communication (GJIC) seems an appropriate mechanism for the 
mediation of bystander effects because they form clusters of intercellular 
membrane channels connecting the cytoplasm of two neighbouring cells. 
Gap junction channels consisting of connexin (Cx) proteins may medi-
ate bystander effects by allowing the direct intercellular exchange of small 
molecules of up to 1000 – 1500 Da, such as cAMP, IP3 and Ca2+ (37). 
Another mechanism to transduce bystander signals is by soluble factors 
released from irradiated cells into the culture medium. Soluble factors like 
cytokines such as tumour necrosis factor α (TNF-α) (38), interleukin 6 
(IL-6) (39), and IL-8 (40) and transforming growth factor-β1 (TGF-β1) 
(41) can be found in literature as mediators of the ‘paracrine’ bystander 
effect.
FIGURE 9.2
Underlying key pathways of the radiation-induced bystander 
effects. Signalling molecules are propagated among irradiated and 
neighbouring bystander cells through two key routes. The first one 
involves direct intercellular communication via gap junctions, the second 
one through diffusible secretion of cytokine signals in the surrounding 
matrix. Figure from (42).
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Moreover, an underlying mechanism of the previously mentioned 
modes of bystander communication is the involvement of ROS. Several 
studies have indicated that the oxidative metabolism mediates signalling 
events leading to radiation-induced bystander effects. Normal oxidative 
metabolism is a key endogenous regulator of ROS and reactive nitrogen 
species (RNS) (35). Physical levels of both ROS and RNS play critical roles 
in numerous cellular functions. A disruption of the oxidative metabolism 
alters the homeostatic cellular redox and results in a state of oxidative 
stress. The role of free radicals in the bystander effect such as ROS released 
into the cell-culture medium has been shown by applying antioxidants 
such as superoxide dismutase or inhibitors of superoxide and NO genera-
tors (42, 43). Zhou et al. showed that treatment of bystander cells with a 
COX-2 inhibitor (NS-398) reduced the bystander effect (44). These results 
provide evidence that the COX-2-related pathway, which is essential in 
mediating cellular inflammatory response, is a critical signalling link for 
the bystander phenomenon.
The mechanisms of bystander signalling are now starting to be eluci-
dated at the molecular level and several key molecules are known to have 
close parallels to inflammatory responses. For example, recent studies 
have shown that inflammatory macrophages are a potent source of mi-
croenvironmental reactive nitrogen and oxygen species that can damage 
bystander cells (43). Gene set enrichment analysis could demonstrate that 
different gene profiles were highlighted after low and high doses of x-rays 
in whole blood samples (44). Inflammatory and immune-related gene sets 
were higher ranked after low dose irradiation, whereas gene sets enriched 
at higher doses were ‘classical’ radiation pathways like p53 signalling, ap-
optosis and DNA damage and repair. Functional analysis of genes differen-
tially expressed at low doses showed the enrichment of chemokine and cy-
tokine signalling. Furthermore, there are several other candidate processes 
suggested in scientific literature that could at least in part mediate the non-
targeted effects due to IR exposure, such as exosomes (45), DNA repair 
capacity (46) and/or mitochondrial dysfunction (47). It is most likely that 
multiple mechanisms are involved in bystander effects, depending on the 
biological endpoint being measured and the cell type (48). The bystander 
phenomenon implies that in the low dose range of diagnostic radiology 
a tissue radiation response is observed rather than a cellular DNA dam-
age response. To gain more understanding of the biological mechanisms 
behind the observed low dose hypersensitivity in both in vivo paediatric 
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studies, it would be interesting to study differential gene profiles before 
and after CT examination in children. 
The in vitro observed bystander effects are possibly linked with the 
longer-range effects observed in response to radiotherapy in humans, 
termed as the controversial abscopal or out-of-field distant bystander re-
sponses (49, 50). It has been reported that non-targeted tissues in partial 
body irradiated rodents also experienced stressful effects, including oxida-
tive and oncogenic effects. A study of Mancuso et al. showed that apoptosis 
and tumour induction were observed in the shielded cerebellum of radio-
sensitive mice after partial body irradiations (51, 52). This phenomenon 
indicates the carcinogenic potential of bystander responses in vivo, such as 
the induction of secondary cancers following radiotherapy.
9.1.3
Importance of blood dose calculation 
in biomarker studies
Biomarker studies require direct measurements on biological media, in 
our set-up peripheral whole blood. The γ-H2AX foci analysis of lympho-
cytes has the advantage that access to blood is easy and fast and does not 
require a massive medical intervention. In order the obtain a reliable inter-
pretation of the in vivo γ-H2AX foci data in our paediatric CT study (pa-
per 2) (7), it was very important to have an accurate blood dose calculation 
for every child. In this calculation, we had to take into account the patient’s 
anatomy, different types of CT systems, dose reduction techniques and 
various types of CT protocols. To obtain an individual blood dose estimate 
for every patient, patient-specific 3D voxel models were created based on 
the CT images of the paediatric patients by using ImpactMC simulation 
software 1.3.1 (CT Imaging GmbH, Germany) (53). Organ volumes were 
segmented in the original CT images and organ dose deposition was cal-
culated based on the Monte Carlo dose distribution, as illustrated in Figure 
9.3. A density value and a mass attenuation coefficient is assigned to each 
voxel contained in the input volume. The density values are determined 
from the CT numbers using validated conversion curves. 
The blood dose was calculated as a weighted sum of the doses of the 
largest blood-containing organs in the field of view with the percentage of 
blood pool in children as weighting factor. For CT chest and CT abdomen, 
these organs are lungs (12.5%), heart (10%), liver (10%) and remainder 
(67.5%) (54). The blood dose calculation in the ‘remainder of the body’ 
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Accurate assessment of the dose to the blood remains a challenge. It is 
already shown in radiotherapy patients that the dependence between dose 
and average incidence of γ-H2AX foci in lymphocytes was found to differ 
by as much as four-fold depending on the location of the irradiated site 
of the body. Lymphocyte distribution, circulation and migration through 
the different organs may explain these differences. An accurate blood dose 
calculation is needed to interpret the γ-H2AX foci results in lymphocytes 
and in an ideal situation, the biodistribution of lymphocytes through the 
FIGURE 9.3
The left picture shows the typical dose distribution of a 
transversal slice of a chest CT scan represented by colour 
scales. The right picture illustrates the segmentation of the 
organs by drawing regions of interest on the same CT image. 
was an important issue in our estimations. We considered the radiation 
dose outside the scan length as negligible, moreover, no voxel data are 
available outside the scanned volume since our voxel model was based on 
the CT images of the patients. The dose was calculated in the remaining 
volume (excluding lung, heart and liver) of the scan region and normal-
ized over the total weight of the patient, excluding liver, heart and lungs. 
The latter methodology was validated and resulted in an uncertainty of 
about 10% (55).
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body should be taken into account. For example, lymphocytes that mi-
grate more slowly in capillaries than in large vessels may receive a higher 
radiation dose (56-58). Assessment of dose to the blood remains a chal-
lenge since blood is a circulating fluid and none of the Monte Carlo simu-
lation CT dose reconstruction programs that are currently available, such 
as ImpactMC and NCI-CT (59), can estimate dose to circulating fluids. 
The methodology applied in our paper 2 is the best we can do so far and 
provides a substantial improvement compared to standard software tools 
in which only anthropomorphic paediatric phantoms for discrete refer-
ence ages can be selected. The dosimetry tools ImPact (www.impactscan.
org), ImpactDose (CT Imaging GmbH, Erlangen, Germany) and CT-Expo 
(Medizinische Hochschule, Hannover, Germany) offer anthropomorphic 
phantoms limited to newborn, child, adult male and adult female. Consid-
ering the diversity among the anatomy of paediatric patients, it is impossi-
ble to perform the dose estimations accurately for paediatric patients with 
only a few phantom models.
9.1.4
Paediatric patient data point to age-
dependency in DNA damage induced 
by CT x-rays
Based on the paediatric CT data, we investigated if we could observe an 
intrinsic higher radiosensitivity decreasing with the age of the children in-
cluded in study (7). The number of induced γ-H2AX foci was divided by 
the calculated blood dose and plotted versus age of the paediatric patient 
(see Figure 9.4). The linear fit indicated a decrease of the foci-over-dose 
ratio data versus age. The diminishing trend of induced foci with age re-
mains present when patients are selected with blood doses in the range of 
0-2 mGy, indicating that the observed tendency is not caused by the fact 
that blood doses are higher in larger volumes, e.g. older patients. These 
findings show small but observable age dependent DNA damage effects 
induced by CT x-rays, however, the regression analysis showed no statisti-
cal significance for the decrease with age.
The previously mentioned classical cytogenetic study of Stephan et al., 
showed that CT examinations enhanced the dicentric yields in children 
aged up to 15 years (19). When the children were subdivided in two groups 
in the same study, those with an age of 0.4 to 9 years and from 10 to 15 
years, it became obvious that the observed increase in CA was mainly con-
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tributed by the younger age group, indicating that children younger than 
10 years may be more radiation sensitive.
In the study of Bakhmutsky et al. regression analysis showed that sig-
nificantly more translocated chromosomes, more dicentrics and more col-
our junctions were observed for newborns as a group compared to adults 
as a group (60). Both studies support the findings that children are at high-
er risk of developing cancer associated with radiation exposure. The age 
effect will be further discussed in chapter 11 of the Discussion.
FIGURE 9.4
The number of γ-H2AX foci normalized to blood dose, as 
a function of age of the 41 CT chest patients and 10 CT 
abdomen patients included in the paediatric CT study 
(7). The dashed line is the result of a linear fit.
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9.2
Uncertainties in paediatric 
radiation risk assessment
The lifetime attributable risk of cancer incidence and mortality associated 
with a chest or abdomen CT scan were estimated for each individual pae-
diatric patient in paper 2. The estimations were based on the calculated 
organ doses of each patient and the risk models from the National Acad-
emy, referred to as the BEIR VII risk models (20). The committee judged 
in their seventh report on the health effect of low levels of low LET IR (< 
100 mGy) that the LNT model provided the most reasonable description 
of the relationship between low-dose exposure to IR and the incidence 
of solid cancers induced by IR. For leukaemia, the committee adopted a 
linear-quadratic model. Data from epidemiological studies (atomic bomb 
survivor studies, medical, occupational and environmental radiation stud-
ies) were used to express the dependence of risk on radiation dose, sex and 
age at exposure. 
The LSS cohort plays a principal role in the development of risk models 
by the BEIR committee. The updated risk estimates did not change signifi-
cantly from the BEIR V estimates published in 1990 (61), but the confi-
dence intervals have narrowed as the result of the availability of additional 
data. For 2 of the 11 evaluated cancers, namely breast and thyroid can-
cer, models were based on pooled analyses that included data on both the 
LSS cohort and medically exposed persons. Data from additional medical 
studies and from studies of nuclear workers were evaluated and found to 
be compatible with BEIR VII models (20). 
The BEIR VII risk models allow to compare cancer risks from radiation 
exposure of medical x-rays and natural background cancer risks. This al-
lows a comparison between potential negative effects from e.g. a childhood 
CT scan with the hazards of everyday living. The dose-effect model of the 
BEIR VII report assumes that risk caused by the exposure is proportional 
to the baseline risk as well as to the exposure, with some modifications. 
This is in line with the ERR model, a product of both baseline risk and 
dose, which is for this reason often referred to as the multiplicative model. 
Table 9.1 shows the expected number of radiation induced cancers based 
on BEIR VII risk estimates from an exposure to 0.1 Gy in a population 
of 100 000 persons with an age range distribution similar to that of the 
entire US population, compared with the number of naturally occurring 
cancers (62). This table illustrates that the number of radiation-induced 
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Site-specific solid cancer and leukaemia lifetime risk for cancer inci-
dence and mortality resulting from a single dose of 100 mGy at several 
specific ages can be estimates by using Tables 12D-1 and 12D2 of the BEIR 
VII report (20). Figure 9.5 shows that these risk estimates depend both on 
sex and age at exposure, with higher risks for females and for those ex-
posed at younger ages. The committee’s estimates are obtained by calculat-
ing a weighted mean of linear estimates based on relative and absolute risk 
transport, and reducing them by a DDREF of 1.5. For thyroid cancer, the 
BEIR VII Committee used only an ERR model to quantify risk, while for 
breast cancer only an EAR model based on a pooled analysis of eight co-
horts was used (63). It is surprising that the LAR for lung cancer is nearly 
All solid cancer Leukaemia
Males Females Males Females
Excess cases (including non-fatal 
cases) from exposure to 0.1 Gy 800 (400, 1600) 1300 (690, 2500) 100 (30, 300) 70 (20, 250)
Number of cases in the absence 
of exposure 45 500 36 900 830 590
Excess deaths from exposure to 
0.1 Gy 410 (200, 830) 610 (300, 1200) 70 (20, 220) 50 (10, 190)
Number of deaths in the absence 
of exposure 22 100 17 500 710 530
TABLE 9.1 
BEIR VII lifetime attributable risk estimates of incidence and 
mortality for all solid cancers and leukaemia for a population 
of mixed ages, with 95% subjective confidence intervals. The 
subjective confidence intervals reflect the most important 
sources of uncertainty (statistical variation, DDREF and method 
of transport). Number of cases or deaths are expressed per 100 
000 persons. Figure from (20).
cancers is very small compared to the number of naturally occurring cancers, 
what makes the detection of this excess very difficult. On average, assuming 
a sex and age distribution similar to the entire US population, BEIR VII life-
time risk calculation predicts that approximately 1 person in 100 would be 
expected to develop cancer (solid cancer or leukaemia) from a dose of 100 
mGy above background, while approximately 42 out of 100 individuals would 
develop solid cancer or leukaemia from other causes.
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Another source for LAR risk estimates taking into account sex and age 
at exposure, comparable with the BEIR VII report, was more recently pub-
lished by the US Environmental Protection Agency, under the EPA Radio-
genic Cancer Risk Models and Projections for the US Population (64). The 
report is generally based on the models recommended by the BEIR VII, 
but a number of extensions and modification have been implemented. For 
some sites such as stomach, liver and prostate, EPA’s LAR projections are 
larger, but comparison of the EPA and BEIR VII LAR projections of cancer 
incidence per 10 000 persons/Gy provides very similar results: total cancer 
incidence for males is 955 compared to 900, and 1350 compared to 1382 
for females, in EPA and BEIR VII respectively. 
FIGURE 9.5
BEIR VII LAR models of cancer incidence for 
males and females, presenting the incidence 
per 100,000 persons exposed to a single dose 
of 0.1 Gy. Figure based on Table 12D-1 of (20).
twice as high for females compared to males, even though the baseline risk 
shows a reverse pattern. This is possibly attributable to statistical anoma-
lies or other biases in LARs estimated with high uncertainty. Estimates for 
persons exposed at age 10 are more than twice as high as those for persons 
exposed at ages 30 or 50. Since current models don’t allow further decrease 
after age 30, the difference in LAR for persons exposed at ages 30 and 50 
is not so high.
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Recent reports of ICRP (65) and UNSCEAR (66) provide also infor-
mation on risk models, in terms of ERR and EAR values. ICRP and BEIR 
VII based their models largely on 1958-1998 LSS incidence data, whereas 
the UNSCEAR models are based on 1950-2000 mortality data (64). The 
ICRP risk projections assume a LNT dose-response and the approach is 
very similar to that used by both EPA and BEIR VII. However, one of the 
main differences is the fact that ICRP uses a DDREF of 2 instead of 1.5. 
In ICRP, the ERR and EAR for most solid cancer sites decrease with age-
at-exposure by about 17% (ERR) or 24% (EAR) per decade (even beyond 
age 30). In BEIR VII, the decrease per decade for exposures before age 30 
was somewhat steeper, typically 26% (ERR) or 34% (EAR), but there is 
no decrease in risk with age-at exposure after age 30. A comparison with 
the UNSCEAR 2008 models is more complicated, since the form of the 
UNSCEAR ERR and EAR models depend on cancer site. In contrast to the 
BEIR VII models, age-at-exposure is seldom used as a dose effect modifier, 
but exceptions are the EAR and ERR models for thyroid cancer and the 
ERR model for brain/CNS cancers. 
The ‘residual site’ cancers in the risk model of BEIR VII and EPA de-
serve special attention. The residual category generally includes cancers 
for which there were insufficient data from the LSS cohort or other epide-
miological studies to quantify reliably radiogenic site-specific risks. For ex-
ample cancer of oesophagus, bone, kidney, skin, brain and CNS are includ-
ed in BEIR VII’s ‘remainder’; while the more recent EPA report provides 
additional lifetime risk models for kidney and skin cancer. Although the 
UNSCEAR 2013 report claims that children are at higher risk to develop 
brain and CNS tumours after IR exposure, neither BEIR VII nor EPA have 
developed separate lifetime risk models for brain and CNS cancers. These 
cancers are also included as part of the ‘remainder’. No conclusive evidence 
is available on which model one should use to estimate brain/CNS cancer 
risks and how the attained age should be included (64).
As BEIR VII uses the primary LSS cohort data for the estimation of 
lifetime risk for the US population, several assumptions had to be made 
that involve large uncertainties. Therefore we should interpret specific 
estimates of LAR with a healthy scepticism. A confidence interval is the 
usual statistical way to reflect the uncertainty. However, the BEIR VII ap-
proach also has to deal with uncertainties external to the data, since the 
uncertainty depends not only on direct numerical observations, but also 
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on opinions. Three major sources of uncertainty in the quantitative analy-
sis are mentioned by the committee:
•	 Sampling variability in risk model parameter estimates from the LSS 
data
•	 The uncertainty about the use of risk estimates based on Japanese 
atomic bomb survivors to estimate risk for the US population
•	 The appropriate value of DDREF to adjust the low dose risks based on 
LNT models 
An additional important remark by EPA on the BEIR VII risk esti-
mates is about the lack of uncertainty on the form of the dose-response 
relationship, which is a more ‘subjective’ uncertainty. Underlying mecha-
nisms of the biological effects of low dose IR are extensively investigated, 
which could eventually mandate a different dose-response model. The lat-
ter could result in large changes in low dose risk estimates. Based on the 
dose-response curve of our in vivo γ-H2AX foci data, application of the 
LNT model in the diagnostic dose range could result in an underestimate 
of the radiation risks. Based on the γ-H2AX foci data, the LAR would be 
approximately 10 times higher when using the foci-LAR conversion factor 
obtained after an in vitro dose of 0.5 Gy x-rays. EPA does not propose to 
quantify the uncertainty on the dose-response, but it is important that all 
predictions of the effects of low doses of ionizing radiation should disclose 
all of the limitations in the current state of knowledge about low dose ra-
diation effects. Because of these limitations and uncertainties in the data 
used to develop risk models, risk estimates can be a factor of 2 or 3 larger 
of smaller. 
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9.3
In vivo biomarker data illustrate 
the necessity of CT dose 
reduction: the “Image Gently” 
message
Our in vivo biomarker study on direct DNA damage induced by CT x-rays, 
clearly demonstrates that lower patient doses result in less DNA damage 
(see Figure 4 in paper 2). The DLP and CTDI values of the Belgian multi-
centre study indicate that most of the participating hospitals applied good 
clinical practice for paediatric CT imaging compared to national DRLs. 
However, substantial differences in dose-sparing CT equipment and pro-
tocols, resulted in differences in blood doses and corresponding DNA 
damage. These results should encourage justification of the indications for 
which CT imaging is used in children and optimization of the scanning 
techniques and protocols. 
CT is still extensively used in paediatric radiology and will not be aban-
doned any time in the near future. MSCT has revolutionised image quality 
by improvement of spatial resolution and reduction of acquisition time, 
thereby reducing strongly the problems of movement artefacts among chil-
dren. From a patient’s perspective, the benefits of a medically indicated CT 
scan exceed by far the small radiation-induced cancer risk (LAR for cancer 
mortality was 0.08 and 0.13 ‰ for paediatric chest CT and abdomen CT 
respectively). Nevertheless MSCT allows rapid and repeated examinations 
of large volumes, which can lead to high individual radiation exposure. Es-
pecially for the radiosensitive paediatric population, this is a topic of high 
concern (see also 2.2.2). We should reduce the medical radiation expo-
sure to children as much as possible, the “as low as reasonably achievable” 
(ALARA) concept (67). Several campaigns have been launched to create 
awareness among CT prescribers, users, vendors and patients (68, 69). The 
most extensive initiative came from the Alliance for Radiation Safety in 
Pediatric Imaging: the “Image Gently” Campaign in the USA (http://www.
imagegently.org/) (69). This initiative presents a coalition of health care 
organizations dedicated to provide safe, high quality paediatric imaging 
worldwide. The primary objective of the Alliance is to raise awareness in 
the imaging community of the need to adjust radiation dose when imaging 
children. The ultimate goal of the Alliance is to change practice. Figure 9.6 
presents the CT campaign poster used to encourage health care providers 
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to pledge to “Image Gently” in paediatric CT imaging. In Belgium we have 
a campaign intended for the whole population and not specifically for chil-
dren, funded by the Belgian government: “Zuinig met straling - Medische 
beelden zijn geen vakantiekiekjes” (http://www.zuinigmetstraling.be/). 
Main messages of the “Image Gently” campaign are justification of the 
CT scans and optimization of the CT protocols taking into account the age 
and biometry of the paediatric patients.
Justification of scan. Some studies suggest that a third of paediatric CT 
scans are unnecessary (2, 70). This means that reduction of the radiation 
dose and its associated risk in children starts with performing CT scans in 
FIGURE 9.6
The left picture represents the Image Gently campaign poster for 
CT imaging (http://www.imagegently.org/). The right picture is the 
2013-2014 campaign poster of the Belgian initiative (http://www.
zuinigmetstraling.be/).
children only when properly indicated. The referring physician and radi-
ologist should consider whether the exam is truly clinically indicated and 
was not recently performed in another hospital. Furthermore, they should 
check if no alternative diagnostic procedure might be available, not involv-
ing ionizing radiation such as ultrasound (US) and MRI. As published by 
Nievelstein et al., US should be the first-line imaging modality in children 
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for most abdominal, neck and muscoskeletal indications, as children usu-
ally lack large amounts of fatty tissue (67). Furthermore, MRI is increas-
ingly been used outside the central nervous system. The latter is of special 
interest in paediatric oncology, where diagnostic imaging is repeatedly 
used during follow-up.
 Optimisation of paediatric CT. When CT is indicated, great care 
should be taken to optimize radiation exposure in order to minimize the 
risk for carcinogenic effects later in life. Updated strategies to optimize 
radiation doses in paediatric CT imaging have recently been published 
on the Image Gently website under “Image Gently Development of Paedi-
atric CT Protocols 2014”. The protocols consist of two Excel worksheets, 
one for body and one for head protocols, to provide guidance on how to 
set up techniques for all size patients, newborns to adults, which provides 
diagnostic image quality at well-managed radiation dose levels for any 
department’s or practice’s CT scanner. The scan and technical parameters 
should be tailored to the size of the child, the body region of interest and 
the clinical indication. Furthermore, dose reduction techniques should 
be implemented taking into account the required image quality (ATCM, 
iterative reconstruction and/or adaptive collimation). The primary goal 
should be to achieve sufficient diagnostic image quality instead of opti-
mal image quality, which means that a certain amount of image noise is 
acceptable as long as the clinical question can be solved (67). Excellent 
strategies for dose optimization in paediatric (MS)CT imaging can be 
found in the following publications (67, 71-73) 
The observations of our paediatric CT study should encourage medi-
cal practitioners to maximize the benefit-to-risk ratio of CT imaging in 
paediatric radiology (7). Even more than for adults, the benefit of each 
imaging study using IR should be balanced against the long-term risk of 
cancer development for children (74). However, we should keep radiation 
risks in perspective. The estimated cancer risk associated with paediatric 
CT examinations in this PhD research were small compared to the natural 
cancer incidence and the uncertainties on the risks are large. Nevertheless, 
this small increase in radiation-associated cancer risk for an individual can 
become a public health concern when we multiply this risk by the 2.7 mil-
lion procedures performed each year in children (75).
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Radiation-induced leukaemia 
and radiosensitivity of 
haematopoietic stem- and 
progenitor cells
While the primary function of stem and progenitor cells during embryonic 
development and early post-natal life is one of “tissue building”, their role 
in adults turns more into one of “tissue maintenance” (1). As described 
in part 1 of the thesis, this is achieved by the ability of stem cells to both 
differentiate to give rise to specialized cell types, and to self-renew so that 
stem cell reserves are maintained over lifetime. However, these unique 
characteristics of stem cells makes them also a logical origin for carcino-
genesis. Stem cells are long-lived, which increases the odds that a single 
cell could accumulate multiple mutations necessary for transformation 
(2). Furthermore, the quiescent nature of stem cells is frequently described 
as a “double-edged sword”, that allows the cells to survive IR exposure but 
renders them intrinsically vulnerable to mutagenesis (3).
The low number of residual DNA DSBs at 24h after radiation exposure 
and the high number of radiation-induced MN yields observed in HSPCs 
(see paper 3), indicate fast error-prone DNA repair and mutagenesis af-
ter IR exposure, which could trigger leukaemia development. Although 
it is clear from literature that DNA damage repair is crucial for maintain-
ing homeostasis and prevent malignant transformation, the radiation re-
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sponse of human HSPCs is not yet fully explored. In the following sections, 
we will give an overview of current literature on DDR of HSPCs and the 
potential link to radiation-induced leukaemia. 
10.1
A distinctive DNA damage 
response in HSPCs
After IR exposure, an appropriate DNA damage response is the initial at-
tempt of the cell to repair the radiation-induced lesions, but if damage is 
too extensive, a signalling cascade will trigger cell death. When we see this 
in the context of stem cell biology, genomic damage which drives HSCs to 
apoptosis may lead to depletion of the stem cell pool. Whereas DNA dam-
age accrual in HSCs may propagate the impact of genomic damage, since 
lesions arising in the stem cell compartment can be horizontally propagat-
ed through self-renewing progeny, and vertically passed on to downstream 
progenitors (1). Several publications suggest that stem cells have specific 
mechanisms to protect their genomes, such as the ATP-binding cassette 
(ABC) transporter (1, 4, 5) and the immortal strand hypothesis described 
for stem cells of crypts of the small intestinal mucosa and neural stem cells 
(6, 7). The basic assumption of this immortal strand hypothesis is that by 
selective conservation of template DNA, adult stem cells avoid acquiring 
mutations arising from errors in DNA replication that could lead to cancer 
(8). However, the latter theory is challenged by an alternative hypothesis 
that states that asymmetric cell divisions and cell fate are codirected by 
epigenetic differences between sister chromatids, proposed as the silent 
sister hypothesis (9). 
In our study presented as paper 3 in this thesis, the number of direct 
γ-H2AX/53BP1 foci did not differ between CD34+ cells and T-lympho-
cytes of newborns after low dose x-ray exposure. However, the number of 
residual γ-H2AX/53BP1 foci after high dose x-ray exposure, was signifi-
cantly lower in CD34+ cells compared to newborn T-lymphocytes. It is 
generally accepted that the disappearance of γ-H2AX foci is representa-
tive for the repair of DNA DSBs after IR exposure (10, 11). The kinetics of 
formation or loss of γ-H2AX foci may reflect the rate or efficiency of DSB 
repair (12, 13). The scoring of radiation-induced γ-H2AX foci after 24h 
in ex vivo irradiated lymphocytes of RT patients, is used to assess their ra-
diosensitivity and to predict patients responses to radiotherapy. It remains 
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questionable if residual γ-H2AX foci mark misrepaired or unrepaired sites 
(14, 15). Studies suggest that residual γ-H2AX foci 24h after irradiation 
were correlated with the percentage of cells that lost clonogenicity, indicat-
ing that residual foci represent incomplete repair and may result in cell 
death (16, 17). However, these studies used cancer cell lines and not lym-
phocytes.
DNA DSB repair shows a biphasic behaviour with a fast (initial hours) 
and a slow (hours to days) component, with the fast component responsi-
ble for the majority of DSB repair (18). Studies indicate that the rejoining 
by the slow component increases with increasing LET, which could reflect 
the higher complexity of the breaks repaired by the slow component (19, 
20). As described by Rothkamm et al. the number of radiation-induced 
γ-H2AX foci at 24h are distinctly higher than background levels, at least 
for doses of several hundred mGy or more (10). A remarkable finding was 
provided by the analysis of human fibroblasts exposed to different doses, 
which showed a similarity in the rate of γ-H2AX foci loss irrespective of 
the initial number of DNA DSBs induced (11). This finding is consistent 
with the rationale that DNA repair enzymes are in abundant supply such 
that the rejoining process can start simultaneously at all damaged sites. 
The number of residual foci will depend on the radiation quality, since 
high LET irradiation induces more complex breaks resulting in slower 
DNA repair. Additionally, our results in paper 3 together with other stud-
ies on DNA repair in HSPCs suggest that speed of DNA repair can also be 
cell type dependent. This could be explained by cell intrinsic differences in 
DNA repair mechanisms or conformational inaccessibility of DNA lesions 
due to location within highly condensed chromatin. The latter results in 
less accessibility for repair proteins to start DDR signalling and results in 
retention of unrepaired foci. A recent study of Brenner and co-workers, 
showed that the residual foci levels for donors were largely influenced by 
age (21), however, no children were included in this study (19 – 50 years). 
Human HSPCs are usually considered CD34+. However, this popula-
tion represents a heterogeneous mixture of cells at various stages of dif-
ferentiation. The maturation of all blood cells from HSCs involves de-
velopmental progression through a series of downstream progenitor cells 
with increasingly restricted lineage potential (see chapter 1). The human 
haematopoietic stem cell population is divided into primitive HSCs (Lin-
CD34+CD38-CD90+CD45RA-), MPPs (Lin-CD34+CD38-CD90-CD45RA-) 
and oligopotent progenitors (CD34+CD38+) (see Table 2 and Figure 12 in 
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chapter 1). There is intriguing evidence to accept that there is a difference 
in radiosensitivity between these hierarchically organised subsets (22). Re-
cently, two research groups investigated independently the maintenance of 
genomic integrity in the face of radiation-induced DNA damage in human 
and murine HSPCs, although the underlying mechanisms may differ in 
the two species (3, 23). 
The first study of Milyavsky et al. compared the DDR in human hae-
matopoietic stem cells, more specifically in primitive HSCs, MPPs and 
oligopotent progenitors (23). The different cell types were purified from 
cord blood and irradiated ex vivo. DNA DSB repair after 15 Gy was as-
sessed by using the neutral comet assay. Remarkably, the initial response 
of HSCs and MPPs was slow and no detectable rejoining was seen in the 
first 30 min. At 1h post irradiation significantly less repair was seen com-
pared to the progenitor population. In order to confirm the finding that 
the DDR response of HSCs and MPPs would differ from more differentiat-
ed progenitors, the formation of γ-H2AX foci was scored at different time 
points after irradiation. One hour after 3 Gy IR, no detectable differences 
in the induction of γ-H2AX foci was observed in the three populations 
(26 γ-H2AX foci/cell). However, 12h after IR, significantly more γ-H2AX 
foci remained in HSCs and MPPs compared to the progenitor fraction (7.1 
versus 2.7 foci/cell respectively). The low number of γ-H2AX foci scored 
after IR exposure in progenitors is in line with our results of paper 3. The 
majority of the observed DNA damage is attributable to the CD34+CD38+ 
progenitor fraction in our study, since only a very small fraction, as low as 
3% of the enriched cells were CD34+CD38- (based on literature, (24-26)). 
Milyavsky et al. could also demonstrate that HSCs and MPPs underwent 
significantly more late apoptosis (Annexin+, 7AAD+) and showed reduced 
clonogenic survival compared to their oligopotent progenitors following 
IR exposure. These results confirm the 7-AAD apoptosis results of a previ-
ous study of Hayashi et al., who reported the highest number of apoptotic 
cells in CD34+/CD38- (HSCs and MPPs) compared to more differentiated 
CD34+/CD38+ and CD34-/CD38+ cells, all isolated from UCB (27). Fur-
thermore, Milyavsky et al. could demonstrate that the p53 plays a major 
role in the maintenance of HSC function. The human HSCs exhibited en-
hance p53-dependent apoptosis after IR exposure. Inactivation of p53 re-
duced apoptosis significantly and rescued the repopulating ability of the 
irradiated HSCs in primary recipient mice. The delay in DSB rejoining and 
persistent γ-H2AX foci may be part of a HSC strategy to emphasize ac-
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In contrast to human HSCs, Mohrin et al. reported that murine HSCs 
have cell-intrinsic mechanisms ensuring their survival in response to IR 
(3). In contrast to human HSCs, murine HSCs are enriched in the CD34- 
negative fraction. Interestingly, scientific evidence suggests that human 
HSCs have little correspondence with murine HSCs in terms of surface 
marker expression (28). In the study of Mohrin et al. HSPCs (Lin-c-
Kit+Sca-1+Flk2-), CMPs (Lin-c-Kit+Sca-1-CD34+FcγR-) and GMPs (Lin-c-
Kit+Sca-1-CD34+FcγR+) were isolated from the pooled bone marrow of 
mice. Clonogenic survival assays showed an enhanced radioresistance of 
HSPCs compared to the more differentiated progenitors after 2 Gy irradia-
tion. The scoring of γ-H2AX foci at 4h and 24h post irradiation showed a 
relatively faster decline in HSCs and MPPs compared to the more differ-
FIGURE 10.1
The murine counterpart of Figure 12 in chapter 1. In mice, 
HSCs can be separated into long-term (LT), intermediate-term 
(IT), and short-term (ST) classes based on the duration of 
repopulation (29).
curacy of DNA repair over efficiency, but not in CD34+CD38+ progenitors. 
Although the biological relevance of the different sensitivities of the CD34+ 
stem cell subpopulations remain elusive, these first data reveal that differ-
ences in radiosensitivity exist in human HSPC populations (22).
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entiated CMPs and GMPs, which is in contrast to their human analogues. 
A comet assay demonstrated less damaged tail DNA content in HSPCs 
without overall loss of cells, which represents active ongoing DNA repair. 
Thus, the murine HSPCs (HSCs and MPPs) generally undergo growth ar-
rest but survive, whereas the more differentiated progenitor cells undergo 
apoptosis after IR exposure. Although the survival of murine HSCs may 
prevent acute defects in haematopoiesis, it may also result in error-prone 
repair of radiation-induced DNA DSBs, since the quiescent HSPCs use the 
NHEJ pathway.
FIGURE 10.2
Specific DNA damage response of HSCs and progenitors in human and 
mouse. a. Human HSCs and MPPs tend to undergo p53-dependent 
apoptosis, whereas committed progenitors tend to survive in response to IR 
exposure. b. Murine HSPCs are more resistant to apoptosis after IR exposure 
compared to their committed myeloid progenitors. As a result, surviving 
murine HSPCs that used NHEJ to repair their radiation-induced DNA damage 
can accumulate genomic alterations. Figure adapted from (30). 
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The differences in results between human and mouse studies may be 
due to species-specificity in DDR or experimental conditions. However, 
caution is urged when data obtained in mice are extrapolated to humans 
(see Figure 10.2). Current literature suggests that human primitive HSCs 
and MPPs (CD34+CD38-) turn out to be more sensitive to apoptosis after 
IR exposure than mature oligopotent progenitors (CD34+CD38+). Further-
more, the data of Milyavsky et al. suggest that there is a faster DNA damage 
signalling in oligopotent progenitors compared to HSCs and MPPs (23). 
This is in line with our findings in paper 3, in which the majority of HSPC 
population was CD34+CD38+, showing a low number residual γ-H2AX 
foci 24h post irradiation. However, the apoptosis studies of Hayashi et al. 
(27) and Milyavsky et al. (23) are based on only three donors and more 
studies are required to confirm these findings and to take into account 
inter-individual differences. 
Our study is the first in which the CBMN assay was used to evaluate 
the mutagenic effects of IR exposure on CD34+ cells, which makes it im-
possible to compare our results with current literature. When we compare 
the chromosomal radiosensitivity of CD34+ cells with newborn T-lympho-
cytes, no significant difference was observed. In a recent study of Becker 
et al., chromosomal aberrations were scored in CD34+ cells isolated from 
peripheral blood of healthy donors in order to characterise the radiation 
response of adult human HSPCs with respect to x-ray and carbon ion ir-
radiation (31). For each experiment, the CD34+ enriched HSPCs from 2 
to 6 donors were pooled. The authors compared the cytogenetic response 
of HSPCs to x-rays and carbon ions with the response of PHA stimulated 
peripheral blood lymphocytes (32) and concluded that the cytogenetic 
response of HSPC was comparable with previously published studies on 
mature lymphocytes. When the CBMN results of HSPCs are compared 
with peripheral T-lymphocytes of donors at the same age, no difference in 
mutagenic effects are observed. 
The determination of the response of HSCs to genotoxic stress (e.g. 
IR exposure) is not only critical for understanding of the fundamental 
mechanisms of cancer, but also of aging. DNA damage accrual in HSCs 
was comprehensively described by Rossi et al. in the context of aging (1). 
This review states that HSC quiescence attenuates checkpoint control and 
DDR for repair and apoptosis, however this is again mostly based on mu-
rine data. Consequently, these murine data indicate that the quiescent state 
would permit DNA damage accumulation during aging, which may result 
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in a diminished capacity of aged stem cells to mediate a return to homeo-
stasis after acute stress or injury. Moreover, this could be a mechanism 
through which potentially dangerous lesions can accumulate in the stem 
cell pool with age. Several publications on HSC aging showed that endog-
enous DNA damage accumulates in repair-competent HSCs with age. In 
particular, Rübe et al. studied the formation and loss of γ-H2AX foci in 
different human stem and progenitor populations exposed to ionizing ra-
diation to gain insight into age dependent changes in DSB repair capac-
ity (33). In CD34+ cells obtained from UCB, the number of endogenous 
γ-H2AX foci was low, which is in line with low background levels of co-
localizing γ-H2AX/53BP1 foci obtained in our study. 
10.2
Extrapolation of “in vitro” 
results to the “in vivo” situation: 
protective role of the bone 
marrow niche
Schofield was the first to introduce the concept of a stem cell niche as a 
stem cell-specific microenvironment (34). He suggested that such a niche 
1) would provide an anatomic space that determines the number of stem 
cells that can be supported, 2) would be responsible for the maintenance of 
the stem cell phenotype, and 3) would affect the mobility of stem cells. In 
case of the bone marrow niche, there reside two major types of multipotent 
stem cells: HSCs and mesenchymal stem cells (MSCs). Unlike most other 
stem cells, which reside either within their niche or within a relatively lim-
ited range of travelling distance surrounding the niche, HSCs are extraor-
dinarily mobile. During homeostasis, HSCs often travel from one bone 
marrow compartment to another. Under stress conditions when the bone 
marrow cannot sustain sufficient haematopoiesis, HSCs can even travel to 
the spleen or liver (35). It seems that HSCs undergo regular trafficking in 
and out the bone marrow, spending brief intervals in the circulation (36).
The hierarchical structure of haematopoiesis puts minimal prolifera-
tive pressure on the HSCs. This results in the hallmark of HSCs, namely 
their ability to adopt a quiescent state and remain in the non-dividing G0 
phase of the cell cycle. It has been described that an appropriate associa-
tion between HSCs and the bone marrow niche, may influence the fate of 
HSCs and modulate haematopoiesis (37). This concept is referred to as the 
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“niche hypothesis”, in which the niche forms a regulatory unit that limits 
the entry of HSCs into the cell cycle, thereby protecting them from exhaus-
tion or from errors in DNA replication. Interaction with the niche is also 
critical for the maintenance of stem cell properties, including self-renewal 
and differentiation potential (38). It has been suggested that low oxygen 
tension is a critical feature of the metabolic environment of the bone mar-
row niche. Bone marrow is considered a tissue with limited oxygen supply 
and therefore often referred to as the “hypoxic niche”. Several studies have 
demonstrated that hypoxic culture conditions efficiently maintain HSCs 
in an undifferentiated state, supporting that the niche is naturally hypoxic 
(19). While not all components of the HSC niche have been defined, grow-
ing evidence suggests that the bone marrow contains at least two different 
types of niches (39). The first endosteal niche is located in the endosteum 
FIGURE 10.3
Most haematopoietic stem cells (HSCs) reside in the bone marrow, which 
can be subdivided into endosteal and perivascular niches. HSCs located 
on the endosteal side tend to be more quiescent, whereas HSCs located at 
the perivascular side are more active. The most dormant HSCs have been 
reported to locate near osteoblast progenitors (pre-osteoblasts). With the 
exception of osteoclasts, all of the cellular components in the diagram have 
been reported to modulate HSC behaviour. Figure from (35).
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close to the bone surface and provides a hypoxic environment, while a 
second perivascular niche is located in the central marrow, both shown in 
Figure 10.3. It has been postulated that the location of HSCs directly affects 
their activity, presumably because of the different environmental stimuli 
they encounter at each location. HSCs are more quiescent when they are 
closer to the hypoxic niche, which is enriched for osteoblasts, osteoclasts 
and stromal fibroblasts. By contrast, HSCs migrating to the perivascular 
niches tend to be more active. The perivascular niche is marked by perivas-
FIGURE 10.4
The quiescent endosteal niche would maintain dormant HSCs long-
term. In response to injury, quiescent HSCs might be activated and 
recruited to the vascular niche. Self-renewing LT HSCs produce 
MPPs either by divisional (cell-fate determinants are asymmetrically 
localized to only one of the daughter cells, while the second daughter 
differentiates) or environmental asymmetry (two identical daughters 
are produced of which one relocates outside the niche to differentiate). 
Figure from (46).
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cular MSCs, sinusoid endothelial cells and neural cells (35). The view that 
the endosteal niche serves more as a compound niche, while the mobili-
zation of HSC occurs more through the vascular niche was recently con-
firmed by Miharada et al. (40).
Nevertheless, it still a question where the physical location of the hy-
poxic niche is and it is possible that the bone marrow sinusoidal endothe-
lium is hypoxic. In this way, HSCs localize close to the endosteal niche 
in trabecular regions of long bones, whereas more differentiated progeni-
tors were found mainly in the central bone-marrow region (41). However, 
large discrepancies exist in literature on the percentage and the anatomical 
localization of HSCs and progenitor cells, but several levels of evidence 
suggest that HSCs prefer the hypoxic environment to more oxygen-rich 
locations (42-44). Figure 10.4 suggests and illustrates a model of the bone 
marrow niches.
The hypoxia levels in the endosteal niche raise the question if there is 
a differential sensitivity of HSCs to IR depending on their location in the 
bone marrow (39). However, most of the niche experiments are performed 
on in vivo mouse models, and it remains to be clarified if the same mecha-
nisms are maintained in humans. According to Richardson, the hypoxic 
conditions of the periosteal niche provide a radioprotective microenviron-
ment that is 2 to 3 times less radiosensitive than vascular niches (45). The 
results of Mohrin et al. (see section 10.1 in this chapter) indicate that the 
quiescence makes (murine) HSCs more radioresistant to apoptosis com-
pared to their lineage-committed progenitors, and relay on error-prone 
NHEJ, what makes the cells susceptible to leukaemogenesis (3).
In a hypoxic environment, HSCs have a low metabolism and a long lifes-
pan, whereas HSCs and their progenitors proliferate under higher oxygen 
pressure (46). It has been demonstrated that hypoxia-inducible factor-1α 
(Hif-1α), the oxygen sensor, is highly expressed in LT-HSCs (47). Hif-1 is 
a master regulator of cellular metabolism and drives hypoxic gene expres-
sion changes that adapt HSCs to survive the exposure to a reduced-oxygen 
environment (41, 42). Hif-1 stimulates glycolysis in hypoxic regions, in 
order to produce energy, it represses mitochondrial oxidative phospho-
rylation and oxygen consumption (41). The glycolytic metabolism in the 
hypoxic niche protects HSCs from ROS and reduces thereby the conse-
quential oxidant DNA damage.
In conclusion, hypoxia appears to regulate haematopoiesis in the bone 
marrow by maintaining important HSC functions, such as cell cycle con-
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trol, survival, metabolism, and protection against oxidative stress. DDR 
and ROS play an important role in the maintenance of the genomic integ-
rity of HSCs in the bone marrow niche. The endosteal niche and its com-
ponents protect stem cells from stress, such as accumulation of ROS and 
DNA damage. Therefore it is very difficult to compare in vivo and in vitro 
radiosensitivity of HSCs, since it is very difficult to mimic the hypoxic en-
dosteal niche in vitro. Humanized xenograft mouse models look promis-
ing to study radiosensitivity of human HSCs in an in vivo model, however, 
several studies reported limitations to this set-up. Human HSPCs may lack 
quiescence after engraftment and they remain in active cycle (48). This 
results in unusual high frequencies of human CD34+ cells in the BM of 
xenografted mice (10-20%) compared to a normal BM (1-2% CD34+ cells). 
It is likely that multiple signals are aberrant in the murine microenviron-
ment, and a complex array of genetic changes will be needed to mimic the 
human BM niche (28). 
10.3
The leukemic stem cell: Are 
HSPCs the target cells for 
radiation-induced leukaemia? 
As already described in the Introduction of this PhD thesis (see section 
1.3.2), leukaemia is hierarchically organized in subpopulations of leu-
kemic cells, similar to normal haematopoiesis. Leukaemia represents a 
dysregulation of the homeostatic mechanisms of the bone marrow. Cer-
tain types of leukaemia have been described as newly formed, abnormal 
haematopoietic tissue generated from transformed cells that have either 
retained or reacquired the capacity of self-renewal, proliferation and re-
sistance to apoptosis through accumulated mutations. These cells can be 
described as leukaemic stem cells (LSCs) (43). The LSC is responsible for 
disease initiation and maintenance, and gives rise to more differentiated 
malignant blasts (49). The leukemic state is very efficient in cell mass pro-
duction, but is compromised by the functionality of the produced cells. 
Given the shared properties between LSCs and normal HSCs, it has been 
proposed that leukaemia’s may be initiated by transforming events taking 
place in HSCs as the result of accumulated mutations. Since HSCs have 
the machinery for self-renewal, it may require fewer mutations to become 
leukemic than more differentiated cells. HSCs also persist throughout life, 
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Most studies on the determination of cancer stem cells (CSCs) (e.g. 
LSCs) follow a common scenario: a cell surface marker or marker com-
bination is found to be expressed heterogeneously in a certain tumour 
type. On the basis of this marker heterogeneity, subpopulations of cells are 
sorted from primary tumours and can be transplanted into immunodefi-
cient mice, after which tumour growth is scored some weeks or months 
later. Different capacities for tumour initiation between tumour cell sub-
sets can be interpreted as evidence for the presence of CSCs in the pri-
mary tumour (51). This technique was also used by John Dick and his 
co-workers, who first identified the presence of cancer stem cells in acute 
lymphoid leukaemia through extensive cell cloning and demonstration of 
their self-renewing capacity (52). Since then, the isolation and identifica-
FIGURE 10.5
The origin of LSCs can be either HSCs, which have 
become leukemic as the result of accumulated 
mutations, or more committed progenitors, which 
have reacquired the stem cell capacity of self-renewal. 
Regardless of their origin, both types of LSCs give rise 
to similar end-stage leukaemia’s. Figure from (50). 
therefore they have a higher chance to accumulate mutations. Alternative-
ly, leukaemia may also arise from more committed progenitors, caused by 
mutations that enhance their normally limited self-renewal capacities (50) 
(see Figure 10.5). 
PA
RT
 II
I 
204
General Discussion
tion of the rare cancer stem cells population (about 1% of the tumour) 
became a challenging issue in cancer biology (43). This research has tradi-
tionally focused on the haematopoietic system, since detailed lineages and 
CD cell surface markers could be used in the attempt to identify leukemic 
stem cells. Bonnet et al. showed that the malignant leukemic stem blasts in 
AML were exclusively CD34+CD38-, suggesting that the primitive HSCs, 
rather than committed progenitor cells, are the target for AML transfor-
mation (53). However, later studies could identify LSCs in CD34+CD38+ 
and even in CD34- fractions (54, 55). More recently, surface markers have 
been identified being present only in leukemic samples and not in normal 
bone marrow, such as CD96+/CD90- for AML (56). More than 90% of the 
CML patients express the Philadelphia chromosome translocation which 
serves as a cytogenetic hallmark of the disease, and contains the BCR-ABL 
fusion gene (57, 58). This fusion protein was found in myeloid, erythroid, 
B lymphoid and occasionally T lymphoid cells, suggesting that the original 
translocation takes place in primitive HSCs (or MPPs). In contrast, a study 
on patients with the M3 subtype of AML, acute promyeloid leukaemia 
(APML), showed that the APML-associated fusion gene PML/RARα was 
present in CD34+CD38+ cell populations, but not in CD34+CD38- HSC 
populations (59). These observations suggest that the transformation pro-
cess in APML may involve a more differentiated cell type than HSCs and/
or MPPs. Furthermore, several studies suggested that the LSC hierarchy 
could also be applied to childhood ALL. One of the studies could identify 
CD34+CD19+CD38- cells as candidate pre-leukemic stem cells for TEL/
AML-1 positive ALL (60). Another study of Cox et al. showed that for a 
variety of ALL blasts expressed CD34, but not CD10 and CD19, suggesting 
that cells with a more immature phenotype, rather than committed B-lym-
phoid cells, may be the targets for transformation in B-ALL (61). Emerging 
evidence indicates that leukaemia’s are initiated by a few LSCs that can be 
heterogeneous in terms of their origin, both HSCs and more differentiated 
progenitors could be the initiating cell, illustrated in Figure 10.6.
Chromosomal alterations induced by external factors, such as IR, can 
be an underlying feature in the emergence of a LSC. The genetic lesions in 
LSCs result in a block of differentiation (maturation arrest) that allow cells 
belonging to a certain clone not only to continue proliferation and to resist 
apoptosis, but also to accumulate in large numbers (43). The development 
of cancer is a multistage process and for most individuals a combination of 
factors appears to be necessary to initiate cancer. In many cases of leukae-
205
PA
RT
 II
I
GeneRAl DIscussIon
mia, the events leading to cell transformation can be traced back to specific 
chromosomal aberrations and a concomitant deletion of genes or altered 
signal transduction. It is most likely that the development of leukaemia 
occurs as a result of a combination of the constitutional genome plus the 
exposure to genotoxic agents (such as IR) and the ability to repair DNA 
damage appropriately (62). 
Several recent publications demonstrate the effect of individual leu-
kaemia-associated oncogenes on human HSPCs, actually building human 
FIGURE 10.6
The left part of the figure illustrates the normal haematopoietic hierarchy, in which long-
term HSCs have self-renewal capacity, while short-term (HSCs and) MPPs have limited self-
renewal capacity. (a) The LSC is derived from an HSC. (b) LSCs exhibit immunophenotypes 
of MPPs or GMPs, supporting the concept that more differentiated cells can give rise to 
LSCs after re-acquisition of self-renewal. (c) Recent studies suggest that some AML LSC 
express low amount of lineage markers, suggesting that differentiated haematopoietic 
cells may serve as cell-of-origin for LSCs. (d) Illustration of the pre-leukemic disease phase, 
genetically unstable, in which self-renewing LSCs expand. (e) The development of different 
leukemic clones. Figure from (49).
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leukaemia using primary human HSPCs. Up to now, most of these stud-
ies suggest only partial phenotypes, but they are consistent with a model 
of stepwise progression to transformation (28, 63). Already in the 1990s, 
studies suggested that high dose IR could induce leukaemia-associated fu-
sion genes (64, 65). An important remark in light of these studies, is the 
finding that human cell are more refractory to transformation than murine 
cells (66). Furthermore, it is also likely that the BM microenvironment 
plays a critical role for pre-leukaemic HSPC initiation and leukaemia pro-
gression.
Our study (paper 3) demonstrates that CD34+ HSPCs of UCB are sensi-
tive to the mutagenic effect of radiation. These results support the strong 
epidemiological evidence on radiation-induced leukaemia and make IR a 
potential causative factor to initiate a LSC. Nevertheless, from the general 
knowledge about leukaemogenesis, it is very likely that the initiation and 
progression of leukaemia would require the combination of a number of 
causative factors (61). Furthermore, the potential radioprotective role of 
the hypoxic BM niche has to be further explored.
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Age dependence in 
radiation sensitivity
In contrast to the well-documented epidemiological evidence for the 
higher radiosensitivity of children (see chapter 1) for specific malignan-
cies, there is only limited ‘biological evidence’ available on the differences 
in cellular or tissue response to radiation exposure between children and 
adults. Radiation-induced elevations in cancer risk can be a consequence 
of corresponding DNA damage and repair. However, there is a serious lack 
on studies that examined the age dependency of radiation-induced DNA 
damage and the outcome of repair. The limited number of biomarker stud-
ies on changes in radiation sensitivity from birth to adulthood is probably 
due to the fact that such studies require blood samples from children of 
all ages, which is very problematic for ethical reasons. Therefore, UCB is 
frequently used as an alternative for blood of a newborn, since it is physi-
ologically and genetically part of the foetus, it can be considered as blood 
of a newborn (1).
One of the major findings of this PhD research, was the difference in 
cellular chromosomal sensitivity and residual DNA damage between new-
born and adult T-lymphocytes (presented in paper 3). In the following sec-
tions we will present the results of a limited number of in vitro biomarker 
and in vivo animal studies supporting the observed age-dependency. Fur-
thermore, a possible underlying mechanism for the observed difference in 
sensitivity between newborns and adult T-lymphocytes will be introduced.
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11.1
Biological evidence regarding 
age-dependent radiosensitivity
In the third paper of this PhD thesis, statistically significant differences 
were observed between newborn and adult T-lymphocytes in residual 
γ-H2AX/53BP1 foci levels and radiation-induced MN yields. At 24h af-
ter 4 Gy x-ray irradiation, 7.13 (±0.25) foci/cell were observed in new-
borns compared to 5.77 (±0.26) foci/cell in adults (p < 0.05). Furthermore, 
a high radiation-induced MN yield of 351 (±23) MN/1000 BN cells was 
observed in newborns compared to a significantly lower yield of 275 (±18) 
MN/1000 BN cells in adults (p < 0.05). Already in 1994, Floyd et al. deter-
mined the intrinsic radiosensitivity of adult and cord blood lymphocytes 
by using the MN assay (2). They analysed the radiation-induced micronu-
clei for 10 different samples of adult peripheral blood lymphocytes (ABL) 
and 5 UCB lymphocytes (CBL). Comparison of the level of MN induced 
after 2 Gy x-rays (dose rate of 2.35 Gy/min) revealed that only two CBL 
samples were more radiosensitive than the mean of the ABLs. However at 
4 Gy, four out of five CBLs were clearly more radiosensitive than the mean 
radiosensitivity of the ABLs. It is important to note that the percentage of 
micronucleated cells was scored in this study and not the more commonly 
used micronucleus frequency. When the slope of the dose-response curves 
of the 5 CBL donors were compared to the mean dose response of the 
adult group, a significant difference was observed (p < 0.02). The higher 
radiosensitivity of newborns was also reported in a study of Bakhmutsky et 
al., where the authors determined the age influence on the frequency and 
types of chromosome damage in response to IR, by irradiating peripheral 
blood samples of 20 adults (range 22 - 78 years) and 10 UCB samples with 
60-Co γ-rays (3). Peripheral blood lymphocytes from newborns showed a 
statistically significantly higher number of induced frequencies of translo-
cated chromosomes, dicentrics, acentric fragments, colour junctions and 
abnormal cells at several radiation doses when compared to adults. How-
ever, when adults were evaluated separately, no significant changes with 
age were observed. The increased sensitivity of newborns relative to adults 
was 37 (±9)%, 18 (±4)%, 12 (±2)% and 4 (±5)% based on the scoring of 
chromosomal aberrations at doses of 1, 2, 3 and 4 Gy, respectively. Even 
though age was a statistically significant factor when the baseline data were 
not subtracted, the effect of age was even stronger when induced values 
were evaluated (Figure 11.1). The lack of an age effect in response to IR ex-
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FIGURE 11.1
a. Translocated chromosomes frequency per 100 CEs (1 cell 
equivalent = 0.56 metaphase cells) by age in non-irradiated 
samples. Each point represents one subject; b. Radiation-
induced translocated chromosome frequencies per 100 CEs by 
age. The graph for 1 Gy is shown here as an example. In both 
graphs, the lines are least squares linear regressions, which are 
statistically significant (p < 0.012). Figures from (3).
Also in vivo rodent studies indicate that the rate of cancer induction 
after IR exposure decreases with age. Hattis et al. evaluated age-related 
differences in susceptibility to carcinogenesis by analysing the U.S. Envi-
ronmental Protection Agency (EPA) animal cancer bioassay data over dif-
ferent periods of life (5). The relative sensitivity for radiation-related car-
cinogenesis decreased tremendously with age. The maximum likelihood 
estimates relative to young adults (90-105 days) for radiation carcinogen-
esis per Gy in mice and rats were 3.1 in the birth-to-weaning period, 1.5 
between weaning and 60 days of age, 0.32 between 6 and 12 months of age 
and 0.36 in elderly animals (19-21 months) The data were based on obser-
posure in the adult population, was already observed by others (4). These 
results suggest that the change in sensitivity appears to occur between birth 
and adulthood, rather than gradually over the years from birth to senes-
cence. The lack of an age effect among adult humans is perhaps the result 
of the completion of growth and development. The statistically significant 
increase in all aberrations types with age observed by Bakhmutsky et al. in 
the non-irradiated samples reflects the increase of accumulated mutagenic 
burden with age (Figure 11.1 – a) (3).
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FIGURE 11.2
Influence of age at irradiation on the lifetime 
excess relative risk for mortality from solid 
tumours as investigated by Sasaki et al. (6).
vations for four radiation types: 137Cs γ-rays, x-rays, neutrons and internal 
β-rays resulting from the injection of tritiated water. The neonatal period 
is suggested to be the most sensitive period, which is consistent with our 
results of paper 3 and the findings of Bakhmutsky et al. (3). Another in vivo 
study on female mice investigated the influence of age at the time of irradi-
ation on the lifetime risk for excess mortality from solid tumours (6). Mice 
were irradiated with 1.9 Gy γ-rays at day 0, 7, 35, 105 or 365 of postnatal 
age. Again, the lifetime excess mortality from solid tumours was appar-
ently higher in mice irradiated during the neonatal to puberty period than 
in the mice irradiated in adult period, as illustrated in Figure 11.2. Sasaki 
et al. proposed already in 1991 that age-dependence of susceptibility for 
induction of specific type of neoplasms is common among animal species 
of mammals. However, it is important to mention that the developmental 
stage at the time of birth in mice is not the same as that in humans. The 
status of development of the early postnatal period in mice corresponds 
to the third trimester of gestation in humans. A next step towards apply-
ing these data for quantitative human risk assessment is to develop time/
age mapping between rodents and humans, to define what ages in human 
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development approximately correspond to the postnatal and adult stages 
in rodents. Furthermore, extensive studies are indicated to investigate the 
organ tissue dependence in radiation-induced carcinogenesis.
Similar to the increase in CA with age in the study of Bakhmutsky et 
al. (3), we observed also a statistically significant higher number of DNA 
DSBs and spontaneous MN in non-irradiated T-lymphocyte samples of 
adults compared to newborns. Moreover, similar results were obtained for 
CD34+ cells of newborns in paper 3. The accumulation of DNA damage 
with age was also examined in CD34+/CD34- stem/progenitor cells by us-
ing the γ-H2AX foci assay in a study on human aging (7). An increase of 
endogenous γ-H2AX foci levels with advancing donor age was reported, 
associated with an age-related decline in telomere length. However, com-
bined immunofluorescence and telomere in situ hybridisation could dem-
onstrate a telomere-independent origin for the majority of foci. Schuler et 
al. reported similar findings for an in vivo model by analysing molecular 
events of the DDR in hair follicle stem cells and epidermal cells of aging 
mouse (8). An increase in 53BP1 foci was observed during the natural ag-
ing process, suggesting substantial accumulation of DSBs in hair follicle 
stem cells. The 53BP1 accumulation in long-living follicle stem cells dur-
ing aging, likely represents DSBs arising from endogenously induced ROS 
damage. Oxidative DNA damage is one of the major contributors to the ac-
cumulation of DSBs in heterochromatin DNA regions and the aging pro-
cess (9). Furthermore, several other publications confirm the low number 
of spontaneous MN expression in cord blood and children’s lymphocytes, 
as observed in paper 3 (10-14). 
11.2
Differences in immunophenotypic 
profile of newborn and adult 
T-lymphocytes
The major difference between UCB T-lymphocytes and adult peripheral 
blood T-lymphocytes, is their immunophenotypic profile. The majority of 
UCB or newborn T-lymphocytes are phenotypically immature or naive, 
expressing the RA isoform of the CD45 cell surface marker. This is a likely 
consequence of poor antigenic experience during pregnancy (15). Our 
immunophenotypic study to determine the percentage of T-lymphocyte 
subsets in the UCB samples and adult PB samples by using flow cytometry 
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The human immune system maintains both naive and memory T-
lymphocytes, which can most simply be characterised by the reciprocal 
expression of the CD45RA or CD45RO isoforms (16). In general, naive 
(CD45RA+/CD45RO-) T-lymphocytes represent the most homogeneous 
pool of T cells as they lack most effector functions. After a combined pro-
cess of positive and negative selection in the thymus, immature thymocytes 
differentiate into mature T cells that exit the thymus to form the long-lived 
pool of naive T lymphocytes, recirculating within the confines of the pe-
ripheral lymphoid tissue (17). Naive T-cells are maintained by IL-7 and 
T cell receptor (TCR) signalling from contact with major histocompat-
ibility complex (MHC). The cells migrate through secondary lymphoid 
organs seeking antigens presented by dendritic cells. Once they encounter 
antigens and become activated through the TCR, naive T cells undergo 
massive expansion for several days and generate effector T cells that are 
CD45RO+ with a variety of functions, able to eliminate the pathogens (18, 
19). Most of these effector cells die within the next few weeks, but a small 
proportion of these effector cells persist as memory cells which give an ac-
celerated response upon a future encounter with the specific antigen (20). 
The latter memory T cells can be further subdivided into central memory 
TABLE 11.1
The percentage of naive and memory CD4+ and CD8+ 
T-lymphocytes determined in umbilical cord blood and 
adult peripheral blood in our study, compared to a previous 
publication of D’Arena et al. (15). Values are expressed as mean 
percentage (± standard deviation).
Subpopulation Umbilical cord blood Adult peripheral blood
Our study D’Arena (15) Our study D’arena (15)
CD4+CD45RA+ (%) 97.3 ± 2.3 87.6 ± 5.2 38.2 ± 19.0 44.8 ± 9.6
CD4+CD45RO+ (%) 2.5 ± 2 12.3 ± 5.2 58.6 ± 17.3 55.2 ± 9.6
CD8+CD45RA+ (%) 99.7 ± 0.3 93.5 ± 7.8 61.9 ± 18.6 71.5 ± 8.1
CD8+CD45RO+ (%) 0.3 ± 0.3 6.4 ± 7.8 35.6 ± 13.8 28.5 ± 8.1
are in line with the results of D’Arena et al. (15). A comparison of the mean 
values of both studies is presented in Table 11.1.
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and effector memory T-lymphocytes with distinct functions and homing 
capabilities. 
The shift in a population of predominantly naive T-lymphocytes to 
memory T-lymphocytes during aging, reflects the cumulative exposure to 
foreign pathogens over time (21). Several large population studies could 
also demonstrate that the degree of environmental antigen exposure in 
early life leads to differences in immune status in individuals (e.g. more 
frequent exposure to various infections in the African environment) (21, 
22). A comparative study of Tsegaye et al. showed a remarkable reduction 
in naive CD4+ T-lymphocytes during childhood (23). The median percent-
age values were: 97% at birth, 32.6% in children aged 5–16, and 14.2% dur-
ing adulthood. In the CD8+ T-lymphocyte compartment, the percentage 
of naive cells also significantly declined from birth to childhood but the 
decline was less pronounced compared to the change seen in the CD4+ T-
lymphocyte compartment. The percentages reported in this study are not 
directly comparable to our own flow cytometry results, since a combina-
tion of CD45RO and CD27 antigens was used to quantify the naive and 
memory subsets. Another study by Shearer et al. determined the distribu-
tion of lymphocyte subsets in a large set-up with 807 children from birth 
through 18 years of age in the United States, to serve as a suitable control 
group for the interpretation of disease conditions in children, notably pae-
diatric HIV-1 infection (24) (see Figure 11.3). 
FIGURE 11.3
Change in distribution of CD4+CD45RO+ and CD4+CD45RA+ peripheral 
blood lymphocytes percentages with age in healthy children (m = 
months; y = years). Box plots indicate data from birth through 18 years 
of age, the middle line of each box is the median, the edges are the 25th 
and 75th percentiles. The brackets represent observations closest to 1.5 
times the interquartile range away from the quartile, and the horizontal 
lines represent outlier points. Figure from (24).
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In our third paper we investigated whether the immunophenotypic dif-
ferences between T-lymphocytes of newborns and adults could explain 
the observed cellular differences in radiosensitivity by scoring residual 
DNA DSBs and MN after IR exposure. In a first pilot study, we selected 
the CD4+ subpopulation, since the shift in CD45RA+ and CD45RO+ ex-
pression is most pronounced for CD4+ lymphocytes and we determined a 
higher prevalence of CD4+ lymphocytes in both UCB (74.2 ± 5.2% of CD3+ 
cells) and adult PB (61.7 ± %6.4 of CD+3 cells) samples. 
11.3
Chromatin condensation plays a 
critical role in radiosensitivity of 
naive and memory T-lymphocytes
In paper 3 of this PhD dissertation, we were able to present for the first 
time a difference in radiation sensitivity between human CD4+CD45RA+ 
and CD4+CD45RO+ cells. A statistically significant higher number of ra-
diation-induced MN and residual γH2AX/53BP1 foci were observed in 
naive CD4+ cells after IR exposure compared to memory CD4+ cells. In 
parallel, we also scored the number of radiation-induced MN and resid-
ual DNA DSBs in purified CD4+ lymphocytes from the same donors. The 
small volume culture method as designed for the CBMN assay on HSPCs 
was used for the purified peripheral T-lymphocyte subsets. When we apply 
the percentage distribution of the CD4+ subsets determined by flow cy-
tometry on the MN and foci results we were able to estimate the expected 
value of radiation-induced MN and residual foci for the CD4+ population 
of the different donors: “estimated” CD4+ value = (CD4+CD45RA+ % * 
CD4+CD45RA+ scoring) + (CD4+CD45RO+ % * CD4+CD45RO+ scoring). 
The difference between the calculated value and the actual observed MN 
and residual foci yields was less than 10% for every donor. In order to 
confirm these findings, the same methodology was applied on naive and 
memory CD8+ cells (see Table 11.2). A paired analysis showed a statisti-
cally significant difference is radiation-induced MN between the naive and 
memory subsets of the different donors (Wilcoxon p = 0.012).
The underlying mechanisms of the observed difference in radiation 
sensitivity of human naive and memory T-lymphocyte subsets remains 
incompletely understood and future research is warranted. The observed 
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difference in radiosensitivity between naive and memory T-lymphocytes 
could be attributable to the chromatin structure of the cells. The presence 
of an open genome-wide chromatin state is a key determinant of efficient 
repair of DNA damage in T-lymphocytes and an explanation for the ob-
served differences in naive and memory T-lymphocyte radiosensitivity.
In line with our findings, studies in murine models found that naive 
T cells were more sensitive to radiation than their memory counterparts 
(25, 26). In a first study, Grayson et al. demonstrated that memory CD8+ 
T-lymphocytes are more resistant to apoptosis than their naive counter-
TABLE 11.2
Radiation-induced number of MN per 1000 BN cells 
CD4+ and CD8+ subpopulations after 2 Gy x-ray 
irradiation. Based on the percentage distribution 
determined by flow cytometry, an estimate of the 
expected radiation-induced MN yield was made 
(indicated in gray).
 Subpopulations
  
CD4+
CD45RO+
CD4+
CD45RA+ CD4
+ CD8+
CD45RO+
CD8+
CD45RA+ CD8
+
Donor 1
RI MN/1000 BN 213 346 259 274 379 360
Flow cytometry 48.2% 51.3% 21.0% 79.0%
“Estimated value” 280 357
Donor 2
RI MN/1000 BN 229 335 263 214 271 225
Flow cytometry 75.8% 25.2% 35.0% 65.0%
“Estimated value” 258 251
Donor 3
RI MN/1000 BN 322 395 334 392 412 393
Flow cytometry 66.7% 35.6% 22.0% 79.0%
“Estimated value” 355 412
Donor 4
RI MN/1000 BN 259 334 312 309 361 337
Flow cytometry 66.8% 36.4% 28.0% 70.0%
“Estimated value” 295 339
Group 
Mean
RI MN/1000 BN 256 353 292 297 356 329
Flow cytometry 64.4% 37.1% 26.5% 73.3%
“Estimated value” 296 339
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parts after whole body irradiation of mice (25). Both naive and memory 
CD8+ T cells decreased in number, but the reduction in the number of 
naive cells was 8-fold larger than that in memory CD8+ T cells. Previously, 
the same research group already documented that Ag-specific memory 
CD8+ T-lymphocytes contain increased levels of Bcl-2 compared with ei-
ther naive or effector CD8+ cells (27). These results are in agreement with 
a former in vitro study of our research group, which showed that memory 
(CD45RA-) T-lymphocytes were more prone to Annexine V apoptosis 
than naive (CD45RA+) cells 24h after 2 Gy 60Co γ-rays (28). Since apopto-
sis has a critical role during development and regulation of homeostasis in 
the immune system, most of the immunological studies on T-lymphocyte 
subset radiosensitivity use apoptosis as an endpoint to evaluate radiation 
sensitivity. 
Dispirito et al. described that memory T-lymphocytes rapidly express 
effector functions, a hallmark feature that allows them to provide protec-
tive immunity (29). Several previous studies suggested that genes involved 
in this rapid recall may maintain an open chromatin structure in resting 
memory T-lymphocytes via epigenetic modifications (30, 31). Dispirito et 
al. developed a novel flow cytometric assay, to detect diacetylated histone 
H3 (diAcH3), a marker of open chromatin. The authors measured histone 
modification on a per-cell basis in murine T-lymphocytes in combination 
with lineage-specific markers. The results showed that murine memory 
CD8+ T-lymphocytes have approximately 2 times more diAcH3 than their 
naive counterparts. Since diAcH3 is a mark of open loci (accessible to the 
transcriptional machinery), the elevated level in memory CD8+ T cells 
may represent their ability to rapidly and robustly accumulate cytokine 
and chemokine transcripts to ensure their protective capacity. However, 
heterochromatic DSB repair also depends on chromatin relaxation, and 
closed chromatin formations impair DSB repair (32, 33). Relaxation of 
the chromatin might facilitate genomic surveillance by enabling faster ac-
cess of DDR factors to the DSB sites. The activation of the DDR (by phos-
phorylation of H2AX) was evaluated in human MCF7 cells by Murga et 
al. in control cells and cells treated with the histone deacetylase (HDAC) 
inhibitor Trichostatin A (TSA) to investigate the influence of decondensed 
chromatin on DDR dynamics at DSB sites (33). The treatment with TSA 
led to a more robust phosphorylation of H2AX (and Chk1) in response to 
IR. Furthermore, Falk et al. demonstrated that TSA treatment of human 
skin fibroblasts slowed down the efficiency of DSB repair post-irradiation 
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(34). In the last years, several small modulators of the chromatin structure 
known as inhibitors of HDAC have been identified and tested, such as val-
proate, TSA and vorinostate. On the other hand there are also compounds 
that modulate chromatin compaction in the opposite direction by decreas-
ing the accessibility of the DNA, such as resveratrol (35). 
We can consider that more open and accessible chromatin should fa-
cilitate DNA repair. Rawlings et al. demonstrated that during thymocyte 
development, a condensation of the chromatin occurs which is required 
for proper T cell development and maintenance of the quiescent state (36). 
This mechanism ensures that cytokine driven proliferation can only occur 
when quiescent naive T cells encounter their TCR-specific antigen. Rawl-
ings et al. demonstrated that TCR activation results in a decondensation 
of the chromatin in naive T lymphocytes, which permits the engagement 
of Stat5, an essential component for proliferation. Finally, Pugh et al. in-
vestigated T-lymphocyte subset radiosensitivity in mice and highlighted 
also the critical role of an open chromatin state on radiosensitivity (26). It 
should be noted that the authors examine also the difference in radiosen-
sitivity between effector memory (EM) and central memory (CM) T cell 
subsets in this paper. However, this comparison is beyond the scope of 
this PhD dissertation. Survival trends between T cell subsets were tested in 
vivo in mice 72h after exposure to 1, 2 and 4 Gy. In agreement with previ-
ously mentioned studies, memory T cells were more resistant and naive T 
cells more sensitive following in vivo irradiation. Maximal upregulation of 
γ-H2AX following irradiation over time was the highest in naive T cells, 
which correlates with the observed survival trends in radiosensitivity. By 
incubating irradiated cells with or without valproic acid (VPA), an HDAC 
inhibitor that opens chromatin, for 12 and 72h, the authors could prove 
that naive T-lymphocyte survival improved, whereas memory T-lympho-
cyte survival remained unchanged. 
The relationship between DNA repair and apoptosis is a complex pro-
cess, which makes it difficult to project the apoptosis results obtained in 
the murine studies on our results of in vitro radiosensitivity differences 
within human T-lymphocytes subsets. However, the murine studies illus-
trate clearly that the chromatin state has a major influence on radiosensi-
tivity. Further research is needed to determine the differences in chroma-
tin state of the human T-lymphocyte subsets and the possible link with 
the higher number of residual DNA DSBs scored after 24h and radiation-
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induced mutagenic effects observed in naive compared to memory human 
T-lymphocytes.
Besides the murine studies on the influence of the chromatin compac-
tion on the radiosensitivity of naive and memory T-lymphocytes, it was 
already clear from earlier studies that the compaction/dispersion status of 
DNA throughout the cell cycle appears to be an important factor for de-
termining intrinsic cell radiosensitivity (37). The influence of chromatin 
structure on the susceptibility of DNA damage, and the efficiency of DNA 
repair in human lymphocytes is also reflected in the different yields of 
chromosomal aberrations observed in the different stages of the cell cycle 
(38). The latter is well established and proven by studies with synchronized 
mammalian cells, which were clearly more sensitive to IR during the G2/M 
phase of the cell cycle when their chromatin is highly condensed (39-41). 
These findings, together our results (in paper 3) of the difference in radi-
ation-induced mutagenic effects and residual DNA DSBs in human naive 
and memory T-lymphocytes, indicate that radiation sensitivity is strongly 
influenced by the chromatin structure. Further research is needed to inves-
tigate if chromatin condensation can be considered as a general phenom-
enon related to explain the observed age dependency of radiation effects.
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Final Conclusions
In this PhD dissertation, we investigated the health effects of CT x-rays in 
children by using biomarkers of exposure. A first purpose was the in vivo 
assessment of the direct DNA damage induced by CT x-ray exposure in 
children using the γ-H2AX foci assay. In order to start this in vivo bio-
marker study on a vulnerable population of paediatric patients in a multi-
centre setting, we had to optimise successfully the sensitive γ-H2AX foci 
assay while taking into account a number of logistic and ethical constraints 
related to paediatric patients and a multicentre set-up. The in vitro experi-
ments comprised two low dose intercomparison studies within the EU FP7 
project EPI-CT and demonstrated that it is feasible to apply the γ-H2AX 
foci assay as a potential cellular biomarker of exposure in a large scale mul-
ticentre prospective study of the effects of paediatric CT imaging.
The in vivo paediatric patient study in Belgium of patients undergoing 
a chest or abdomen CT shows that even at low doses, CT x-rays induce 
a small, but significant number of DNA DSBs in children’s lymphocytes. 
The observed low dose hypersensitivity challenges the LNT hypothesis 
and may indicate the presence of a bystander effect. The steep increase in 
the low dose range was confirmed by an in vitro dose response study on 
umbilical cord blood. However, our study also demonstrated that the use 
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of optimised paediatric CT protocols and CT dose reduction techniques 
results in less DNA damage for the patient. Furthermore, the data of the 
paediatric CT study indicate an intrinsic radiosensitivity decreasing with 
age, but regression analysis was not statistically significant. These conclu-
sions should encourage medical practitioners to minimize radiation doses 
in paediatric radiology and to apply the “Image Gently” philosophy. Al-
though our results suggest that the widely accepted LNT model may un-
derestimate low dose radiation risks, we have to put the estimated risks in 
perspective. First of all, one should be aware of the large uncertainties on 
current low dose risk estimations and not forget that the calculated risks 
are small compared to the overall cancer incidence. 
The age dependency of the health effects of CT x-rays was further in-
vestigated in a comparative in vitro study of lymphocytes of cord blood 
and adult volunteers. In this study we used the γ-H2AX/53BP1 foci assay 
in T-lymphocytes to assess the number of DNA DSBs induced by x-rays 
and the residual number of DSBs 24h post-irradiation, which is represent-
ative for DNA damage repair. Furthermore the CBMN assay was used to 
assess the mutagenic effects induced by x-rays. We could demonstrate that 
the T-lymphocytes of newborns were more sensitive to IR compared to 
adults for the residual DNA damage and the mutagenic effects. The main 
difference between newborn and adult T-lymphocytes in these in vitro ex-
periments, was their immunophenotypic profile. This brings us to one of 
the major findings of this PhD dissertation, which is the observed higher 
radiation sensitivity of the phenotypically immature naive T-lymphocytes 
compared to memory T-lymphocytes. For these studies the radiosensitiv-
ity of isolated subpopulations of lymphocytes was investigated. A possible 
underlying mechanism of this difference in sensitivity is the more con-
dense chromatin structure of naive T-lymphocytes.
Since radiation-induced leukaemia is an endpoint of great concern at 
young ages, we investigated the radiosensitivity of HSPCs (CD34+ cells) of 
newborns, defined as target cells for radiation-induced leukaemogenesis. 
In this study we used the same biomarkers of x-ray effects as in the com-
parative study of lymphocytes of newborns and adults. The low number 
of residual DNA DSBs in CD34+ cells suggest fast error prone DNA repair 
and the CBMN results confirm that the quiescence of HSPCs promotes 
mutagenesis after IR exposure, which may trigger leukaemia development.
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Future Perspectives
Currently, we are forced to rely on the LNT hypothesis for the extrapola-
tion of radiation risks to low doses (< 20 mGy). The growing number of 
epidemiological studies on radiation-induced cancer following CT scans 
in childhood (1-5) and the large scale EU-FP7 funded epidemiologic EPI-
CT project will provide great potential to substantiate the epidemiologi-
cal evidence for radiation effects at low doses as used in paediatric radiol-
ogy in children. Furthermore, it is anticipated that significant insights will 
emerge from the integration of epidemiological and biological research, 
made possible by molecular epidemiology studies incorporating biomark-
ers and bioassays (6). After the in vitro feasibility studies, low dose inter-
comparison studies and the Belgian in vivo paediatric CT study, presented 
in this PhD dissertation, the next step would be an international European 
multicentre CT study in which the γ-H2AX foci assay is used as a mo-
lecular epidemiology biomarker in a large scale paediatric patient popula-
tion. Besides patients undergoing a CT chest or CT abdomen scan, also 
head CT scans should be included as an extension of the study performed 
in Belgium, since this is the most frequently performed CT procedure in 
children. Due to the ethical constraints regarding the collection of blood 
samples from children, it would be interesting to develop a non-invasive 
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method to assess direct low-dose effects in children. Detection of γ-H2AX 
foci can be done with non-invasive methods as collecting exfoliated buccal 
cells, to assess DNA damage in buccal mucosa after CT head in children 
(7, 8). In this framework, pilot studies are warranted to test the low dose 
sensitivity of the γ-H2AX foci assay on buccal cells. 
The low dose hypersensitivity observed in the paediatric CT study can 
be attributed to the bystander effect. This implies that in the low dose range 
a tissue radiation response is observed rather than a cellular DNA damage 
response. The bystander phenomenon is subject to active debate in the 
scientific community (9). However at present, there is evidence that at least 
two independent and probably non-exclusive mechanisms of communica-
tion are involved in bystander effects, namely gap junction-mediated com-
munication (GJIC) and secreted soluble factor dependent signalling (10). 
Further studies on the underlying non-targeted effects of the hypersensi-
tive response induced by low-doses of x-rays could imply the inhibition of 
GJIC by using carbenoxolone (CBX), a widely used gap-junction inhibi-
tor (11). However, this PhD research was focused on peripheral blood T-
lymphocytes and in these suspension cultures, direct intercellular interac-
tion between irradiated and bystander cells is less obvious. In this way, it 
seems more appropriate that soluble factors released from irradiated cells 
into the culture medium would initiate the bystander response. The influ-
ence of soluble factors can be studied by performing medium-transfer ex-
periments. The medium harvested from irradiated T-lymphocyte cultures 
could be transferred to recipient bystander cells cultured in separate plates. 
Furthermore, it is also possible to co-culture irradiated and non-irradiat-
ed T-lymphocytes, by mixing cultures in which one population of cells is 
labelled with a cytoplasmic dye cell tracker (CellTracker™ Red CMTPX, 
Life Technologies) in order to score the bystander-induced γ-H2AX foci 
in non-irradiated cells. The role of free radicals in the bystander response 
such as reactive oxygen species (ROS) released into the cell-culture medi-
um has been shown by applying antioxidants such as superoxide dismutase 
or inhibitors of superoxide and NO generators. Zhou et al. showed that the 
COX-2-related pathway, which is essential in mediating cellular inflam-
matory response, is a critical signalling link for the bystander phenom-
enon (11). Treatment of bystander cells with a COX-2 inhibitor (NS-398) 
could reduce the bystander effect. Another approach is the use of radia-
tion microbeams that can be delivered in a highly temporal and spatially 
constrained manner. The combination of microbeams with multiphoton 
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fluorescence microscopy, which allows to study living tissue samples in 3D, 
could be used to map post-irradiation cellular dynamics (13). 
For the evaluation of the radiation sensitivity of haematopoietic stem 
cells, we used a heterogeneous population of CD34+ cells. In a next phase 
of this research, the radiation sensitivity of the different primitive and 
more lineage-committed subsets should be investigated. As described in 
the discussion of this PhD dissertation, caution is urged when data on the 
radiosensitivity of HSPCs in mice are extrapolated to humans. However, 
more evidence is needed to elucidate the differences in radiation sensitiv-
ity of HSPCs in mice and human (14, 15). The latter is of utmost impor-
tance in studies on the radioprotective characteristics of the bone marrow 
niche, since in vivo murine models are required to study this phenomenon. 
Based on the observed difference in radiosensitivity between newborn 
and adult T-lymphocytes and the link with the immunophenotypic profile 
of the cells, it would be appropriate to study the chromatin state of naive and 
memory T-cell subsets. Epigenetic hallmarks of silenced heterochromatic 
DNA include histone 3 lysine 9 and lysine 27 trimethylation (H3K9me3, 
H3K27me3), and histone 4 lysine 20 di-/trimethylation (H4K12me2/3). 
Histone modifications specific for active euchromatin are acetylation of 
histone 3 lysine 9 (H3K9ac), histone 4 lysine 16 (H4K16ac) and methyla-
tion of histone 3 at lysine 4 (H3K4me) (an overview can be found in (16)). 
Schuler et al. have established a transmission electron microscopy (TEM) 
method to detect gold-labelled repair components in different chromatin 
environments (17). The ultra-high resolution of TEM allows to detect core 
components of the DNA repair machinery (e.g. ATM, γ-H2AX…) at the 
single-molecule level and visualizes their molecular interactions with spe-
cific histone modifications for hetero- or euchromatic DNA. Another ap-
proach to determine the differences in chromatin state between human 
CD45RA+ and CD45RO+ T-lymphocyte subsets, is the use of flow cytom-
etry to measure histone modification (e.g. diAcH3 as a marker of open 
chromatin) in combination with lineage-specific cell surface markers (18). 
In a last step, it is also possible to study the influence of the condensed 
chromatin structure of naive CD45RA+ CD4+ and CD8+ T-lymphocytes 
on their radiation sensitivity by using inhibitors of chromatin compaction 
(19). In our set-up, the incubation of naive T cells with a HDAC inhibitor 
such as TSA (20), should reduce the number of residual DNA DSBs in 
naive T-lymphocytes to the level observed for memory T-lymphocytes. In 
previous studies, it was already demonstrated that the compaction/disper-
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sion status of DNA throughout the cell cycle appeared to be an important 
factor for determining intrinsic cell radiosensitivity (21). Studies with syn-
chronized cells have shown that mammalian cells are most sensitive to IR 
at mitosis, the time at which their chromatin is maximally condensed (22, 
23). This scientific literature together with the results obtained in present 
PhD thesis indicate that the radiation sensitivity is strongly influenced by 
the chromatin structure. Further research is needed to investigate if chro-
matin condensation can be interpreted as a general phenomenon to ex-
plain the observed age dependency in radiation effects.
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